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StMCVRY
The rat adapted strain of B^_ divergens was used as a model 
to investigate the mechanisms of immunity to this parasite. The 
course of infection as well as the haematological changes that 
accompanied the infection were followed in splenectomised rats.
The course of infection in splenectomised rats was short 
lasting (5-6 days) and no recrudescences were observed after the 
primary patent parasitaemia. The animals either died from the 
infection or recovered and were immune to challenge. The i.v.
O
injection of 1.5 x 10 PRBC into splenectomised rats resulted in 
an infection from which most rats recover. The parasite, 
however, became more virulent with increasing passages and the 
injection of 1.5 x 10® PRBC resulted in a fatal disease. The drug 
diampron was used for treating infected rats. A single 
subcutaneous injection of diampron was enough to cure the 
animals.
The acute parasitaemia was accompanied by severe anaemia 
evident as a drop in red blood cell counts. Red cell counts 
started returning to normal 8-10 days after recovery. Recovery 
from the infection was immediately followed by a pronounced blood 
leukocytosis which was predominately a lymphocytosis. The 
possibility that lymphocytes might be accumulating in the livers 
of immune rats was investigated. Histological studies showed the 
appearance of accumulation of cells around the central veins in 
the livers of immune splenectomised rats. These accumulations of 
cells have the appearance of "pseudofollicles" as described by 
Weiss (1985) in splenectomised gerbils infected with P. berghei.
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Preliminary histological studies have showed that some of these 
cells were B and T lymphocytes which might be important for the 
development and mediation of protective immunity in 
splenectomised rats.
In splenectomised immune rats, the possible removal of 
B. divergens PRBC by the liver was investigated using Cr~^ 
labelled PRBC. It is suggested that either the parasites within 
the red cells were opsonised and then removed by the liver where 
they were phagocytosed, or the merozoites may have been destroyed 
by antibody as they emerged from erythrocytes and the damaged red 
cells were removed by the liver.
Irradiated parasites were injected into immune rats to 
determine whether it was intact PRBC or free merozoites which are 
cleared by the immune rats. It was concluded that immune 
splenectomised rats were able to clear PRBC from the blood stream 
and that immunity was not necessarily against merozoites. The 
effector mechanisms which were responsible for the destruction or 
removal of PRBC are unknown.
The possible participation of humoral factors in acquired 
immunity to B^ divergens was investigated. Antibodies to 
B. divergens were detected by the IFA test in sera collected 
during the infection and at different times after recovery. The 
antibody titre as measured by this test, rose from day 5 and 
reached a peak on day 19 at which level it remained for at least 
seven weeks. The possible role of antibody in protection was 
investigated iui vivo by passive transfer with immune and 
hyperimmune serum. The levels of serum protection with immune
xiii
sera rose rapidly from day 6 to reach a peak between day 7 and 13 
and thereafter the levels declined rapidly. It was not possible 
to correlate protection with antibody levels measured by IFAT 
indicating that some antibodies to Ik_ divergens were not 
protective. The role of antibody in protection was confirmed 
after fractionating immune and hyperimmune sera. The protective 
activity of sera collected immediately after recovery (day 7) was 
mainly due to IgM antibodies. The protective activity of sera 
collected 3-4 days after recovery (day 10) and of hyperimmune 
serum was mainly due to IgG antibodies. In hyperimmune sera, IgM 
antibodies were, however, partially protective.
In order to compare the protective activity of immune sera 
in vivo with its effect on parasite growth in vitro, a method for 
cultivation of divergens was established. divergens was 
cultured continuously for six months in rat erythrocytes using 
the candle jar technique. Parasites were cultured in rat 
erythrocytes in RPMI medium containing 20% FCS. Parasitaemias 
exceeding 35% have been observed in cultures which were initiated 
with 2% infected red cells. After five weeks in culture, some 
cultures were used to infect a splenectomised rat. The rat 
developed a high parasitaemia and died five days post infection, 
indicating that the parasite was still virulent after five weeks 
of culture.
Cultures with high parasitaemia contained a large number of 
free merozoites which were collected and either used to initiate 
new cultures or used for the merozoite neutralisation test, or 
they were stored in liquid nitrogen or at -70°C for future use.
Some aspects of the mechanisms of action of antibody were tested 
in vitro. The possible role of opsonizing antibody in protection 
was investigated using hyperimmune serum and divergens PRBC or 
free parasites in the presence of peritoneal macrophages. No 
evidence was found for a role for opsonising antibody in 
protection in vitro.
The protective activity of immune serum in vivo was compared 
with its effect on parasite growth in vitro. Rat immune and 
normal serum inhibited parasite growth to a similar extent when 
tested in vitro, as did the immunoglobulin fractions of both 
sera. In passive transfer tests in vivo, protective activity was 
observed only in the unfractionated and the immunoglobulin 
fraction of immune serum. These results have indicated that 
normal serum was toxic to cultures. With immune serum, there was 
no evidence that antibody agglutinates merozoites and prevents 
their invasion in vitro. Evidence that antibody neutralises 
merozoites and prevents their invasion was, however, demonstrated 
only by preincubating free merozoites with immune serum, before 
adding them to cultures containing normal rat erythrocytes. The 
possibility that antibodies might only be protective in the 
presence of cellular elements was investigated in an ADCC assay 
using immune spleen cells and immune peripheral blood mononuclear 
cells. The results did not demonstrate specific ADCC killing by 
immune spleen cells or peripheral blood mononuclear cells. It is 
suggested that other immune mechanisms are involved in the 
destruction of parasites or PRBC. This might involve a non
specific type of immunity mediated by soluble factors secreted by 
activated T cells or macrophages or the release of toxic oxygen 
mechanisms which would lead to the death of the parasite within 
the erythrocytes and might therefore be important in divergens 
infection. It is also possible that effector cells can recognise 
PRBC in the peripheral circulation. The possible participation 
of NK cells is considered.
New isolates of divergens have also been adapted to long 
term culture. Two bovine field isolates which had been passaged 
into gerbils and then cryopreserved as stabilates were used. On 
recovery from cryopreservation, the isolates were subpassaged 
through two gerbils each and then either put directly into 
culture with gerbil or rat erythrocytes or subpassaged through a 
splenectomised rat for one day before going into culture without 
any additional red cells. No growth was observed in cultures 
initiated with parasitised gerbil blood in normal rat 
erythrocytes or those initiated with parasitised gerbil 
erythrocytes in normal gerbil erythrocytes. Cultures initiated 
with parasites in rat erythrocytes grew and the parasite was 
maintained continuously over a period of 75 days through 32 
cultures. After five weeks of culture, some cultures were used 
to infect splenectomised rats successfully, while the same 
isolates that were injected directly from gerbils to 
splenectomised rats did not grow.
Some of the rat adapted cultures were initiated with human 
erythrocytes and the effect of diluting infected rat erythrocytes
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with normal human erythrocytes was followed. The parasite was 
maintained for two weeks in culture and three subcultures with 
normal human erythrocytes. The cultures were, however, 
discontinued after this period, as the increase in the number of 
human erythrocytes in each subculture did not apparently support 
parasite growth and it was concluded that gerbil and human 
erythrocytes are not suitable for the growth of B. divergens in 
culture using RPMI and FCS.
These results are discussed in Chapter Nine.
B. divergens in splenectomised rats provides a useful model 
for investigating this parasite. Apart from the inconvenience of 
carrying out splenectomy, rats have advantages in that they are 
easy to handle, provide relatively large volumes of infected 
blood for immunological studies and for culturing the parasite 
when compared with gerbils, another laboratory host for 
B. divergens (Lewis and Williams, 1979). In addition, inbred 
rats are : inexpensive and available, which would permit studies 
such as adoptive transfer to be carried out, not possible with 
cattle, the natural host of B. divergens, since cattle are 
expensive animals and therefore cannot be used in large numbers 
for experimental studies. Studies such as those carried out on 
the gerbil model for the screening of babesicides (Gray, 1983) 
can be carried out in the rat, which could provide important 
information relevant to the treatment of infection in humans, 
another abnormal host.
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CHAPTER GNE
GENERAL IOTRODUCnCN
1
Chapter One 
General Introduction
Babesia species are tick transmitted protozoan parasites 
which are found throughout the world and cause disease in wild 
and domestic mammals. Some of the species infect cattle 
(B. bovis, bigemina, B. divergens and B^ major)/ sheep 
(B. foliata, B. motasi, B. ovis), horse (B. caballi, B. equi) 
goat (B^ motasi, B. ovis, B.taylori), pig (B. perroncitoi, 
B. trautmanni), dog (B^  canis, B. gibsoni, B. vogeli) and cat 
(B. felis). Some of these species are found in wild animals, 
such as B. canis in jackals, B. equi in zebra and B. divergens in 
reindeer (reviewed by Purnell, 1981), and some can also infect 
man and laboratory animals (reviewed by Callow and Dalgliesh, 
1982).
Babesia was first described in Rumania in blood of sheep and 
cattle (Babes, 1888 - quoted by McCosker, 1981). In 1893, Smith 
and Kilbourne (quoted by McCosker, 1981) were the first to 
identify the tick transmission of and the symptoms cause by 
B. bigemina, which causes red water fever in cattle. This was 
the first demonstration of an arthropod transmitting a protozoan 
parasite. Since then, more than 71 different species of Babesia 
have been identified in both domestic and wild animals (Levine, 
1971). Bovine babesiosis is economically the most important 
disease caused by Babesia. It has been reported that there are 
approximately 1.2 x 10^  cattle in the world and the majority of 
these are potentially exposed to one or more Babesia species 
(McCosker, 1981).
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The infective agent of Babesia (the piroplasm) multiplies 
within the mammalian erythrocytes. In the red cells, the 
parasites appear as single, oval, amoeboid, round or elongate or 
as pyriform bodies arranged in pairs. The size of Babesia varies 
depending on the species, but they are normally classified as 
"small" and "large" babesias.
Four species of Babesia infect cattle. B. bovis is a small 
babesia and is distributed all over the world. It is found in 
Africa, Asia, Europe, Central and South America, and in Australia 
where it is considered to be a major pathogen and is transmitted 
by Boophilus microplus. B. bigemina is a large babesia which in 
Australia is also transmitted by Boophilus microplus. It is 
found over the same geographical regions as B^ bovis, although it 
is not highly pathogenic in Australia. It was the babesia that 
caused Texas fever in the United States and some reports have 
indicated its prevalence in the southern U.S.S.R.
B. divergens is a small babesia (1.5 x 0.4 urn) which is 
morphologically similar to bovis. It is the babesia of most 
importance in Western and Central Europe. It is transmitted by 
the tick Ixodes ricinus and causes significant mortality in 
cattle in these areas (Barnett, 1974). B. major is a large 
babesia which is transmitted by the tick Haemaphysalis punctata. 
It is found in Europe and in the Middle East, and it is less 
pathogenic than any other bovine species.
Whitlock (1949) has described two states of infection in the 
vertebrate host, defined as "babesiosis" and "babesiasis". 
"Babesiosis" refers to the period where there is rapid
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multiplication of the parasite, which is accompanied by clinical 
signs of the disease. At this stage, the host either dies or 
recovers from the disease. "Babesiasis" refers to the 
subclinical infection observed in young, passively immune animals 
and also those recovered from the infection. The parasites 
remain in the blood but their number is insufficient to cause 
illness.
The clinical symptoms of the disease are variable depending 
on the host and species of Babesia, but are generally 
characterised by fever, haemolytic anaemia caused by the 
destruction of erythrocytes as parasites multiply, 
haemoglobinuria (red water), followed by jaundice. Other signs 
may include blood stained faeces, signs of nervous disturbances, 
such as muscle weakness, grinding of the teeth and sunken eyes as 
a result of dehydration. The rectal temperature normally rises 
as the parasitaemia increases. Mahoney (1972), has also reported 
damage of the internal organs such as the liver and the kidney as 
a result of the infection in IL_ bovis. In B^ bovis infection, 
signs of cerebral damage also appear. This cerebral damage is 
caused by the clumping and adherence of parasitised erythrocytes 
in brain capillaries causing blockage which is followed by coma 
and finally death of the animal. Babesia, however, may cause no 
significant disease in some hosts (Mahoney, 1977; Ristic and 
Lewis, 1977).
IJJE  CTCLE
Babesia parasites are transmitted by hard ticks belonging to
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the family Ixodidae. Although the life cycles of most Babesia 
species are not known or have not been studied in detail, the 
life cycles of the most economically important species (B^  bovis 
and B^ bigemina) have been intensively investigated by Riek 
(1964), who described the invertebrate phase of the life cycle of 
both species by following their transovarial development in the 
one host tick B^_ microplus. Similar findings were reported by 
Holbrook et al., 1 968 for _B^  caballi in the tick
Dermacentor nitens and by Friedhoff (1969) for B. ovis in the 
tick Rhipicephalus bursa. Joyner et al. (1 963) have described 
the development of B^ divergens in the tick I^_ ricinus, but no 
detailed pattern of development in the tick organs has yet been 
reported. Riek (1968), suggested that sexual reproduction in 
B. bigemina takes place in the tick in the first* 24 hours after 
ingestion, but this has not been confirmed. Recent observations, 
however, on the erythrocytic stages of B^ canis and B^_ equi in 
culture (reviewed by Mehlhom and Schein, 1984) and on B. microti 
in Ixodes tick guts (Rudzinska et al., 1983), have thrown some 
light on sexual stages.
The terminology of the life cycle of Babesia is confused. 
Friedhoff (1981), proposed a hypothetical life cycle for Babesia 
in which he introduced new descriptive terms. These are 
currently used for the description of the known life cycles of 
Babesia species (Mehlhom and Schein, 1984; Young and Morzaria, 
1986). The new terms will be used for the following description 
of the life cycle of bigemina in the tick B^ microplus, and in 
the vertebrate host (see Figure 1 - after Riek, 1964).
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Figure 1: 
The Life Cycle of Babesia bigemina in the Bovine and 
the One Host Tick Boophilus microplus, (after Riek, 1964)
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In the tick
It is believed that when female Boophilus ticks feed on an 
infected vertebrate, most of the babesia parasites in the bovine 
erythrocytes die within the tick gut, but some become ray bodies, 
believed to be gametes (Riek, 1964). These gametes fuse to form 
motile kinetes (vermicules) which are then detectable in the 
haemolymph 3-5 days after repletion. Further multiplication and 
production of more kinetes occurs in the haemocytes, malpighian 
tubules, ovaries and muscle. After oviposition by the tick, the 
kinetes multiply in the ova and the daughter cells invade the gut 
epithelium of the developing larva, where more kinetes are 
produced. The final cycle takes place in the salivary gland of 
the nymph, in which infective sporozoites are produced and 
released in the salivary duct during feeding. These sporozoites 
infect the vertebrate host.
Most Babesia species are transmitted transovarially from 
infected female ticks to their progeny. microti which is 
transmitted by the tick dammini and B^ equi which is 
transmitted by ticks of the genera Dermacentor, Hyalomma and 
Rhipicephalus are the only species to be transmitted 
transtadially like Theileria species. In transovarial 
transmission, the primary infection takes place only in the adult 
stage, and is then transmitted by larvae, nymphs, and adults of 
the following generations. For many Babesia species, vertical 
transmission is common. The tick can remain infective for 
several generations and the vertebrate host is not essential for 
maintaining the parasite in the tick population. Holbrook 
et al., 1968, working on B. caballi, reported that kinetes
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(vermicules), observed in the ovaries of immature adults, will 
infect the next generation of ticks. Donnelly and Pierce (1975), 
reported that divergens sometimes persisted into the second 
generation of ricinus when ticks were maintained on a host not 
susceptible to Babesia.
Transmission occurs at different times in the parasitic life 
of the one host tick. For example, transmission occurs from 
larvae in B^  bovis and from nymphs in bigemina and B^ caballi 
(Riek, 1 964; 1 966; Holbrook, 1968). In the two host tick as in 
B. ovis, infection occurs only through adult stages of the tick 
and transmission happens through the subsequent nymphs or adults. 
B. divergens have a three host tick as vector. Here infections 
can only be initiated in the adult stage of the ricinus tick, 
subsequently larvae, nymphs and adults are all infective, but the 
larvae and nymphs of the first generation cannot acquire the 
infection (Donnelly and Pierce, 1975). When adult female ticks 
feed on infected vertebrate hosts, they are able to transmit the 
infection to other hosts. Lewis and Young (1980) found that 
adult ticks which were fed on calves infected with a human strain 
of B^ divergens were able to transmit the parasite to other 
splenectomised calves and to Meriones unguiculatus gerbils. 
Other babesias which have a three host tick as vector are 
B. canis and B^ major, which are transmitted by IL_ sanguineus and 
H. punctata respectively.
Erythrocytic parasites are believed to be the main source of 
infection for ticks. Infectivity for ticks may, however, be lost 
as a result of continuous blood passaging of the parasite as was
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demonstrated by Stewart (1978) for B. bovis.
In the vertebrate
During tick feeding, the sporozoites are inoculated into the 
vertebrate host, where they attach and penetrate the erythrocytes 
(Hoyte, 1961). The mechanisms of entry of sporozoites into 
erythrocytes are not known. The development of most Babesia 
species in the vertebrate hosts occurs in the erythrocytes 
(Friedhoff, 1 981). B^_ microti and B^ equi are the only species
in which sporozoites invade the lymphocytes of their hosts 
(reviewed by Mehlhom and Schein, 1984). The sporozoites within 
the erythrocytes then become trophozoites, which undergo asexual 
division (merogony) to form merozoites. In most Babesia species, 
two merozoites are produced, while microti and B^ equi produce 
four to form what is called a "Maltese cross". The merozoites 
are covered by a pellicle consisting of three membranes. They 
have an apical and a posterior polar ring, micronemes, rhoptries 
and sub-pellicular microtubules. Only equi merozoites possess 
a micropore, which is a typical feature of malaria parasites. 
Some Babesia species (e.g. B^_ bovis, B. bigemina, B. caballi), 
have, in addition, the so-called spheroid bodies near the 
nucleus. The function of these is not known.
The merozoites then escape the erythrocytes, after 
destroying them to invade more red blood cells. This asexual 
division continues until the host either dies or recovers from 
the infection. The invasion of erythrocytes by merozoites was 
well studied in some Babesia species (Mehlhom and Schein, 1984; 
Rudzinska, 1981). Some reports have indicated the role of
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complement in the invasion of erythrocytes by merozoites (Jack 
and Ward, 1980). Some of the parasites inside the erythrocytes 
do not divide but acquire unusual shapes. These are considered 
to be gametocytes which are transformed to what are called 
gamonts in either the erythrocytes as in B. canis (iMehlhorn 
et al., 1980) or in the gut lumen of the tick as in IL_ microti 
(Rudzinska et al., 1979).
BM3NTIY TO Babesia
Both non specific and specific immune mechanisms are 
involved in the host's resistance to Babesia infection. Non 
specific immune mechanisms are normally possessed by all animals, 
while specific mechanisms are acquired as a result of an active 
infection, immunisation, or passive transfer of protective 
elements from an immune donor. These specific immune mechanisms 
are directed against the parasite or its products.
Non specific imrane mechanisns
a. Host specificity
The various Babesia species were assumed to be restricted to 
the host in which they were discovered (Levine, 1971). The 
detection of Babesia in man, however, and the search for suitable 
laboratory models for research studies, stimulated a new interest 
in experiments examining the host specificity of these parasites. 
Some domestic and laboratory animals were not susceptible to 
infection with species of Babesia other than their own natural 
parasites, for example B. caballi and B. equi (Crowe and Pullen, 
1968; Frerichs et al., 1969) > will only infect horses and donkeys 
and the two parasites, B. bigemina and B. bovis will only infect
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bovines, although Callow (1965) has reported that B. bigemina 
would infect sheep and horse, and Enigk and Friedhoff (1963) have 
suggested that the same parasite would also infect splenectomised 
gazelle, but these reports were not confirmed. hylomysci 
which was isolated from an African tree rat (Hylomyscus), was 
adapted to laboratory mice and also produced infections in a 
squirrel and a splenectomised rhesus monkey (Bafortet al.1970)* In 
mice the infection was virulent after several passages (Hussein, 
1977a). B. rodhaini was also isolated from the African tree rat 
host (Thamnomys) into laboratory mice (Van den Berghe et al.,
1 950) and became virulent later in this host (Beveridge, 1 953), 
and produced subpatent infections in several primates (Hawking, 
1973). These last two species of Babesia have not been reported 
in domestic animals or man.
Removal of the spleen seems to be an important factor in 
breaking down natural resistance to infection with Babesia. 
Skrabalo and Deanovic (1957), reported the first acute case of 
B. divergens in a splenectomised man. Since then, more than 22 
cases of babesiosis in splenectomised humans have been reported 
(reviewed by Rosner et al., 1984). Splenectomy of deer and goats 
also rendered them susceptible to this parasite (Enigk and 
Friedhoff, 1962). Injection of bovine blood infected with
B. divergens into splenectomised chimpanzees and rhesus monkeys 
initiated acute parasitaemias (Garnham and Bray, 1959; Garnham 
and Voller, 1965). B. divergens was also adapted to 
splenectomised laboratory rats (Phillips, 1984). This parasite, 
however, infected intact reindeer (Nillson et al., 1965) and 
mongolian gerbils (Lewis and Williams, 1979; Lewis et al., 1981b;
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Liddel et al., 1980). microti naturally infects field mice 
(Microtus pennsylvanicus) and white footed or deer mice 
(Perctnyscus leucopus) and man (Healy et al.f 1 976) in the United 
States, and in the laboratory will also infect intact rats, 
hamsters, gerbils and mice (Nowell, 1970; Gleason et al., 1970; 
Ruebush and Hanson, 1979) and rhesus monkeys (Ruebush et al., 
1979). Ristic et al. (1971) were, however, unable to infect 
splenectomised dogs with this parasite.
b. Age and Sex
Susceptibility of some hosts to Babesia infection can depend 
on the age of the host. In some studies older cattle were found 
to be more susceptible to babesiosis than young calves (Riek, 
1963; Smith et al., 1978). With B. rodhaini in rats, however, 
where neonates exhibited resistance to Babesia, this was thought 
to be in some cases at least, the result of immunity passively 
acquired from the mother (Beveridge, 1953; Phillips, 1968). 
Other workers, did not however, observe an age effect in the 
hosts. For example Brocklesby et al. (1971) reported that young 
and old cattle responded in a similar way to B^ divergens 
infection.
Little is known about the effect of sex on the 
susceptibility of the host of Babesia infections. Male mice were 
found to be more susceptible than females to B. rodhaini (Goble, 
1966) and B. microti infections (Rosenberg and Evans, 1979; Cox, 
1980; Irvin et al., 1981).
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c. Cross infections
Concurrent infections with Babesia may induce specific 
resistance to other parasites, for example Cox (1970), Cox and 
Young (1969) and Cox and Turner (1970b) demonstrated that mice 
that recovered from microti and B^ rodhaini infections were 
not only protected against reinfection but were also partially 
protected against Plasmodium vinckei and chabaudi. These 
authors thought that this cross protection was a result of shared 
common antigens between the two species. Mahoney (1972) reported 
that splenectomised calves infected with T^_ mutans were more 
resistant to B^  bovis than calves free from Theileria. Mahoney 
(1972) suggested that this cross resistance was due to the fact 
that the reticuloendothelial system was being stimulated by 
Theileria infection or possibly due to the alteration of the 
erythrocytes in the doubly infected animals making them less 
suitable for B^ bovis.
Immunostimulatian
Non specific stimulation by a number of agents has been 
intensively studied particularly in the rodent parasite B^ microti 
and B^ rodhaini (Cox, 1 980). Pretreating mice with agents such 
as BCG (Clark et al., 1976) and Corynebacterium parvum (Clark 
et al., 1977a; Carrier and Wagner, 1984), protected them against 
subsequent challenge. Protection against B. rodhaini in rats can 
be achieved by pretreating them with C^ parvum (Cox and Saleh, 
1983). Corrier and Wagner (1984) found that C. parvum has a 
slight protective effect against B^ bigemina. Brocklesby and 
Purnell (1977) could not, however, protect cattle against
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B. divergens after injecting them with BCG.
The appearance of intraerythrocytic damaged parasites 
(crisis forms) in mice previously infected with BCG or other 
agents is thought to be due to soluble non antibody factors which 
mediate the killing of Babesia parasites in the red cells (Clark 
et al., 1977a, b, c). These soluble factors are associated with 
macrophage activation (Clark, 1979a), interferon tumour necrosis 
factor (Clark, 1979a) and natural killer (NK) cells (Allison 
et al., 1978; Clark, 1979b; Irvin et al., 1981). Such soluble 
factors may also damage malaria parasites and could explain the 
cross immunity existing between rodent babesias and rodent 
malaria parasites as suggested by Cox (1978)* Clark (1978) 
speculated that these soluble non antibody factors are released 
as the result of endotoxin shock, which is produced as a result 
of the presence of coli liposaccharides during the rising 
parasitaemia in mice infected with Babesia and Plasmodium 
parasites.
Specific immune mechanisms
a. Acquired imnunity
The course of Babesia infection depends on the host and the 
species involved. In some hosts the infection is fatal and 
rapidly kills the host. In others, the host can recover and is 
strongly immune to reinfection. Sergent et al., (1924) 
introduced the term "premunition" to describe the situation where 
the persistence of subclinical infection in recovered animals is 
necessary to maintain immunity. In recent years, however, work 
done on a number of Babesia species, indicated that immunity
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remained for several years in animals after completely recovering 
from the infection i.e. sterile immunity, such as in B. divergens 
(Davies et al., 1958; Joyner and Davies, 1967), B. bovis (Mahoney 
et al., 1973b) and B. bigemina (Callow, 1967) in cattle, 
B. caballi in horses (Frerichs et al,, 1969) / and B^_ rodhaini in 
rats (Phillips, 1969a). In Australia, immunity in cattle 
infected with B. bovis and treated with drugs, persisted a t least 
for six months after chemotherapy (Callow et al., 1974) • The 
persistence of immunity was demonstrated after challenge with 
both homologous and heterolgous parasite strains (Johnston 
et al., 1 978).
b. Role of antibody
The role of antibody in protection has been demonstrated by 
passive transfer experiments from immune animals. Mahoney 
(1967a), Mahoney et al. (1979) demonstrated that antibodies play 
an important role in B^ bovis infection in cattle, especially 
when hyperimmune serum was used. The protective activity of 
hyperimmune serum was confined to the IgG fraction of the serum. 
Antiserum was also effective against B. rodhaini in mice (Roberts 
et al., 1972; Roberts and Tracey Patte, 1974) and in rats 
(Phillips, 1969b; Rogers, 1974). Protection was achieved as a 
delay in the onset of parasitaemia when antiserum was injected at 
the time of the infection. Some other workers, however, failed 
to show any protection with immune serum and suggested therefore 
that antibody has a minor role in protection as was reported for 
P. berghei and B. rodhaini (Mitchell et al., 1978) and B^ microti 
(Allison et al., 1978) infections. Work done on rodent malaria,
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however, has shown that the protective activity of serum is short 
lasting and that serum collected 5-6 days after peak activity is 
not protective (Phillips and Jones, 1 972; McLean and Phillips, 
1979). It is possible therefore that workers who failed to show 
protection with immune serum, were collecting serum at the wrong 
time.
The antibody levels in the serum can be detected by various 
serological tests (Todorovic, 1975; 3idwell et al., 1978), but 
levels measured by these tests do not relate to protective 
levels, indicating that some antibodies are not protective 
(Callow et al., 1974). The mode of action of antibody in vivo is 
not clear. Some reports have indicated a role for monocytes and 
neutrophils in the destruction of Babesia, as was reported for 
B. canis (Neitz, 1938), where phagocytosis of free parasites, 
parasitised red cells and non infected red cells has been 
promoted by specific antibodies that combine with free parasites, 
parasite antigen on or in the red cell membrane. Rogers (1 974) 
observed that the addition of immune serum in vitro increased the 
phagocytosis of rodhaini by peritoneal macrophages and 
suggested that opsonising antibody plays an important role in 
protection when the opsonising activity was correlated with the 
protective activity of immune sera in passive transfer 
experiments. Mahoney etaj.1979 passively protected cattle against 
B. bovis and suggested that merozoites may be destroyed as they 
leave the red blood cells but that parasites within the red cells 
were not affected by antibody. Mathematical analysis of the rate 
of removal of B. bovis, however indicated that some infected red
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cells must have been opsonised and engulfed by phagocytes.
The recent advances in the in vitro cultivation of Rates i 3 
permits more detailed examination of the effect of antibody 
and/or cells on parasite growth in culture. Erp et al. (1978) 
were the first to develop a method for short term cultivation of 
B. bovis. Later, Bautista and Kreier (1979) cultivated 
B. microti in short term cultures and tested the effect of 
addition of immune hamster serum on parasite growth in vitro. 
They found that the addition of immune hamster serum inhibited 
parasite growth and suggested that immune serum prevented the 
invasion of red cells by the parasite. In further experiments, 
the same workers cultured B^ microti from hamsters over 
peritoneal macrophages with immune serum, and suggested that 
opsonisation and phagocytosis was not the major cause of parasite 
death in culture, but immune macrophages produced a soluble 
factor which inhibited growth of B^ _ microti in the presence of 
immune serum (Bautista and Kreier, 1980).
The development of the microaerophilous stationary phase 
cultures (MASP) for B. bovis (Levy and Ristic, 1980), where a 
large quantity of cell free merozoites and soluble Babesia 
antigens were released in the culture supernatant, has provided a 
tool to examine the protective role of anti-Babesia antibodies. 
It was found that when free merozoites of B^ bovis were 
preincubated with sera of recovered or immunised cattle and then 
introduced to in vitro culture, they failed to invade 
erythrocytes (reviewed by Ristic and Levy, 1981).
It has been reported for berghei (Miller et al., 1975) 
and bovis (Gravely et al., 1979), that the merozoite surface
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coat elicits the production of antibodies that prevent 
erythrocyte invasion by parasites and facilitates their immune 
destruction by phagocytic cells. Ristic and Levy (1981) were 
able to recover a large quantity of B. bovis soluble antigens in 
a MASP culture and found that if they were preincubated with 
immune serum, antibody lost its ability to prevent in vitro 
infection of erythrocytes by bovis merozoites because it was 
neutralised by the soluble antigens. Smith et al. (1981) 
observed that antisera to soluble antigens released into the 
supernatant of B^ bovis cultures reacted with the merozoite 
surface coat causing its lysis. Kuttler et al. (1982, 1983), 
vaccinated cattle with culture derived soluble bovis antigens, 
and found that cattle responded with a strong humoral response to 
B. bovis challenge as measured by the indirect fluorescence 
antibody test (IFAT), and that immunity induced by vaccination 
persists for at least six month periods. They suggested, 
however, the participation of T-helper cells in immunity since it 
was observed that vaccinated cattle were still immune to 
babesiosis when circulating antibody titre was below detectable 
levels as determined by the IFA test.
c. Cellular imnunity
Many reports on Babesia infections indicate that T cells 
play an important part in acquired immunity to this parasite. 
Roberts (1968) compared immunity to B. rodhaini in rats in 
transfer experiments using immune spleen cells and immune serum. 
He concluded that adoptive transfer of immunity is effective, 
whereas passive transfer of serum led to the enhancement of
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Babesia infections. Clark and Allison (1974) reported that 
parasitaemias in neonatally thymectomised mice infected with 
B. microti (King's strain) were more severe than in normal mice* 
Mitchell (1977) reported the same observations in thymectomised 
mice infected with B. rodhaini. Ruebush and Hanson (1980) 
working on B^ microti (Human strain), also using thymectomised 
mice, concluded T cells were the major cells required for the 
development of acquired immunity to this parasite in mice. In 
further experiments, the same authors observed that spleen, or 
nymph node cells of recovered mice could adoptively transfer 
immunity to recipients and in the spleen cells it was T cells and 
not B cells which carried immunological memory of microti. 
They suggested that these T cells stimulated macrophages to 
produce a soluble factor toxic to the parasite. Evidence that 
cell mediated immunity plays a part in immunity to Babesia came 
also from the results of leukocyte migration inhibition tests in 
hamsters infected with B^ microti (Perez et al., 1977) and in 
delayed skin tests in B^ equi infection in donkeys (Banarjee 
et al., 1977; Singh et al., 1979). The role of T cells in 
protection was also reported for malaria infections in 
thymectomised rats (Brown et al., 1968 ; Stechschulte, 1969), 
hamsters (Chapman and Hanson, 1971), mice (McDonald and Phillips, 
1978) and athymic nude mice (Clark and Allison, 1974) were more 
susceptible to P^ berghei, P. chabaudi or P^ yoelii than intact 
controls.
T cells may act as helper cells in protective antibody 
production or as mediators of various cell mediated immune
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mechanisms. Wolf (1974), studied the effect of anti lymphocyte 
serum and splenectomy on resistance to microti infection in 
hamsters. He suggested that although cellular immunity is a 
major factor in host resistance, humoral antibodies may 
contribute to controlling the level of parasitaemia. Previously 
Phillips (1970) reported that adoptively transferred cells may 
promote antibody production in the adoptive transfer of immunity 
to P. berghei in the rat. Meeusen ^ t al. (1984a), working on 
B. microti in mice suggested that antibodies produced by 
sensitised B cells were responsible for the adoptive transfer of 
immunity. In further experiments, the same workers suggested the 
possible role of subpopulations of B cells, namely antibody 
forming cells in the adoptive transfer of immunity with immune 
spleen cells (Meeusen et al., 1984b). Antibody forming cells 
were also responsible for the adoptive transfer of immunity in 
P. berghei infection (Gravely and Kreier, 1976). Allison et al. 
(1978) examined the role of B, T and other unidentified cells in 
acquired immunity to Babesia. They transferred resistance to 
mice infected with B^  microti, using spleen cells and found that 
the protective activity of the spleen cells was not reduced by 
treatment with anti-thyserum (which removes T cells) or by nylon 
wool separation (which decreases the number of B cells).
Natural killer cells
The role of natural killer cells in cellular immune 
responses to babesial infections has been studied by several 
workers. Eugui and Allison (1980), reported that differences in 
the susceptibility to microti infection among various mouse
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strains could be correlated with natural killer cell activity. 
They found that in CBA, C57/B1 and B1 0.A mice, B. microti 
infection is rapidly controlled, whereas in A strain mice the 
parasitaemia persists for a long time, and they correlated the 
greater resistance of CBA, C57/B1 and B10.A mice with the rise in 
the natural killer cell activity in the spleen which is measured 
by the capacity of spleen cells to kill sensitive tumour target 
cells in vitro. In contrast, A strain mice had a much lower NK 
activity in their spleens. It was suggested that the increase in 
NK activity results from sensitised T cells and macrophages 
activated by T cell products which stimulate natural killer cells 
through the release of interferon which in turn releases factors 
that inhibit the development of the parasite. Irvin et al. 
(1981) also working on B. microti found that congenitally 
asplenic mice (DH/+mice) were less susceptible to the infection 
than surgically splenectomised mice, and suggested that the 
functional splenic activity in congenitally asplenic mice is 
taken over by other tissues which may be mediated by natural 
killer cells. Wood and Clark (1982) have shown, however, that 
increased natural killer cell activity in the spleens of 
B. microti and I\_ vinkei peteri infected mice was not associated 
with the host's response against these parasites. They found 
that parasitaemia in mice (CBA/Ca mice) infected with microti 
or P. v. peteri increased normally after maximal NK activity had 
been achieved. They also observed that the course of infection 
with B^ microti of P^ v^ peteri was normal in mice pretreated 
with strontium®^ or oestradial which both reduce NK activity, and 
the course of infection with B. microti was also unaltered in
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beige mice which are genetically deficient in NK cells. After 
all the above observations they concluded that it is unlikely 
that NK cell are important in the resolution of Ek_ microti and 
P. v. peteri Infections in mice •
Role of the spleen
The spleen plays an important role in the development of 
acquired immunity to Babesia infections (reviewed by Carson and 
Phillips, 1981). It has been reported that removal of the spleen 
in rats infected with B. rodhaini results in their death (Matson, 
1964; Phillips, 1969c). Todorovic et al. (1967), working on the 
same parasites in the same hosts as above, reported, however, 
that rats do not always die from B^ rodhaini infection when 
splenectomised. Removal of the spleen also had no effect on 
cattle infected with B. bovis (Legg, 1935). Splenectomy also 
allows the establishment of Babesia in animals and man to which 
these hosts are usually completely immune. For example, Garnham 
and Voller (1965) reported that intact chimpanzees were 
completely resistant to B^  divergens, but after splenectomy, they 
become highly susceptible. In man, severe cases of babesiosis 
occurred in splenectomised individuals (reviewed by Rosner 
et al., 1984).
The spleen is important in that it is the major site of 
phagocytosis. Free parasites and infected and uninfected 
erythrocytes were reported to be phagocytosed in this organ in 
B. rodhaini infection in rats (Phillips, 1969c) and mice (Roberts 
et al., 1972). The spleen is also important in the production of 
antibabesial antibodies and in cellular immunity (Roberts, 1968;
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Phillips, 1970 b), and splenectomy reduces the level of antibodies 
against various antigens present in the blood circulation 
(Winebright and Fitch, 1962; DeCarvalho et al., 1967). The 
spleen may also remove parasites from circulation by the process 
of pitting, as it was reported for knowlesi infection 
(Schnitzer et al., 1972), and the parasite numbers are therefore 
reduced before any specific immune response. Roberts and Tracey 
Patte (1974), suggested however the "pitting" is not important in 
the control of B. rodhaini infection in mice. The spleen seems 
also to be important in dealing with antigenic variation. 
Phillips (1969c) reported that in normal rats, the spleen plays 
an important role in the control of the first wave of 1  rodhaini 
parasites. When the rats survived the primary attack, the spleen 
was primed for the secondary wave of antigenically different 
B. rodhaini and was much more efficient in controlling this. 
When the rats were splenectomised after the first parasitaemia, 
the relapse was fatal. Phillips (1969c) suggested that after 
splenectomy the memory of the previous attack had been lost and 
the relapse strain developed as if it were a primary infection. 
Antigenic variation has also been reported for B^ rodhaini in 
mice (Roberts et al., 1972) and B. bovis in cattle (Curnow, 
1973a, b).
BMNISATIGN
Bovine babesiosis is considered to be a serious problem 
which threatens the health of cattle in many regions of the 
world. Although the disease has been eliminated in countries 
such as the United States (Bram and Gray, 1983), it is still
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persisting and spreading due to the transport of infected 
domestic animals across the world (Young and Morzaria, 1986). 
This, and the cost of eradicating ticks, makes establishment of 
effective control programmes difficult. Control of bovine 
babesiosis is therefore mainly directed at the development of 
methods for controlling the disease rather than eradicating the 
tick vector. Various vaccination methods have been developed for 
disease control, and three principle methods of vaccination are 
being followed:-
1. The use of parasite antigens derived from infected hosts.
2. The use of culture derived antigens.
3. DNA technology.
1. The use of parasite antigens derived from infected hosts
A. Live vaccines
The oldest form of immunisation against babesiosis consisted
of inoculating infected blood into susceptible animals (Hunt,
1897 - quoted by Mahoney, 1972). In Australia, immunisation of 
cattle against babesiosis caused by IL_ bovis was achieved by 
using live vaccines which have been attenuated or made avirulent 
by rapid passage of infected blood through splenectomised calves 
(Callow, 1977). This method has been extensively used for 
vaccinating cattle against babesiosis in the state of Queensland, 
Australia (FAO, 1984). In Ireland, it was not, however, possible 
to attenuate divergens by such means (Taylor et al., 1983; 
Murphy et al., 1986).
There are risks of using live vaccines, and these include; 
first, the accidental transmission of unrelated diseases such as
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bovine leukosis (Hugosan et al., 1968); secondly, repeated 
vaccination of animals results in the production of antibodies to 
blood group antigens which in turn cause haemolytic disease in 
the newborn (Langford et al., 1971) and thirdly, the live 
vaccines might occasionally cause severe babesiosis and 
transmission of the attenuated parasite from vaccinated animals 
can cause reversion to virulence (Young and Morzaria, 1986).
b. Irradiated parasites
Other attenuated vaccines for the control of bovine 
babesiosis have been in the form of irradiated infected blood 
(reviewed by Wright, 1984). Previous reports have shown that 
rats and mice can be protected against challenge with rodhaini 
(Phillips, 1970a-1971) and cattle against B. bovis (Mahoney 
et al., 1973a), B. major (Brocklesby et al., 1972; Purnell 
et al., 1978; 1979a), B. bigemina (Bishop and Adams, 1974) and 
B. divergens (Lewis et al., 1 979a; 1 980a_jTaylor et al., 1 980) by 
prior inoculation of irradiated parasites. Phillips (1971) 
suggested that the use of irradiated infected blood to protect 
mice and rats against challenge with B. rodhaini might provide a 
method of vaccination against Babesia of domestic animals. Lewis 
et al. (1979a) speculated that protection resulted from the 
combined inoculation of a large number of parasites which have 
been irradiated at a dose to kill them, and a small number of 
live parasites which had survived irradiation. This was later 
confirmed by Purnell and Lewis (1981). Taylor et al. (1983), 
however, concluded that this method of producing attenuated 
vaccines (i.e. irradiation of infective blood) is not reliable to
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protect cattle against divergens infection, since the 
irradiation of infected blood results in the destruction of most 
of the parasites in the infective dose rather than the reduction 
of viability of individual parasites, and some parasites may 
survive to produce a clinical infection.
c. Inactivated vaccines
The early work of immunisation against babesiosis showed 
that immunisation can be achieved with either antigens derived 
from parasitised erythrocytes or the plasma of infected blood 
(Mahoney, 1981). Antigens that were contained in the infected 
blood were purified, lyophilised or used fresh and inoculated 
with an adjuvant. Mahoney (1967b) and Phillips (1967), induced 
protection against B^ bovis and rodhaini respectively by the 
inoculation of washed parasite suspension in Freund's complete 
adjuvant into susceptible hosts.
Mahoney and Wright (1976) found that B. bovis infected 
erythrocytes protected susceptible non-splenectomised adult 
cattle even against a heterologous strain of B^ bovis when 
injected subcutaneously or intramuscularly in Freund's complete 
adjuvant. Some protection against B. divergens was conferred by 
using fractions of parasitised erythrocytes separated by 
isolectric focussing (Taylor et al., 1984). Goodger et al. 
(1983), also found that a simple distilled water lysate of 
infected erythrocytes, was effective against homologous challenge 
to B. bovis when used as a vaccine. Increasingly more efficient 
methods have been developed for purifying such antigens by the 
Australian workers (reviewed by Irvin, 1987). The antigens
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released into the plasma of IL_ bovis infected cattle (Mahoney,
1 971; Mahoney and Goodger, 1 972) and divergens (Purnell and 
Brocklesby, 1977) were, however, lass protective than the 
antigens contained in the infected erythrocytes. Goodger et al. 
(1987) reported that although an immune complex detected in the 
plasma of animals recovering from acute B^ bovis infection 
contained babesial antigens as well as the major proteins, it had 
little or no role in protective immunity. Banarjee and Prasad 
(1985) however, reported that a vaccine which consists of plasma 
separated from B^ bigemina infected blood, gave better protection 
in calves even when challenged 264 days after vaccination. On 
the other hand, a vaccine which is composed of the lysate of 
infected erythrocytes containing bigemina parasites and some 
erythrocyte stromata was less protective. The plasma antigens of 
two other non-bovine babesias, B. rodhaini and B. canis were also 
protective, not only in homologous but also in the heterologous 
situations (Sibnovic et al., 1967; 1969).
2. The use of culture derived antigens (attenuated vaccines)
Methods for in vitro culture of Babesia species have 
facilitated the collection and preparation of antigens for 
immunisation trials. The culture approach has been extensively 
studied by the American workers arri is based on the development 
of culture methods for B^ bovis (Erp et al., 1978; Levy and 
Ristic, 1980). Smith et al. (1979; 1981), reported that cattle 
could be protected against homologous challenge with cell free 
soluble antigens prepared from culture supernatants. The 
development of a MASP culture system (Levy and Ristic, 1980),
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resulted in a series of studies where a high yield of cell 
culture derived antigens were produced. These were purified, 
mixed with a Quil-A saponin adjuvant and used to immunise cattle. 
Immunised cattle had milder infections than controls when both 
groups were given homologous (Kuttler et al., 1982; 1983) or 
heterologous challenge (Montenegro-James et al., 1985; 1987). 
Other studies have shown however, that culture derived antigens 
were less protective against a heterologous challenge than live 
culture derived parasites (Timms et al., 1983; 1984). The 
application of new techniques in immunochemistry has led to the 
identification and characterisation of antigens on the surface of 
Babesia merozoites that might be associated with protection. 
Montenegro-James et al. (1983) found that the principle antigens 
associated with protection are located on the surface coat of 
merozoites. James et al. (1981) found that protection of the 
merozoite surface coat is associated with proteins of 30-40 KDa. 
Wright et al. (1985) found that vaccination against B. bovis 
could be achieved with a low molecular weight antigen which 
appeared to be 29 KDa. Winger and Canning (1 985) and Winger 
et al. (1987a) have raised monoclonal antibodies against 
merozoites of B. divergens. Winger et al. (1987a or b)were able to 
induce partial protection in gerbils to homologous challenge by 
immunisation, with an affinity purified 50-60 KD B^ divergens 
merozoite antigen.
Chemotherapy
A large number of chemical compounds have been used in the 
treatment of babesiosis. Compounds such as amicarbalide,
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imidocarb, quinuronium sulphate and oxytetracyclines have been 
extensively used especially in the treatment of bovine babesiosis 
(reviewed by Kuttler, 1981). Amicarbalide has been successfully 
used for the treatment of divergens and bigemina in cattle 
when it was administered intramuscularly (Adams et al,, 1978; 
Barnett, 1965; Shone et al., 1961). Another compound, imidocarb, 
in addition to its therapeutic properties, can also act 
prophylactically and protection of up to 15 weeks has been 
recorded against B. bovis (Todorovic et al., 1973). The 
prophylactic activity of the drug was found, however, to be 
limited since it did prevent the exposure of cattle infected with 
B. bovis (Callow and McGregor, 1970; Dalgliesh and Stewart, 1977) 
and with B^ divergens (Lewis et al., 1981a) to new infections. De 
Vos et al. (1986) reported that the prophylactic activity of 
imidocarb in B. bovis infection can be disadvantageous since it 
can suppress the establishment of immunity in cattle immunised 
with live vaccine. Another aspect of imidocarb is that infection 
of ticks which feed on imidocarb treated cattle can be reduced 
or eliminated as reported for bigemina and B^ microplus ticks 
(Kuttler et al., 1975; De vos et al., 1984). This drug was also 
used for the treatment of canine babesiosis (Adeyanju and Aliu, 
1982; Guelfi, 1982) and it was found to be effective in in vitro 
short term cultures of B. bovis (Akinboade, 1984). Another 
compound, quinuronium sulphate, has been used for treating 
splenectomised calves infected with B. divergens (Purnell, 1981). 
Gray (1983) made a comparative study on the chemotherapy of the 
gerbil Meriones unguiculatus infected with B^ divergens and found
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that four drugs, namely quinuronium sulphate, diminazene 
aceturate, amicarbalide, and imidocarb, were all effective, 
leaving the gerbils with a sterile immunity. Tetracycline is 
another drug which was used to ameliorate the severity of post 
immunisation reactions in highly susceptible cattle given live 
B. bovis vaccine (Pipano et aJL, 1985) and was recently used for 
the treatment of cattle infected with B^_ divergens (Taylor 
et al., 1 986).
2. ENA technology
The various approaches to vaccination against Babesia have 
concentrated on the use of live, attenuated or irradiated 
parasites derived from infected hosts as described above. There 
are, however, risks in using these vaccines as they might be a 
source of transmitting unrelated diseases to the vaccinated 
hosts, and although irradiated parasites have been extensively 
used against challenge with B^ bovis (Mahoney et al., 1973a), 
this method was found to be unreliable since the radiating dose 
was found to be important, for example, strong protection was 
achieved when low doses of irradiation were used, which 
inactivated the majority but not all of the parasites. On the 
other hand partial protection was achieved when high doses of 
irradiation were used. Similar results have been obtained for 
B. major (Purnell et al., 1978) and with B^ divergens (Lewis 
et al., 1979; Taylor et al., 1980). The difficulty in producing 
large amounts of parasite material from infected hosts has also 
presented a problem and led to the need for finding an 
alternative source for producing parasite antigens. The
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development of methods for the in vitro cultivation of 
P. falciparum (Trager and Jensen, 1 976) and B^_ bovis (Levy and 
Ristic, 1980) in recent years has presented a partial solution 
for producing a large number of these antigens. Sufficient 
amounts for the synthesis of parasite antigens was achieved by 
the use of recombinant DNA technology which was based on gene 
cloning and allowed the expression of eukaryote genetic material 
in organisms such as Escherichia coli (Wakelin, 1984). Although 
there are no reports on applying recombinant DNA technology for 
producing vaccines against Babesia, this method has been 
extensively tested for producing vaccines against malaria. This 
was achieved by first identifying antigens responsible for 
protection using monoclonal antibody technology, which in turn 
made it possible to understand their molecular structure. A 
number of protective antigens have been identified in the 
merozoite and schizont stages of both yoelii in mice, 
P. knowlesi in primates, and for P^ falciparum in humans 
(Wakelin, 1984). Wright et al. (1983) have isolated an antigen, 
using a monoclonal antibody raised against a soluble bovis 
antigen. This antigen has been shown to provide protection 
against challenge in immunisation trials on cattle (Wright 
et al., 1985). Wright et al. (1983) speculated that since this 
antigen was small and a single polypeptide chain it could be an 
ideal candidate for producing large amounts of vaccines using 
recombinant DNA technology. Using DNA technology, it was 
possible to extract total RNA from thoraxes of P^ knowlesi 
infected mosquitoes, and it was possible to prepare double 
stranded cDNA, which was inserted into plasmids and cloned in
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E. coli. Subsequently it was possible to screen recombinant 
organisms for the sporozoite antigen using monoclonal antibody 
technology and successful recombinants have been produced 
(Wakelin, 1984).
EXPERIMENTAL RATIONALE
Babesia divergens is the babesia of major importance in the 
United Kingdom and Ireland where it causes losses in cattle. 
Little is known about the mechanisms of immunity to this parasite 
in the bovine. Phillips (1984) has adapted the parasite to 
laboratory splenectomised rats using infected bovine blood. It 
was of interest, therefore, to study the mechanisms of immunity 
to this parasite using the rat adapted strain as a model although 
it is appreciated that the immune mechanisms in the bovine might 
be different from those in the rat.
Although the spleen plays a major part in the development of 
acquired immunity in splenectomised animals, extra splenic 
sources may take over the function of the spleen and immune 
mechanisms may develop in other sites (Allison et al., 1978; 
Carson and Phillips, 1981). The course of infection of 
B. divergens in splenectomised rats was short lasting and no 
recrudescences were observed after the primary patent 
parasitaemia. The rats either died or recovered and were immune 
to reinfection. The persistence of acquired immunity was 
apparently not dependant on the spleen. Reports on murine 
malaria have shown that the liver is a major site for parasite 
destruction and for development of protective immunity. 
Increased cell migration and leukocyte accumulation in the liver
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have been reported in berghei (Playfair and de Souza, 1 982; 
Weiss, 1985), and in P. chabaudi (Kumararatne et al., 1987) 
infections. Histological studies on livers collected from 
recovered rats were carried out to investigate the possible role 
of this organ in the destruction of parasites and in protective 
immunity. The haematological changes that accompanied the 
infection were also followed.
There is good evidence that antibody is involved in the 
acquired immunity to Babesia. Passive transfer of immunity with 
serum from immune animals has been reported for B. canis in the 
dog (Nocard and Motas, 1902), B. rodhaini in rats (Matson, 1964; 
Phillips, 1969a and b; Abdalla et al., 1978) and B. bovis in 
cattle (Mahoney et aj. 1979 ) > Using the same parasite as in the 
present study but in mongolian gerbils, Liddel et al. (1982), 
reported however, a minor role of antibody in protection. The 
role of antibody in protection against B. divergens was studied 
in passive transfer experiments with sera collected during the 
infection at different times after recovery and with hyperimmune 
serum. The different immunoglobulin classes were determined and 
the antibody levels in the sera were measured by the indirect 
fluorescence antibody test (IFAT). Immunological studies with 
B. divergens in the rat may therefore provide a suitable model 
system, the results of which could be extrapolated to Babesia in 
the bovine.
The development of methods for in vitro cultivation of 
malaria and Babesia has provided a laboratory tool for 
investigations of various aspects of human malaria and bovine
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babesiosis that were not possible before. Trager and Jensen 
(1976), were the first to develop a method for long term 
cultivation of P. falciparum using the candle jar technique. 
Levy and Ristic (1980) have developed a method for continuous 
cultivation of B. bovis in a microaerophilous stationary phase 
culture (MASP) in which the isolation of infectious merozoites 
and soluble antigens was possible and provided an opportunity for 
various in vitro studies on babesiosis without the need of use of 
animals. Studies such as the properties of protective anti- 
B. bovis antibody drug sensitivity and the development of 
vaccines were carried out in vitro.
In order to compare the protective activity of immune serum 
in vivo with its effect on parasite growth in vitro, a method for 
cultivation of B^ divergens was developed. Three isolates of 
B. divergens were adapted to long term cultures in rat 
erythrocytes using the candle jar technique. Apart from 
producing a large number of infected erythrocytes, the cultures 
produced extracellular Babesia merozoites. Some aspects of the 
mechanisms of action of antibody, the effect of adding immune or 
normal serum to culture on parasite growth and some aspects of 
cellular immunity were studied in vitro. The development of a 
method for the long term cultivation of Rj_ divergens has also 
provided an opportunity to adapt new Babesia isolates for long 
term cultivation and to test suitability of erythrocytes from non 
rat species to support parasite growth in culture.
It has been reported that immunogens consisting of soluble 
exoantigens collected from culture supernatants are prime 
candidates for babesiosis vaccines (Levy and Ristic, 1980). The
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in vitro cultivation of divergens therefore provides a good 
tool for further studies on protective anti-B. divergens 
antibodies, for drug sensitivity assays, and for studies 
utilising cell culture derived antigens which are released in the 
culture supernatant. This might provide valuable knowledge for 
producing a suitable vaccine for bovine babesiosis.
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Chapter Two 
Materials and Methods
Host animals
Wistar rats and gerbils were bred in the Wellcome 
Laboratories for Experimental Parasitology, University of 
Glasgow. The sex and the age of the animals at the start of each 
experiment are given in the text.
Splenectomy
Splenectomy was carried out under ether anaesthesia 
(Phillips, 1 969c; 1984). Rats were not infected until at least 
seven days after splenectomy.
Parasite
B. divergens was originally cryopreserved in liquid nitrogen 
as infected bovine blood (Phillips and Wilson, 1978). These 
parasites were subsequently adapted to splenectomised rats and 
cryopreserved (Phillips, 1984) until used in the present project. 
The blood was recovered from liquid nitrogen using the method of 
Gray and Phillips (1981). Parasites were recovered from 
stabilate by thawing under running water and diluted 50 : 50 with 
17.5% sorbitol (see Appendix C) and immediately injected into a 
splenectomised rat, intravenously (i.v.) into the tail vein or 
intraperitoneally (i.p.). The parasite was subpassaged through 
splenectomised rats every 2-3 days, or kept at 4°C for 3-4 days 
before it was subpassaged into splenectomised rats.
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Parasitaemia and aourse of infection
Babesia infections were evaluated by counting the percentage 
of infected red cells in thin blood smears taken daily from the 
tails of infected rats. The blood smears were air dried, fixed 
in 100% methanol (Analar, BDH Ltd.) and stained in 10% Giemsa's 
stain (BDH) in phosphate buffer pH 7.2 (see Appendix A). The 
blood smears were examined under oil immersion using a 10 x eye 
piece and a x 100 objective on a Leitz SM Lux binocular 
microscope. Low parasitaemias were counted by counting the 
number of parasites observed in a total of 30 field (i.e. 
approximately 10,000 cells). Parasitaemias were considered to be 
subpatent when no parasites were observed in 30 fields. If more 
than 3-4 parasites were observed per field, the number of 
parasites and erythrocytes were counted in 1-3 fields (300-500 
erythrocytes).
The course of infection of a group of rats is presented in a 
graphical form by plotting the geometric mean of the parasitaemia 
(Mean Log^® of the number of PRBC/10^ RBC) against time 
(expressed as days post infection). Vertical bars showing one 
standard deviation are included where necessary.
Infection of rats
Rats were infected with parasitised red blood cells (PRBC) 
collected in heparin (10 i.u./ml). The blood was diluted where 
necessary using RPMI 1640 (Gibco) (see Appendix B). Parasites 
were kept on ice until they were inoculated into the rats.
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Cryopreservation of parasites
Parasites were cryopreserved using the method of Phillips 
and Wilson (1978). Infected blood was collected into heparin 
(10 i.u./ml) and diluted 50 : 50 with a solution of 
sorbitol/glycerol (Appendix C). The sorbitol glycerol was added 
to the blood, slowly dropwise with frequent mixing 0.5 - 1ml 
aliquots were snap frozen and stored in liquid nitrogen as 
stabilates.
Haematology
Blood was collected from the tail of the rats into 
heparinised glass capillary tubes. Red blood cell counts and 
white blood cell counts were made with a haemocytometer after 
dilution of red blood cells in PBS (pH 7.2) (see Appendix A) and 
white blood cells in white cell diluting fluid (Appendix D). 
Differential white blood cell counts were made by examining 
Giemsa's stained blood smears and counting the different types of 
white blood cells present.
Raising and collection of sera
Large volumes of immune, hyperimmune and normal sera were 
collected by exsanguination. The different sera were raised in 
rats as follows:
a. Immune serum
Immune serum was obtained from donors which were inoculated 
with 1x10^ PRBC and recovered. Immune sera were collected at 
different times after recovery as will be described at the start 
of each experiment.
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b. Hyperimnunp serum
Hyperimmune serum was obtained from donors which were 
inoculated with 1x10^ PRBC and challenged at least twice at one 
monthly intervals. The rats were bled one week after the last 
challenge.
c. Normal serun
Normal serum was collected from normal non infected rats.
In each experiment, the blood from each day was pooled and 
allowed to clot. The clot was loosened from the edges of the 
container and left for 2-3 hours at room temperature. The serum 
was collected and contaminating erythrocytes removed by 
centrifugation (300g for five minutes). The serum was then 
aliquoted, frozen and stored at -20°C. Small volumes of sera 
were collected from the tail blood by the method of Gray (1 979) 
using hard glass capillary tubes.
Indirect fluorescent antibody test
Infected red blood cells were collected from infected rats 
and used as antigen. The parasitised red blood cells were washed 
three times in 20ml PBS (pH 7.2) by centrifugation (300g for 
five minutes) and resuspension. After the last wash, the cells 
were resuspended in PBS to approximately 50% haematocrit and used 
to make blood smears covering the microscope slide. 
Parasitaemias of 8-20% were used for antigen slide preparation. 
The slides were dried over silica gel, packed with silica gel and 
stored at -20°C. Before use the slides were brought up to room 
temperature in a dess icator.
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The IFAT used was basically the method of Van Meirvenne 
et al. (1975). Reaction zones were marked on antigen slides 
using an H series texpen (Deacon Laboratories). The slides were 
washed twice in PBS, drained and rehydrated for 15 minutes in 
PBS. The area around reaction zones was dried and serial 
dilutions of test and control sera were added to the reaction 
zones. The slides were incubated for 15 minutes then washed and 
rehydrated as above. FITC Conjugated rabbit antiserum to rat Ig 
(Sera-Lab) diluted 1 in 400 in PBS containing Evans blue (1 in 
10,000 w/v) was applied to the slides and incubated for a further 
15 minutes. The optimal working concentration of the rabbit anti 
rat Ig was determined against a known positive rat anti-
B. divergens serum. The slides were then washed again and 
rehydrated, mounted 1 : 1 PBS/glycerol. Fluorescence was 
observed using a Leitz Ortholux microscope. The overhead 
ultraviolet source was a Wotan HBO-50 mercury lamp with 
2 x KP 490 exciting filters and a TK 510 dichroic beam splitting 
mirror and a K 515 suppression filter. The slides were examined 
using a x 50 water objective and x 12 eye pieces. The titre of 
the serum was considered to be the last dilution of serum at 
which specific parasite fluorescence was observed.
Passive transfer of sera
Rats were injected with the different sera i.v. or i.p. (as 
will be described at the start of each experiment) within one 
hour of infection. Their subsequent course of infection was 
followed in blood smears (see above). Results of passive 
transfer tests were usually presented in a graphical form as
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described for the course of infection.
BKvenoNaneN cf antisera
Isolation of IgG from serun using DEAE cellulose
The IgG fraction of pools of hyperimmune sera, immune sera 
and normal sera was isolated using a variation of the method 
described by Johnstone and Thorpe (1982). First the Ig fraction 
of the serum was collected as follows: Twenty mis of serum was
thawed and warmed to 25°C. Anhydrous sodium sulphate (Analar) 
was added to 18% (w/v) and the solution incubated for 30 minutes 
at 25°C. It was then centrifuged at 3000g for 30 minutes at room 
temperature. The supernatant was discarded and approximately 3- 
5mls of the precipitate redissolved in 10mls distilled water and 
anhydrous sodium sulphate added to make a 1 4% solution. The 
solution was incubated for 30 minutes at 25°C and centrifuged as 
above. The precipitate was again dissolved in water and dialysed 
overnight against 0.07 M phosphate buffer pH 7 (see Appendix A). 
The IgG was isolated from the Ig fraction using ion exchange 
chromatography. DEAE cellulose (Whatman) was used as an ion 
exchanger. This was equilibrated with the 0.07 M phosphate 
buffer pH 7 (Appendix A) and packed into a column 1.6 x 30 cm 
(Pharmacia) and washed with the same buffer at room temperature 
overnight. When both exchanger and sample were fully 
equilibrated, the serum sample was applied to the column and 
eluted with the starting buffer. 6-9ml/tube fractions were 
collected in a fraction collector (LKB).
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Isolation of IgM on sephadex G200
Pools of hyperimmune, immune and normal sera were 
fractionated using the method described by Hudson and Hay (1976), 
except that borate buffer (pH 8) (see Appendix A) was used for 
elution instead of phosphate buffer saline, as follow: - 
Seventeen grams of sephadex G-200 powder (Pharmacia) were heated 
in about 750ml of phosphate buffered saline (pH 7.2) in a boiling 
bath for five hours. The gel was then poured into a column 
100 x 2.5cm (Pharmacia) along a glass rod to avoid air bubbles. 
The column outlet was left open during packing. The gel was 
equilibrated with borate buffer (pH 8) overnight. After the gel 
was equilibrated, 1ml of blue dextran solution (see Appendix E) 
was added to the column. This is to check on the homogeneity of 
the column and on the void volume. After the blue dextran was 
washed into the gel, the buffer reservoir was attached to the 
column. As soon as the blue dextran had entered the gel, the 
eluate was collected in a graduate cylinder. The volume needed 
for the blue dextran to reach the outlet was approximately 100ml 
of buffer. The serum sample (20ml of serum) was then centrifuged 
for five minutes at 30Og, applied to the column, and eluted with 
approximately 100ml of borate buffer. Fractions of 5-10ml were 
collected in a fraction collector (LKD).
Isolation of IgM on sephacryl S-300
Pools of immune serum (day 7 = serum collected immediately 
after recovery) were eluted from a column of sephacryl S-300 
(Pharmacia), with either borate buffer (pH 8) (see Appendix A) or 
0.1 M Tris Nacl (pH 8) (see Appendix A). Sephacryl S-300 was
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already packed in a column 2 x 100 cm (Pharmacia) in the 
Veterinary Parasitology Department, Glasgow University. The 
serum was dialysed against either borate buffer or Tris NaCl 
overnight. The gel was equilibrated with either borate buffer or 
Tris NaCl overnight, and the serum sample was applied. Fractions 
of 5-10mls were collected as above.
Estimation of rat immunoglobulin IgG and IgM
The relative concentration of IgG and IgM in the eluted 
samples was measured by a spectrophotometer (LKB) at 280nm. 
Fractions of IgG and IgM were pooled separately and placed in 
dialysing tubes and dialysed overnight against phosphate buffered 
saline (pH 7.2). The samples were concentrated up to half their 
volumes by sprinkling polyethylene glycol 6000 (BDH) over the 
dialysing sac. Rat IgG and IgM were demonstrated by either agar 
gel immunoelectrophoresis (the Shandon System) (see below) or by 
double diffusion test using the rat monoclonal typing kit 
(Serotec, Oxford) against anti rat whole serum (Sigma), sheep 
anti rat IgG (heavy chains) (Serotec) or sheep anti rat IgM 
(Serotec). IgG fractions were kept at -20°C until used. IgM 
fractions were normally kept at 4°C.
Immunoelectrophoresis on IgG and IgM fractions
Immunoelectrophoresis was carried out using the Shandon 
System according to the manufacturer's instructions with some 
modifications. Briefly 3 - 3.5ml of 1% Agarose 15 (Electron- 
BDH) in barbitone buffer (pH 8.6 - Appendix A) were poured onto 
microscopic slides which had previously been covered with gel 
bond (Pharmacia). The slides were kept in a humid chamber.
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Wells were cut in each slide using a gel cutter (Shandon), and 
the agar plugs were removed using a pasteur pipette attached to a 
vaccum line. The wells were filled with 2 - 3 ul of the 
fractions tested on whole normal serum (control) to which 2u| of 
bromophenol blue (BDH) were added (bromophenol blue is used as a 
marker throughout the electrophoresis). The electrophoresis tank 
(Model 6 00 electrophoresis chamber - Shandon) was filled with 
barbitone buffer (Appendix A). The slides were placed in the 
tank and each end of the slide was connected to the buffer 
chamber using a filter paper. Immunoelectrophoresis was applied 
at a current of approximately 2mA/cm width of slide at a total 
voltage drop of 150-200 volts for 1 1 / 2 - 2  hours. The slides 
were taken out of the electrophoresis chamber and antiserum 
troughs were cut. Approximately 90-100 uls of anti rat whole 
serum (Sigma) or anti rat IgG or IgM (Serotec) (neat or diluted 
1 in 10) was added to each trough. The slides were kept in a 
humid chamber at 4°c for 24-48 hours. At the end of this period, 
the slides were washed x 3 with PBS (Appendix A) for 20 minutes, 
followed by two ten minute washes in distilled water. The gels 
were then covered either by leaving them at room temperature for
24-48 hours after they were covered with a thick absorbent tissue 
(Whatman no.4), or they were dried using a current of warm air. 
The gels were stained with coomasie blue (Appendix E), then 
washed in a destain solution (Appendix E) until the background 
was clear. The gels were dried using a current of warm air after 
which they were ready for inspection.
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Quantitative determination of protein concentration
The quantitative concentration of IgG and IgM was 
preliminarily determined using the protein assay reagent (Pierce).
Chrctnium-51 labelling of infected and non infected RBC
Infected blood was obtained by bleeding splenectomised 
infected rats with a parasitaemia of approximately 45% using 
heparin as anticoagulant (10 iu heparin/ml blood). The blood was 
pooled and spun at 700g for five minutes. The supernatant was 
discarded and 200uci of sodium chromate Na2Cr^ 0 4  (Western 
Infirmary, Glasgow) was added to each ml of packed cells. The 
blood was incubated at 37°C for 30 minutes. Labelled cells were 
washed three times with PBS (pH 7.2) and resuspended in PBS to 
give a concentration of 5x10® PRBC/ml. Normal uninfected blood 
from normal rat donors was labelled in a similar manner and used 
as a control.
Clearance and organ uptake of chromium-51 labelled
erythrocytes
Groups of immune and non-immune splenectomised rats were 
injected intravenously with 5 x 1 0 ®  chromium®^ (Cr~^  ) labelled 
parasitised red blood cells (PRBC) or Cr®^ labelled normal red 
blood cells (NRBC) which were equivalent to the total number of 
erythrocytes injected into the group receiving infected cells. 
Two rats from each group were sacrificed and bled at intervals as 
will be described in the experiment and the volume of blood 
collected was noted. The radioactivity of the blood injected and 
the blood collected from the rats was measured in a 1280 ultra 
gammacounter (LKB). The radiolabel present in circulation was
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expressed as percentages of the counts which were present in the 
blood injected into the rats. Blood smears were taken from the 
tail vein of infected rats every 30 minutes. To determine organ 
uptake of chromium^ labelled erythrocytes, the livers and lungs 
of immune and non immune rats that received either Cr^ labelled 
PRBC or Cr~^  labelled NRBC were collected at the same intervals 
when the rats were sacrificed for blood collection. 
Radioactivity was measured in weighed samples of tissue and total 
organ uptake was calculated based upon the determined wet weight 
of the organ.
Organ uptake was expressed as the percentage of total organ 
uptake = Counts per 20 seconds organ
------------------------------ x 100
Counts per 20 seconds injected
Irradiation of parasites
Whole infected blood was divided into two aliquots. One 
aliquot was irradiated with 40k rad using a cobalt 60 source 
(Veterinary Physiology, Glasgow University). The other aliquot 
was not irradiated and received the same handling as the 
irradiated blood before it was injected into the rats.
Liver histology
Livers from rats that recovered from a primary infection or 
from immune rats and naive non-infected rats, were collected, cut 
into small pieces, fixed in formal saline (see Appendix A) and 
processed by standard paraffin wax embedding for histology. The 
rest of the tissue was fixed in isopentane (Analar) then snap 
frozen in liquid nitrogen. The tissues were then kept in small
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plastic tubes and stored at -70°C, until used (see below).
Immunofluorescence staining for determination of B and T 
lymphocytes in rat liver
The immunofluorescence technique as described by Poulter 
et al. (1983) was used to demonstrate B and T lymphocytes in rat 
livers. Rabbit anti rat IgG-FITC conjugate (Sigma) was used to 
demonstrate B-cells. T cells were demonstrated by monoclonal 
anti rat T lymphocytes clone W3/I3HLK (Sera-Lab) in combination 
with fluorescein conjugated (FITC) sheep anti mouse gamma 
globulin (Scottish antibody production unit). Briefly 5 urn of 
frozen liver sections which were embedded in O.C.T. compound 
(Tissue TEK-II) were cut on a cryostat Mod.2700 Frigocut, 
Reichert-Jung, at -25°C, and air dried for one hour at room 
temperature. The sections on slides were then fixed with acetone 
(Analar) for five minutes at room temperature. The slides were 
washed for ten minutes in PBS at room temperature and placed 
horizontally in humid chambers and 5-1Oul of appropriate 
dilutions of either rabbit anti rat IgG-FITC conjugate or 
monoclonal anti rat T lymphocytes was added. The slides were 
incubated at room temperature for 30 minutes and washed for 
another 30 minutes in PBS. 5-10ml of appropriate dilutions of 
FITC conjugate sheep anti mouse gamma globulin was applied to the 
slides which had the monoclonal anti rat T lymphocytes and 
incubated for 30 minutes. These slides were washed in PBS for 30 
minutes and finally all slides were mounted in 1 : 1 glycerol/PBS 
solution. Fluorescence was observed using a Leitz Ortholux 
microscope.
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CDLTORE GF PARASITES
Infected Blood
Rat adapted strain of divergens
The cultures were normally initiated with a starting 
parasitaemia of 2%. The infected blood was either obtained from 
infected splenectomised rats with a parasitaemia of 2% or from 
infected rats with higher parasitaemias of 4-10% which was 
diluted with normal uninfected blood to a starting parasitaemia 
of approximately 2%. A blood smear was normally prepared from 
this mixture. The rats were bled aseptically by cardiac puncture 
and blood was defibrinated by dispensing it into a flask 
containing sterile glass beads. The defibrinated blood was 
transferred to sterile uni versa Is and centrifuged for ten minutes 
at 800g. The plasma and buffy coat were removed and the cells 
resuspended in incomplete medium (see Appendix B) and again 
centrifuged. The blood was given two more washes in incomplete 
medium as above. The infected blood was then resuspended in a 
small volume of incomplete medium and kept at 4°C until used.
Bovine isolates of divergens
Two bovine isolates which had been passaged into gerbils and 
then cryopreserved as stabilates were recovered from 
cryopreservation and subpassaged to gerbils and then either put 
into culture with gerbil or rat erythrocytes (see below), with a 
starting parasitaemia of 2%, or subpassaged through 
splenectomised rats before going into culture. Infected rats and 
gerbils were bled aseptically by cardiac puncture and the blood
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was defibrinated and washed as above before diluting it with 
normal uninfected rat or gerbil erythrocytes.
Uninfected erythrocytes
Rat and gerbil erythrocytes
Uninfected blood was obtained from normal intact male or 
female adult gerbils or rats. The gerbils or rats were bled 
aseptically by cardiac puncture, the blood was defibrinated and 
washed as bove. The uninfected gerbil or rat blood was 
resuspended in incomplete medium (see Appendix B) and kept at 4°C 
until used.
Hunan erythrocytes
Outdated (nine weeks after donation) normal human blood 
group 0 rhesus positive red blood cells were kindly provided by 
the West of Scotland Blood Transfusion Service, which were 
received in 450ml packs of whole blood collected into citrate 
phosphate dextrose adenine (CPDA). Aliquots were removed 
aseptically and washed as above. The blood was then resuspended 
in incomplete medium (see Appendix B) before being stored at 4°C 
for up to four weeks before use in cultures.
Foetal calf serum and heat inactivated foetal calf serum
Foetal calf serum (FCS) was provided by Gibco Ltd.
This was received deep frozen and was thawed on arrival. It was 
then dispersed in 20ml aliquots or heat inactivated at 56°C for 
30 minutes, before aliquoting. All aliquots were frozen and 
stared at -20°C until used.
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Cultivation procedure and routine maintenance of
B. divergens in vitro
The candle jar technique (Trager and Jensen, 1976) was used 
for culturing either the rat adapted strain or the bovine 
isolates of 3^_ divergens. Packed cells containing 2% infected 
rat or gerbil erythrocytes were diluted with complete medium (see 
Appendix B) to make a 10% haematocrit suspension. This was 
dispensed in 35mm plastic petri dishes (Cel-Cult) with 1.5mls in 
each. The dishes were placed in a humidified glass dessicator 
with a candle. The candle was lit and the cover put on with the 
stop cock open. When the candle flame went out the stop cock was 
closed. This provides an atmosphere low in oxygen and high in 
carbon dioxide. The jar was put into a 37°C incubator. Each day 
the cultures were removed from the candle jar and the medium 
replaced with approximately 1.5ml fresh complete medium. The 
dishes were then returned to the candle jar and to the incubator. 
Blood smears were taken daily from the cultures, fixed and 
stained with Giemsa's stain (Appendix A). The parasites were 
counted in relation to the red blood cells to determine the 
extent of multiplication. Subcultures were prepared by diluting 
the cultures every 48-72 hours depending on the parasitaemia. 
Cultures were normally diluted when they reached a 10-12% 
infected red cells. These were diluted 1 in 5 or 1 in 6 with 
normal red blood cells and a 10% haematocrit suspension was made 
with complete medium. The cultures were dispensed in fresh petri 
dishes (1.5ml each) and reincubated as described above.
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Recovery of cryopreserved cultures
Cryopreserved cultures were recovered from stabilates by 
thawing in a 37°c water bath. The contents in one ampoule were 
transferred to a sterile universal tube and diluted with 0.5ml of 
4.5% saline followed by 4.5mls of 3.5% saline (see Appendix A). 
This was added dropwise with frequent mixing. The PRBC were 
washed twice in incompleted medium. This method proved to be 
unsuitable for recovering divergens cultures as will be 
described later in the text.
Collection of free merozoites
Extracellular merozoites were collected from cultures with
25-30% infected red cells. The cultures were pooled and 
centrifuged at 200g for ten minutes to sediment erythrocytes. 
The supernatant fluid was retained and spun again at 40Og for ten 
minutes, to bring down the remaining erythrocytes. The 
supernatant fluid was retained and spun at 2000g for 20 minutes 
to pellet the merozoites. The pellet was resuspended in 3mls of 
incomplete medium (Appendix B) and spun at 2000g for 20 minutes. 
The pellet was resuspended in 200ml of incomplete medium. Some 
of the merozoite suspension was further diluted 1 in 200 with PBS 
and a count was made with a haemocytometer. The pellet contained 
a large number of merozoites, red cell ghosts but no intact 
erythrocytes. All procedures were carried out at 4°C.
Cryopreservation of free merozoites
Free merozoites were cryopreserved using the method of 
Canning (personal communication). Merozoites were resuspended in 
a cryoprotectant which is composed of 10% dimethylsulphoxide
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(DMSO) in Puck's saline (Gibco) containing 20g/L glucose (see 
Appendix C). 0.5ml aliquots in sterile ampoules were made and
placed in an expanded polystyrene box packed with insulating 
clips and was placed in -70°C for 1 6-24 hours. The vials were 
then transferred to liquid nitrogen. Some merozoites were also 
frozen in incomplete medium at -20°C for future use.
Precipitating of the Ig fraction from normal and immune 
serun
The Ig fraction of immune and normal serum was precipitated 
using anhydrous sodium sulphate as described before, except that 
2 x 5mls aliquots of either immune or normal serum were used. To 
one aliquot sodium sulphate was added to give 18% w/v solution. 
This was kept at 4°C until used. To the other aliquot sodium 
sulphate was added also to give 18% w/v solution, centrifuged as 
described before, redissolved in distilled water and sodium 
sulphate was added to give a 14% w/v solution. Both the 18% and 
the 14% w/v Ig solutions were aliquoted and either dialysed with 
PBS overnight or kept at 4°C until used. All aliquots were 
filtered aseptically using sterile 0.22um filters (Millex - GV), 
before they were added into culture.
Heat inactivating immune and normal sera
Immune and normal sera were heat inactivated in a 56°C water 
bath for 30 minutes.
Collection of free parasites
Free parasites were collected by lysing infected red blood 
cells obtained from infected rats with 0.2% saline (see
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Appendix A). Infected blood was washed three times with PBS 
(pH 7.2). After washing the supernatant was removed and six 
volumes of prewarmed 0.2% saline was added to the pellet. The 
mixture was stirred for 20 minutes and then spun at 900g for ten 
minutes. The supernatant was aliquoted in small eppendorfs and 
the aliquots were spun for 7-10 minutes using a microcentaur 
(MSE) at 11,600g. The pellet contained free parasites.
Opsonisation test using hyperimmune serum and free parasites
oar parasited red blood cells
Peritoneal macrophages were collected as follows 
Normal uninfected rats were killed and about 20ml' of medium 199 
(Flow) (see Appendix B) were injected into the peritoneal cavity. 
The medium containing macrophages was flushed out and spun at 
700g for five minutes. The cells were resuspended in medium 199 
containing 5% foetal calf serum and approximately 1.2 x 10^  cells 
in 0.5mls medium were dispensed into each well of a 24 well 
culture plate (Nunc) containing plastic cover slips to which 
macrophages adhere. 0.1ml of test dilutions (with medium 199) 
of hyperimmune serum or control serum (normal serum) were then 
added to each well. A positive control of fluorescent latex 
beads (kindly provided by Dr. J. Kusel, Biochemistry Department, 
Glasgow University) was included. Hyperimmune serum and normal 
serum were tested at dilutions of 1 in 2, 1 in 10 and 1 in 100. 
The plate was incubated for two hours at 37°C in a CO2 incubator, 
then 5 x 10^ PRBC's or free parasites were added into each well. 
The plate was reincubated in the CO2 incubator and two cover 
slips from both hyperimmune sera and normal sera wells at
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different dilutions were removed within the next 24 hours at 20 
minutes of two hourly intervals. The cover slips were rinsed 
with saline (Appendix A) then fixed in 100% methanol and stained 
with Giemsa's stain for microscopical examination. Cover slips 
in wells containing latex beads were washed with the medium and 
examined with the fluorescence microscope.
Preparation of peripheral blood mononuclear cells and spleen
cells for culture
Intact rats were injected with 2.5 x 10^  PRBC. Peripheral 
blood mononuclear cells and spleen cells were collected as 
follows.
Peripheral blood mononuclear cells
Both immune and normal rats (controls) were bled aseptically 
by cardiac puncture. The blood was defibrinated using sterile 
glass beads and transferred into sterile plastic universals. 
Peripheral blood mononuclear cells were collected by layering the 
blood onto Ficoll hypaque (see Appendix F) and centrifugation at 
300g for 30 minutes at 4°C. The layer containing the mononuclear 
cells was centrifuged at 250g for five minutes and the pellet 
resuspended in incomplete medium (Appendix B) and washed twice as 
above and resuspended in complete medium (Appendix B). 
Peripheral blood mononuclear cells were counted using a 
haemocytometer after dilution in white cell diluting fluid 
(Appendix D). The cells were kept on ice until used.
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Spleen cells
Spleens were removed aseptically from immune and normal rats 
into 5ml incomplete medium (Appendix B). The spleens were 
disrupted by rough chopping with scissors. Spleen pieces were 
forced through a fine mesh sieve and then through a 21 g needle. 
Cell clumps were allowed to settle out and the remaining cells 
washed three times in 15 ml incomplete medium by centrifugation 
(250g for five minutes) and resuspension in complete medium. 
Spleen cell numbers were counted in a haemocytometer using white 
cell diluting fluid after lysis of the contaminating erythrocytes 
with Tris ammonium chloride (Appendix A). Briefly 9ml of Tris 
ammonium chloride were added to each ml of spleen cell suspension 
and incubated for 5-7 minutes at room temperature. Spleen 
suspensions were washed three times with incomplete medium at 
250g for five minutes and resuspended. The counts were adjusted 
after cell viability was determined using the trypan blue 
exclusion test (see below).
Trypan blue exclusion test
The viability of spleen cells were estimated by diluting the 
cells 1 : 1 in 0.2% w/v Trypan blue in PBS (pH 7.2) (Appendix A). 
The cells were observed by phase contrast under oil immersion 
(x 100 objective x 10 eye piece). Dead cells were unable to 
exclude the dye and stained blue. The proportion of live to dead 
cells was expressed as a percentage viability.
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Chapter Three
The course of infection and haematologicai observations 
in splenectcmised rats 
INIIJCDUCriCN
In 1 979, Lewis and Williams reported that the mongolian 
gerbil Meriones unguiculatus proved to be useful for the 
isolation and establishment of bovine strains of 3^  divergens by 
direct inoculation of blood from splenectomised experimentally 
infected bovines, and the course of infection in gerbils was well 
documented (Liddel et al., 1980; Lewis et al.y 1 980b/1981b). 
Recently, Phillips (1984) reported that B. divergens can be 
adapted to splenectomised rats by passaging infected bovine blood 
through gerbils then to splenectomised rats, and preliminary 
observations on the course of primary parasitaemia, morphology,
and haematology in splenectomised rats were described.
In this chapter the course of infection in splenectomised 
rats and a brief description of the morphology of the parasite 
during the primary infection are described. The haematologicai 
changes that accompany the infection, the virulence of the 
parasite together with a brief description on the use of the 
babesiacidal drug amicarbalide, and the development of acquired 
immunity after challenge are also described. The different 
observations made on the rat model are compared with those
described for the mongolian gerbil infected with the same
parasite. The results are also compared with those described for 
B. divergens in cattle.
58
The course of infection
The course of infection is illustrated by two experiments.
Experiment 3 (i)
Cryopreserved divergens rat blood was passaged through 
two four week old splenectomised rats before it was inoculated 
into adult splenectomised rats as follows:
Twenty-one 4 1/2 month old female rats were injected with
o
1.5 x 10° PRBC, i.v., one week after they were splenectomised. 
The rats were divided into three groups of seven. In one group 
the course of parasitaemia was followed in blood smears taken 
daily from the tail vein. The other two groups were used as 
serum donors as will be described in Chapter Four. The course of 
infection in the first group is illustrated in Figure 2A. 
Parasitaemia was patent on day 1 post infection and increased 
subsequently reaching a peak on day 3 (1 4-1 8%). Six out of the 
seven rats recovered and the parasitaemia became subpatent on 
day 5. No parasites were detected over 21 days of further 
observation. The seventh rat in this group had a peak 
parasitaemia on day 4 (43%) and died on day 5 post infection.
Experiment 3 (ii)
Fresh blood collected from a passage rat was used to 
inoculate adult splenectomised rats as follows: -
Twenty four four month old female rats were inoculated with 
the same number of parasites as in experiment 3 (i) (i.e.
1.5 x 10® PRBC) i.v. The rats were divided into one group of ten 
and two groups of seven and the course of parasitaemia was 
followed in the first group. The other two groups were used as
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Figure 2A:
The course of infection in 7-17 week old 
splenectomised rats injected with 1.5x108 PRBC i.v.
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Figure 2B:
The course of infection in 10-16 week old 
splenectomised rats injected with 1.5x108 PRBC i.v.
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serum donors as will be described in Chapter Four. The first 
group developed a patent parasitaemia on day 1 and increased 
subsequently, reaching a peak on day 3 16-50%) (Figure 2B).
Eight out of ten rats recovered and became subpatant by day 6. 
No parasites were detected in blood smears taken over 21 days of 
further observation. The other two rats in this group were found 
dead on day 5 post infection.
Morphology of the parasite: 
Experiment 3 (iii)
The appearance of B. divergens in Giemsa's stained rat blood 
smears was similar to that described by Phillips (1984). 
Typically divergent forms, rings, oval forms and maltese cross 
forms were seen (Figure 3). The parasite measured approximately 
(3.4 urn x 0.57 urn). At high parasitaemia, multiple 
parasitisation of the red cells was seen and up to four parasites 
were noted in one cell. Free parasites were also seen in blood 
smears with high parasitaemias.
Experiment 3 (iv) and 3 (v) 
Haematologicai observations:
Red blood cell counts and total white blood cell counts were 
made by collecting blood in heparinised capillary tubes from the 
tail veins of rats used in experiments 3 (i) and 3 (ii) above. 
Other experiments not reported here, confirmed these results. 
Differential white blood cell counts were made by counting 100 
leukocytes in blood smears taken 2-6 days preinfection, during
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Figure 3:
B. divergens in the blood of infected rats.
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the infection and 1-18 days after recovery. The data for 
differential white blood cell count is given for individual 
animals or as groups.
The acute parasitaemia was accompanied by a drop in the red 
blood cell count, between days 2 and 4 (Figure 4A) and days 3-5 
(Figure 4B). Red cell counts started rising immediately after 
recovery from the infection (from day 5 - Figure 4A and day 6 - 
Figure 4B). The white cell count fell slightly at peak 
parasitaemia, but rose continuously from day 4 and reached a peak 
by days 5-6, then fell to preinfection levels by day 22 post 
infection (Figure 4A and 4B). The pronounced leukocytosis after 
recovery was predominately a lymphocytosis and the lymphocyte 
number and percentage correlates with the white cell count 
described above (Table 1 and Figure 5). Neutrophil percentages 
rose during peak parasitaemia (day 3) and fell rapidly by day 6, 
then rose again from day 6. The percentage of monocytes rose 
slightly by days 4-5, then remained relatively low after recovery 
(Figure 5).
Experiment 3 (vi) and 3 (vii) 
Virulence of the parasite and the use of the babesiacidal drug 
"Diaiqpron”
It was shown at the beginning of this chapter that the i.v. 
injection of 1.5 x 10® PRBC into splenectomised rats resulted in 
an infection from which most rats recover. The parasite, 
however, became more virulent with increasing passages and the 
injection of 1.5 x 10® PRBC resulted in a fatal disease. Although 
the inoculation of a decreasing number of the virulent parasites
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Figure 4A & 4B:
RBC and total WBC counts in rats infected with 
B. divergens.
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Figure 5:
% Differential Wbc Counts In Individual Rats
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TABLE 1
Total W.B.C Counts and absolute lymphocyte count in 
splenectomised rats infected with B. diveraens.
Days of infection White cell counts (x 106 /ml)
Lymphocyte counts 
(x 106 /ml)
- 2 6.8 x 106
3 6 .5  x 106 (2.1) 2.1 x 10®
4 5 .9  x 106 (2.6) 2 .4  x 10®
5 1 4.8 x 10® (6.8) 7.1 x 10s
6 22.1  x 106 (10.5) 1 4 x 1 0 ®
8 1 3 x 10® (6.1) -----
1 0 1 0 .6  x 10® (9.8) 3 .2  x 10®
1 1 5 .6  x 10® (1.6) 1 .5  x 10®
Control 8 .2  x 10® 2 .7  x 10®
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resulted in increased prepatent periods, the disease was still 
severe and most rats died from the infection. It was necessary, 
therefore, in some experiments to control the parasites with the 
babesiacidal drug amicarbalide (Diampron). In the following two 
experiments, a comparison was made between the effect of the 
injection of 1 x 104 of infected blood derived from an avirulent 
stabilate and the effect of inoculation of 1 x 1 04 virulent 
parasites and the use of the drug amicarbalide for the treatment 
of some infected rats:-
Experiment 3 (vi):
The use of avirulent stahilates:
Eight (four males and four females) five month old 
splenectomised rats were injected with avirulent parasites as 
follows:-
An avirulent cryopreserved infected blood (WEP 37) was 
passaged twice into four week old male splenectomised rats before 
it was injected into the adult rats. Each rat was injected with 
1 x 104 PRBC, (five rats i.v. and three rats i.p.) and the course 
of infection was followed (Figure 6). No parasites were detected 
in blood smears taken for four days. Parasitaemia was patent on 
day 5 and all rats had a mild infection which lasted for four 
days after which they recovered. No parasites were detected in 
blood smears taken for 21 days after recovery. This experiment 
was repeated twice and the same results were obtained.
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Figure 6:
The course of infection in 8-5 month old
splenectomised rats injected with 1x104 PRBC i.v. 
(avirulent blood).
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Experiment 3 (vii): 
The use of virulent infected blood:
The avirulent stabilate used in experiments 3 (i) and 3 (ii) 
became virulent after approximately 48-50 passages. Fresh 
infected blood collected from a passaged rat was used to inject 
adult splenectomised rats as follows:-
Thirteen (six males and seven females) four month old 
splenectomised rats were injected with 1 x 10  ^PRBC i.v. and the 
course of parasitaemia was followed (Table 2). In some animals 
the parasitaemia was subpatent for 8 days although most rats were 
patent on day 3-4, and five out of 13 rats were treated with 
30 mg/kg diampron subcutaneously, some at the onset of 
haemoglobinuria and some when the parasitaemia reached 18%. Two 
rats were kept untreated and were used as controls. In the 
treated rats, recovery was rapid and parasitaemia was subpatent 
2-3 days after treatment. The parasitaemia in the untreated rats 
increased subsequently and they died on day 8 post infection. In 
the six remaining rats the parasitaemia peaked on day 7 (between 
7-21%), but started decreasing on day 8, and they all recovered 
naturally without treatment. Infected rats were treated on 
occasions in other experiments as required.
Experiment 3 (viii): 
Challenging of normally recovered and drug treated rats:
Rats that recovered naturally from the infection and those 
treated with diampron, were challenged a month after the primary 
infection with 1x10® PRBC i.v. Two control splenectomised rats
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Table 2
The injection of virulent blood into splenectomised 
rats and the use of the drug Diampron.
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Figure 7:
Challenging of normally recovered and drug treated
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that were not infected previously were included. All challenged 
rats (naturally recovered and drug treated) had a detectable 
parasitaemia five minutes after challenge (parasitaemias not 
shown on figure). Smears taken five hours after challenge showed 
that the parasitaemias were declining and no parasites could be 
detected the day after challenge (Figure 7). Blood smears were 
taken daily for three weeks afterwards and no parasites were 
detected. The controls had a patent parasitaemia immediately 
after they were injected with the parasites. The parasitaemia 
increased subsequently and peaked on day 7 (50%). Both controls 
were found dead on day 5 post infection.
Discussion
In this chapter, the course of infection in splenectomised 
rats, the morphology and the size of the parasite, and the 
haematologicai changes that accompany the infection were 
investigated. The virulence of the parasite, the infection with 
different doses and some preliminary observations on the effect 
of using the babesicidal drug "amicarbalide" for the treatment of 
infected animals, and the development of acquired immunity in 
animals naturally recovering from the infection and in drug 
treated animals were investigated. The data showed that the 
course of infection in splenectomised rats is short lasting (6-8 
days) and no recrudesences were observed after the primary patent 
parasitaemia. The course of infection was similar to that 
described previously by Phillips (1984) when adapting the 
parasite to splenectomised rats. Early in the experimental work, 
the i.v. injection of 1.5 x 10® PRBC into splenectomised rats
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produced a patent parasitaemia on day 1 post infection. The 
parasitaemia rose steadily and peaked between day 3 (16-50%) and 
the animals either died or recovered from the infection. The 
pattern of infection in splenectomised rats differed, however, 
from that described for bovine babesia. Davies and colleagues 
(1958) described the course of infection in splenectomised calves 
of what was thought to be B. divergens when studying the British 
species of babesia. They reported that the inoculation of 
1 x 1 0  PRBC subcutaneously into splenectomised calves resulted 
in a prepatent period of six days and a patent infection which 
lasted for 10-12 days. The parasitaemia, however, reappeared in 
the circulation in some calves after recovery from the primary 
patent parasitaemia, at an interval of 11-16 days. In this 
secondary peak of parasitaemia fewer parasites were observed.
Phillips (1984), reported that B. divergens cannot be 
adapted to intact rats. In the present study, it was observed 
that the inoculation of B^ divergens infected red cells into 
intact rats resulted in the disappearance of the parasites from 
the circulation within 7-8 hours (results not shown). Joyner and 
Davies (1967) working on the same parasite as in the present 
study but in calves, described the course of infection in 
splenectomised calves as reported by Davies et al. (1958), but 
found that the inoculation of B. divergens infected blood into an 
intact calf resulted in the lack of development of patent 
parasitaemias. Passage of blood from this animal to other 
susceptible calves produced, however, an infection six months 
later and continued to do so for over three years. In the 
present study, no attempt was made to passage blood from intact
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infected rats to other susceptible rats.
B. divergens was also adapted to mongolian gerbils by Lewis 
and Williams (1979) and the course of infection in the gerbils 
was described by Liddel et al. (1980) and Lewis et al. (1980b, 
1981b). Liddel et al. (1980), found that the i.p. injection of 
mongolian gerbils with 4.5 x 10® PRBC of the human derived "J" 
strain of B^ divergens resulted in a patent parasitaemia two 
hours post infection, and a fatal infection after continuous 
passage which resulted in the death of the animals within 48 
hours. Lewis et al. (1981b) when titrating the infective dose of 
B. divergens (derived from gerbil cryopreserved blood) in the 
mongolian gerbils, found however, that the injection of gerbils 
with 1x10® PRBC i.p. resulted in a prepatent period of 1-4 days 
and an infection which lasted for 6-7 days after which the 
animals either died or recovered. No recrudesences have been 
reported for B^ divergens in the gerbil. It can be concluded 
therefore that the pattern of infection depends on the host used, 
the number of parasites injected, the route of injection and the 
strain of B^ divergens used.
The appearance of B. divergens in blood smears was similar 
to that described in cattle (Davies et al., 1958) and in gerbils 
(Liddel et al., 1980). Typically divergent forms, rings, oval 
forms and maltese cross forms were seen which measured about 
(3.4 x 0.57um) with occasional pairs located peripherally as in 
bovine red blood cells. No direct comparison was, however, made 
between the bovine and the rat propagated B. divergens. Davies 
et al. (1958) compared the British species of Babesia in cattle
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(B. divergens) with the European bovine species (B^  bovis) and 
found that they differ morphologically. The European species 
differed from the British species in being markedly larger with 
the absence of divergent forms. On the other hand, Liddel et al. 
(1980) thought that the gerbil propagated parasites were larger 
than those found in bovine infected red blood cells and larger 
non peripheral non divergent forms were observed by these workers 
in the gerbil propagated parasites.
Several workers have also reported morphological changes in 
B. divergens in their attempt to adapt the parasite to different 
laboratory hosts. Canning et al. (1976) reported morphological 
changes in transient IL_ divergens parasitaemia in rats and 
hamsters from typically darkly staining forms to vacuolated forms 
which were less densely stained. Similar findings have been 
reported by Adam and Blewett (1974) and Irvin et al. (1978), in 
their attempts to adapt B. divergens to mice. The morphology of 
the parasite was also found to differ in different strains of 
B. divergens. Lewis et al. (1980b) made a morphometric comparison 
between B^ divergens parasites in blood smears infected either 
with a human or bovine strain and found more amoeboid forms in 
smears taken from calves infected with a strain of bovine origin. 
The parasites of human origin were found to be also significantly 
larger than the bovine originated strains. In the present study, 
multiple parasitisation of the red cells was very common and up 
to four parasites were seen in a single red cell. Liddel et al. 
(1980) reported that multiple parasitisation of red blood cells 
was a feature of human and gerbil red cells infected with the "J" 
strain of B^ divergens, and up to six parasites in the human
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cells and nine or more have been observed by these workers in the 
gerbil erythrocytes. Such high numbers of parasites in one cell 
were never noted in the rat erythrocytes. With high 
parasitaemias a large number of free parasites were always 
observed. These free parasites were apparently released from the 
red cells after destroying them, to invade other red blood cells.
The acute parasitaemia was accompanied by severe anaemia 
evident as a drop in RBC counts. RBC counts started rising again 
immediately after recovery. It should be noted, that only 
preliminary observations were made on the anaemia that 
accompanies the infection, but its cause was not investigated. 
It is expected, however, that some anaemia must have been caused 
by the vascular destruction of RBC as the parasites leave the red 
cells to invade other cells, as was reported for most acute cases 
of babesiosis (Koch, 1968; Wright, 19731 Callow and Pepper, 
1974). Anaemia has been reported during most babesia infections. 
It was reported for B. canis in the dog (MaeGraith et al., 1957),  
for B. bovis and B. bigemina in cattle (Wright, 1 9 7 3 ) , ,  for 
B. divergens in cattle (Davies et al., 1958; Purnell et al., 
1977b) ,  and in the gerbil (Liddel et al., 1980; Lewis et al., 
1981b)*  The cause of this anaemia may be due to a number of 
mechanisms. It might be due to the intravascular destruction of 
erythrocytes by escaping babesia as described above, or due to 
immunological factors. These factors include phagocytosis of 
both normal and PRBC either in the peripheral blood or in the RES 
(Hildebrandt, 1981),  autohaemagglutinins or opsonins which are 
present in the serum of babesia infected animals and can react
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with infected and even normal erythrocytes and cause anaemia as 
was reported for rodhaini (Shroeder et al., 1966; 1968) and 
P. berghei (Zuckermann, 1977) infections in the rat. Hussein 
(1976) using radioactive labelling techniques found that both 
B. hylomysci infected and uninfected RBC were destroyed in 
infections in mice and related this to autoimmune reactions.
T-lymphocytes were also reported to cause the activation of 
macrophages which resulted in erythrophagocytosis in rodent 
malaria and cause anaemia. Roberts and Weidanz (1978) compared 
anaemia and splenomegaly in athymic "nude" mice, B-cell deficient 
mice, and immunologically intact mice, infected with P. berghei. 
They found enhanced phagocytosis and anaemia in B-cell deficient 
mice and immunologically intact mice. On the other hand infected 
athymic "nude" mice had minimal splenomegaly and failed to 
develop anaemia. They concluded that phagocytosis, anaemia, and 
splenomegaly are thymus dependent in P^_ berghei infection and 
related this to T-lymphocytes which caused activation of 
macrophages which subsequently resulted in erythrophagocytosis 
and finally anaemia.
Antibodies to soluble antigens on the surface of infected 
and normal erythrocytes were also found to be effector mechanisms 
for the removal of erythrocytes in some Babesia and malaria 
infections. Sibinovic (1966), Sibinovic et al. (1967; 1969), 
reported that anaemia in B. canis and B. rodhaini infections was 
mediated by an antigen (antigen B) which appeared in the serum 
during acute parasitaemia. They found that this antigen became 
attached to erythrocytes within a few minutes of intravenous 
injection, after which most of the erythrocytes to which the
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antigen was bound were removed rapidly from the peripheral 
circulation, by a process which involves binding of antibodies to 
the antigens and triggering complement or cell dependent effector 
mechanisms. Similar findings have been reported for some malaria 
infections (reviewed by Smith et al., 1972) which suggest the 
protective role of soluble plasma antigens in infections caused 
by Babesia and Plasmodium species. Finally, immune complexes 
were found to be important in the development of anaemia in some 
Babesia and malaria infections. Immune complexes were 
demonstrated in rats infected with rodhaini (Annable and Ward,
1 974) in P^_ falciparum (Wilson et al., 1 975) and in berghei 
infections in mice (June et al., 1979). These immune complexes 
were found bound to normal and infected erythrocytes and caused 
anaemia.
Recovery from the infection was immediately followed by 
leukocytosis which was predominately a lymphocytosis. It was not 
known whether lymphocytosis was due to newly formed lymphocytes 
entering the blood or due to altered patterns of migration to the 
different lymphoid organs. The first possibility that 
lymphocytosis could have been due to the rapid production of new 
lymphocytes was not investigated but the possibility that 
lymphocytes might be accumulating in the liver was investigated 
and will be described and discussed in Chapter Six. Leukocytosis 
has also been reported for B^ canis infections (Sanders, 1937; 
Siebold and Bailey, 1957; Alperin and Bevins, 1963), B. bovis 
and B. bigemina infections in cattle (Wright, 1973)^ and 
B. divergens in splenectomised calves (Purnell et al., 1977b)
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Liddel et al. (1980) reported, however, that leukocytosis in 
gerbils infected with B^ _ divergens was absent or minimal. The 
leukocyte picture, during Babesia infections varied from one 
author to the other, for example Rodriguez and Rivas (1971) 
described leukopenia with R_ bigemina infections and leukocytosis 
with B. bovis. Wright (1973) on the other hand noticed that 
leukopenia occurred at the beginning of both B^ bovis and 
B. bigemina infections, and was followed by terminal leukocytosis 
after the acute haemolytic phase had passed. There were also 
authors who considered the leukocyte picture during bovis and 
B. bigemina infections is within the normal range (Sergent 
et al., 1945; Hugoson, 1 969).
In the present study, the percentage of absolute numbers of 
neutrophils rose during peak parasitaemia (day 3-4) and fell 
rapidly at recovery (day 5-6), and then it was followed by 
lymphocytosis. The percentage of absolute number of monocytes 
remained low during the course of the infection and after 
recovery. The differential count in various Babesia species also 
varied. Reusse (1954) for example, reported lymphopenia in 
B. canis infection, while Alperin and Bevins (1963) reported 
lymphocytosis. In B. bovis and B. bigemina infections, a decline 
in the percentage of the absolute number of neutrophils followed 
by lymphocytes was described by Wright (1973) • Similar findings 
have been reported by Purnell et al. (1977b) for EL_ divergens in 
splenectomised calves. Lymphocytosis has also been reported for 
other protozoal infections such as yoelii in mice (Playfair 
and De Sousa, 1982), Trypanosoma vivax in cattle (Esievo and 
Saror, 1983) and P. chahaudi in mice (Kumararatne et al., 1987).
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B. divergens in splenectomised rats become virulent with 
increasing passages and the i.v. injection of 1.5 x 108 PRBC 
resulted in a fatal infection and death of the animals, although 
previously the injection of 1.5 x 108 PRBC of the avirulent 
parasites resulted in an infection from which most rats 
recovered. The inoculation of a decreasing number of virulent 
parasites, resulted in an increased prepatent period but with a 
fatal infection even when 1 x 10^ PRBC were injected. Similar 
findings have been reported for B^ rodhaini in mice (Overdulve 
and Antonisse, 1970), for B. bovis in calves (Mahoney et al.,
1 973 b )  for B^ divergens in cattle (Purnell et al., 1 977a)and in 
gerbils (Lewis et al., 1 9 8 1 b ). Purnell et al. ( 1 977a )titrated 
B. divergens in splenectomised calves (108 - 10^ parasites) and 
found that B^ divergens retains its pathogenic identity 
regardless of the number of parasites inoculated. Lewis et al. 
(1981b reported, however, that the same parasite produced a less 
severe disease when 1 x 10  ^ infected erythrocytes were 
inoculated. The present data with the virulent B. divergens is 
therefore in agreement with that described for splenectomised 
calves (Purnell et al., 1977a)and differs from that described for 
gerbils (Lewis et al., 1981b). The host parasite relationship 
apparently differs between different hosts. Splenectomised rats 
that were infected with 1 x 10^ PRBC, but with blood derived from 
an avirulent cryopreserved stabilate, normally produced an 
infection with a prepatent period of 3 -4  days and a less severe 
disease which was followed by recovery.
Rats that received 1x10^ parasitised fresh red blood cells
80
and were treated with the drug diampron when they showed 
haemoglobinuria (at parasitaemias of 8-10%) or higher 
parasitaemias (18-20%), recovered 2-3 days after treatment. Only 
a single injection at a dose rate of 30 mg/kg of the drug was 
injected subcutaneously and the data showed that a single 
injection was enough to cure the animals. Challenging these 
animals with a large number of parasites (1 x 10®) i.v. one month 
after treatment showed that they were strongly immune to 
reinfection. The duration of immunity after drug treatment was 
not, however, investigated. Diampron was also used for the 
treatment of rats infected with rodhaini (Phillips, 1968) and 
for the treatment of gerbils infected with the same parasite as 
in the present study (Gray, 1983). Rats treated against 
B. rodhaini and gerbils treated against B^ divergens were also 
found to be immune to challenge. Rats naturally recovering from 
a B^ _ divergens infection were strongly resistant to reinfection 
when challenged with a large number of parasites i.v. one month 
after recovery. The duration of immunity was not followed but 
preliminary observations have indicated that recovered rats that 
were challenged two months after recovery were resistant to 
reinfection. Phillips (1984) reported that resistance to 
reinfection in splenectomised rats lasts for at least three 
months. Previously Davies et al. (1958) and Joyner and Davies 
(1967) reported that challenging cattle that have naturally 
recovered from B^ divergens infection showed no evidence of 
reinfection after periods varying from 3-7 years and suggested 
that sterile immunity may play a part in the resistance of cattle 
to reinfection. Sterile immunity was also reported for other
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Babesia infections after drug treatment. It was reported for 
B. microti in mice (Cox and Young, 1 969) and for IL_ bigemina in 
cattle (Callow, 1967; Lohr, 1972).
The persistence and development of acquired immunity was 
apparently not dependent on the presence of the spleen and this 
was evident in challenging experiments. The spleen, however, 
appears to be less important in controlling B^ divergens 
infection in gerbils (Lewis and Williams, 1979). Splenectomised 
gerbils were no more susceptible to infection. The role of the 
spleen in acquired immunity will, however, be discussed in a 
later chapter.
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Chapter Four
The protective activity of innune sera and the antibody levels 
as measured by the indirect fluorescent antibody test (IFAT) 
Introduction
Nocard and Motas (1902), were the first to report the 
passive protective activity of immune serum against babesias. 
They demonstrated that the serum of a dog which had recovered 
from canis, had a protective activity. Robertson (1 906) and 
Kikuth and Mudrow (1 939) however, were unable to confirm this 
finding. The protective activity of immune sera in some other 
Babesia species have been reported by several workers: 
B. rodhaini in rats (Matson, 1 964; Phillips, 1969b) and in mice 
(Abdalla et al., 1 978) and B^ argentina (= B.bovis) in
splenectomised calves (Mahoney etaj;1979). There are,
however, no reports of experiments demonstrating the protective 
role of antibody in cattle infected with B^_ divergens although 
the presence of anti B^ divergens antibodies in cattle has been 
demonstrated by several serological tests (Donnelly et al., 1972; 
Purnell et al., 1976)* Antibodies to B. divergens have also 
been detected in recovered gerbils (Liddel et al., 1982), in 
recovered rats and in the offspring of recovered mothers 
(Phillips, 1984), but a definite role for antibody in protection 
was not demonstrated. In this chapter the role of antibody in 
protection was investigated in splenectomised rats infected with 
B. divergens. The antibody levels were measured in sera 
collected during the course of infection and at different 
intervals after recovery, by the indirect fluorescence antibody
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test (IFAT). The protective activity of the same sera was 
investigated using passive transfer experiments and compared with 
the antibody levels as measured by IFAT.
Tfte indirect fluorescence antibody test (IFAT)
Sera for IFAT and passive transfer studies were raised in 
two experiments as follows
Experiment 4 (i):
Twenty one, four and a half month old female splenectomised 
rats were injected with 1.5 x 10® PRBC i.v. The rats were 
divided into three groups of seven rats. The course of infection 
in one group is shown in Figure 2A (see Chapter 3). Rats that 
survived the infection from the three groups were pooled and 
divided into groups of three rats. A group was sacrificed on the 
following days : day 4 (during the infection), day 7 (immediately 
after recovery), day 10, 15, 22 and 40 post infection and their 
sera collected. Normal uninfected rats were also bled and their 
sera collected. These sera were used as controls. The different 
immune sera were aliquoted and kept at -20°C, to be used for 
passive transfer experiments. Small volumes of the sera were 
also aliquoted in eppendorfs and were used for IFAT. Three to 
four different sera with a control (normal serum) were tested 
each time and a 10 fold dilution (from 1/5 to 1/500,000) of 
immune and normal sera were prepared for the first IFA tests. 
Two fold dilutions (from 1/5 to 1/10,240) were prepared for the 
rest of the test sera. All dilutions were made in microtitre 
plates. A 1/400 dilution of FITC conjugated rabbit antiserum to 
rat Ig in PBS containing evan's blue was found to be suitable for
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all tests. The mean antibody titre in the sera is shown in 
Figure 3A. The results showed that no antibodies could be 
detected at peak parasitaemia (day 4). The antibody titre rose 
from day 4 and reached a peak on day 22 at which level it 
remained until day 40. No sera was tested after this time in 
this experiment.
Experiment 4 (ii)
Twenty four, four month old female splenectomised rats were 
inoculated with 1.5 x 10® PRBC i.v. The rats were divided into 
one group of ten and two groups of seven rats. The course of 
parasitaemia was followed in the first group as shown in 
Figure 2B (Chapter 3). Rats that survived the infection from 
all groups were pooled and divided into groups of three rats and 
were sacrificed on the following days: day 4 (during the
infection), day 7 (immediately after recovery), day 13, day 19, 
day 27 and day 53 post infection and their sera collected. The 
sera were aliquoted and tested for IFAT as in experiment 4 (i) 
above, except that a two fold dilution (from 1/5 to 1/10,240) was 
prepared for all the sera tested. The mean antibody titre in the 
sera is shown in Figure 8B. The results showed that no 
antibodies were detected at peak parasitaemia (day 4) as was 
shown in experiment 4 (i) (see above). The antibody titre rose 
from day 5 and plateaued between day 7 and day 13, then rose 
again and reached a peak on day 19 at which level it remained for 
seven weeks (until day 53). No sera were collected or tested 
after this period.
86
Lo
g 
Re
ci
pr
oc
al
 A
nt
ib
od
y 
Tit
re 
Lo
g 
Re
ci
pr
oc
al
 A
nt
ib
od
y 
Ti
tre
Figure 8A & B:
The a n t i b o d y  titre as measured by IFAT in 
splenectomised rats infected with B. divergens.
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Passive transfer experiments 
Sera collected in Experiment 4 (i)
Experiment 4 (iii)
The protective activity of day 4,15 and 40 sera: Preliminary
experiment
In this preliminary experiment, the protective activity of 
day 4, 15 and 40 sera was investigated. A volume of 2 ml of 
serum was tested in splenectomised infected rats as follows: -
Twelve (eight females and four males) 7-8 week old 
splenectomised rats were infected with 1 x 1 0 ^  PRBC i.v. The 
rats were pooled and then groups of 2-3 rats were given 2 ml of 
day 4, 15 or day 40 immune sera i.v. Controls receiving normal 
serum or a highly protective serum (positive 
control = hyperimmune serum) were also included. The 
parasitaemia in day 4 serum recipients was patent on day 1 and 
subsequently increased at the same rate as the normal serum 
recipients (Figure 9). All day 4 serum and normal serum 
recipients (except one normal serum recipient) died on day 4 post 
infection. One normal serum recipient recovered. No parasites 
were detected in blood smears taken on day 5 post infection. In 
the day 15, 40 and the positive control serum recipients, no 
parasites were detected in blood smears taken during 28 days of 
observation.
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Figure 9:
The protective activity of sera collected on days 4,
15 and 40 using 2ml of serum.
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Experiment 4 (iv)
The protective activity of day 7, 10 and 22 sera
In the above experiment, it was shown that 2 ml of serum 
could completely protect the rats and no difference could be made 
between the protective activity of immune sera (i.e. day 15 and 
40). In this experiment, it was decided to reduce the volume of 
the serum injected from 2 ml to 0.5 ml to test the protective 
activity of day 7, 10 and 22 sera.
Ten male 8-9 week old splenectomised rats were injected with 
1 x 10 PRBC i.v. The rats were pooled, then groups of two rats 
were given 0.5 ml of day 7, 10 or day 22 sera i.v. Controls 
receiving normal serum and a highly protective serum (hyperimmune 
serum) were also included. In one day 7 recipient and both 
day 1 0 serum recipients, no parasites were detected in blood 
smears taken during 28 days of observation (Figure 10). The 
other day 7 serum recipient had a subpatent parasitaemia for 
seven days which became patent on day 8 and peaked on day 11 
(21%) after which it decreased. No parasites were detected in a 
blood smear taken on day 15 post infection. In day 22 serum 
recipients no parasites were detected in blood smears taken for 
8-9 days. Parasitaemia was patent on days 9-10 and subsequently 
increased, peaking on day 12 in one rat (17%), which died on 
day 13 post infection, and on day 1 4 in the other rat (38%), 
which died on day 15 post infection. In rats which received a 
highly protective serum, no parasites were detected in blood 
smears taken for six days. The parasitaemia was patent on day 7 
and peaked on day 9 in one rat (16%), which died on day 10 post
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The protective activity of sera collected on days 7,
10 and 22 usingoSml of serum.
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infection, and on day 10 in the other rat (14%) which died on 
day 11 post infection. Normal serum recipients had a patent 
parasitaemia on day 1 which increased subsequently and peaked on 
day 4 (31-41%). The rats died on day 5 post infection.
Sera collected in Experiment 4 (ii)
Experiment 4 (v)
•Hie protective activity of day 4, 13 and 53 sera
In the above experiment, it was shown that 0.5ml of serum 
was completely protective in most rats. In this experiment, it 
was decided to reduce the volume of serum injected from 0.5 ml to
0.4 ml to test the protective activity of day 4, 13 and 53 sera. 
It should be noted that both parasites and serum were injected
1.p. because i.v. injections were not possible at that time. The 
protective activity of day 4, 13 and 53 sera using 0.4 ml of sera 
was tested in infected splenectomised rats as follows:
Twenty female 7-9 week old splenectomised rats were injected 
with 1 x 10 PRBC i.p. The rats were pooled and then groups of 
four rats were given 0.4 ml of day 4, 13 or 53 sera i.p. 
Controls receiving normal serum and a highly protective serum 
(hyperimmune serum) were included. Three of the four day 4 serum 
recipients and three of the four day 53 serum recipients had a 
patent parasitaemia on day 1 (Figure 11). In one day 53 serum 
recipient no parasites were detected on day 1. Parasitaemia was 
patent on day 2. Parasitaemia in the three day 4 serum 
recipients and the four day 53 serum recipients increased 
subsequently at the same rate as the normal serum recipients and
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Figure 11:
The protective activity of sera collected on days 4,
13, and 53 using 0.4 ml of serum.
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peaked between days 4-6 to reach 33-65%. Both day 4 and day 53 
serum recipients died between days 5-7 post infection as did the 
normal serum recipients. In one day 4 serum recipient no 
parasites were detected in blood smears taken on day 1. The 
parasitaemia was patent on day 2 and the rat had a mild infection 
which lasted for four days after which it recovered. In three of 
the four day 13 serum recipients, no parasites were detected in 
blood smears taken over 28 days of observation. In the remaining 
day 13 serum recipient, no parasites were detected in blood 
smears taken for three days. The parasitaemia was patent on 
day 4 post infection and subsequently increased peaking on day 8 
at 65%, and the rat died. No parasites were detected for 3-6 
days in three of the four rats which received a highly protective 
serum (hyperimmune serum). The parasitaemia was patent on 
days 4-7 and subsequently increased. Two of the three rats died 
on days 8 and 12 respectively, and one rat recovered. No 
parasites were detected in blood smears taken from this rat on 
day 12 post infection. The fourth rat in this group had a patent 
parasitaemia on day 6 which increased subsequently and reached a 
peak on day 9 post infection, and the rat died on day 1 0 post 
infection.
Experiment 4 (vi) 
The protective activity of day 7, 13, 19 and 27 sera
In this experiment, the protective activity of day 7, 19 and 
27 sera was tested using the same volume of sera as in the above 
experiment (i.e. 0.4 ml). It was shown in the previous 
experiment that day 13 serum was highly protective. Three of the
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four day 13 serum recipients did not show any parasites in blood 
smears taken for 28 days. One day 13 serum recipient had, 
however, a patent parasitaemia on day 3 and died on day 8 post 
infection. In this experiment it was decided to test the 
protective activity of day 13 serum again using the same volume 
as above to confirm the protective activity of this serum. Both 
parasites and serum were again injected i.p. since i.v. 
injections were not possible at that time:
Twenty female 4-6 week old splenectomised rats were injected 
with 1 x 10' PRBC i.p. The rats were pooled, then groups of four 
rats were given 0.4 ml of day 7, 13, 1 9 or 27 sera i.p. A group 
of rats receiving normal serum was included as a control. Two of 
the day 7 serum recipients had a patent parasitaemia on day 1 and 
3 respectively (Table 3). One of the recipients had a mild 
infection which lasted for four days and then it recovered. In 
the other recipient, the parasitaemia increased subsequently and 
peaked on day 4 at 50% and the rat died on day 5 post infection. 
The other two day 7 serum recipients had no detectable 
parasitaemia in blood smears taken for 28 days. One of the 
day 13 serum recipients had a patent parasitaemia on day 1 which 
increased subsequently and peaked on day 4 at 58% and the rat 
died on day 5 post infection. In the other three day 13 serum 
recipients, no parasites were detected in blood smears taken for 
28 days. In two of the day 19 serum recipients, no parasites 
were detected in blood smears taken for three days in one 
recipient and for nine days in the other recipient. Parasitaemia 
was patent on day 4 in one recipient and on day 10 in the other
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Table 3
The protective activity of day 7, 13, 19 and 27 after 
I.P. injection of both parasites and serum.
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recipient which increased subsequently to reach 62% and 42% on 
days 7 and 1 3 respectively. These both died, on days 8 and 1 4 
respectively. In the other two day 19 serum recipients, no 
parasites were detected in blood smears taken over 28 days of 
observation. Three of the day 27 serum recipients had a patent 
parasitaemia on days 2, 11 and 12 respectively which increased 
subsequently and peaked at 66, 36 and 62% on days 4, 13 and 16. 
All three of these recipients died, on days 5, 14 and 17
respectively. In the fourth recipient in this group, no 
parasites were detected in blood smears taken over 28 days of 
observation. All normal serum recipients (controls) had a patent 
parasitaemia on day 1 which increased subsequently and they all 
died between days 5 and 6 post infection.
Experiment 4 (vi) 
Hie protective activity of day 7, 13, 19 and 27 sera
In experiments (v) and (vi), it was shown that there was 
variation in the results and the protective activity of some sera 
(for example day 7 and day 13) was not confirmed. This variation 
was due to the fact that both parasites and serum were injected 
i.p. The disadvantage of i.p. injections is that it is possible 
that not all the parasites or the serum injected enter the blood 
cirulation. Some might for example enter the gut. It was 
decided, therefore, to repeat the experiment. In this 
experiment, both parasites and serum were injected i.v. and the 
protective activity of day 7, 13, 19 and 27 serum was tested in 
splenectomised rats as follows:
Twenty male five week old splenectomised rats were injected
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with 1 x 107 PRBC i.v. Of these three groups of four rats were 
given 0.4ml of day 7, 13, 1 9 or 27 i.v. A group of rats which 
received normal serum was included as a control. In all day 7 
and day 13 serum recipients, no parasites were detected in blood 
smears taken during 28 days of observation (Figure 12). In all 
day 19 and day 27 serum recipients no parasites were detected in 
blood smears taken for 6 days and 7 days respectively. The 
parasitaemia in groups was patent on days 7 and 8 respectively, 
which increased subsequently and peaked between days 1 0 and 1 3 
post infection (26-86%). All rats in both groups died between 
days 11 and 13 post infection. All normal serum recipients had a 
patent parasitaemia on day 1 which increased subsequently and 
peaked on day 3 (19-40%). All rats in this group died on day 4 
post infection.
Experiment 4 (vii) 
The protective activity of day 7, 13, 27 and 53 sera
In the previous experiment, it was shown that both day 7 and 
day 13 sera were strongly protective when 0.4 ml of either sera 
were used, and no difference could be found between the 
protective activity of the two sera. It was decided, therefore, 
to reduce the volume of serum injected from 0.4 ml to 0.2 ml, to 
test which of the sera (day 7 or day 13) is more protective, and 
to compare the protective activity of these sera with the 
protective activity of day 27 (which was partially protective 
when 0.4 ml of serum was used) and day 53 serum (which was not 
protective when 0.4 ml of serum was used) using 0.2 ml of serum.
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Figure 12:
The protective activity of sera collected on days 7,
13, 19 and 27 using 0.4ml of serum.
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The protective activity of day 7, 13, 27 and 53 sera was tested 
in splenectomised infected rats as follows:
Twenty female, 5-6 week old splenectomised rats were 
injected with 1 x 10 PRBC i.v. The rats were pooled and then 
groups of four rats were given 0.2 ml of day 7, 13, 27 or 53 sera
i.v. A group of rats which received the same volume of normal 
serum was included as a control. Three of the day 7 serum 
recipients had a prepatent period of 10-11 days. Parasitaemia 
was patent on days 11-12 which increased subsequently and peaked 
on day 14 (39-56%) (Figure 13). All three recipients died on 
day 15 post infection. The fourth recipient in this group had no 
detectable parasites in blood smears taken for 28 days. Day 13 
serum recipients had a prepatent period of 7-9 days. 
Parasitaemia was patent on days 8-10 which increased subsequently 
and peaked between days 10-13 (41-65%). All recipients in this 
group died between day 11 and 1 4 post infection. Day 27 serum 
recipients had a prepatent parasitaemia of 1-3 days. 
Parasitaemia was patent on days 2-3 which increased subsequently 
and peaked on days 6-8 and the rats died between days 7 and 8 
post infection. Two of the day 53 serum recipients and three of 
the normal serum recipients had a prepatent period for one day. 
The other two day 53 serum recipients and one normal serum 
recipient had a patent parasitaemia on day 1 which increased 
subsequently. All rats in both groups died on days 5 and 6 post 
infection.
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Figure 13:
The protective activity of sera collected on days 7,
13, 27 and 53 using 0.2 ml of serum.
Rats d Rats d Rat d
5 1 Rat d
DAY 7 
-o- DAY 13 
DAY 27 
DAY 53 
-o- N.S
Or-
8 10 1 2 14 1 6
Days Post Infection
101
Experiment 4 (viii)
Challenging of serum recipients:
In order to test whether immune serum was still protective 
four weeks after serum administration, serum recipients were 
challenged on day 28 with 1 x 1 0® PRBC i.v. A splenectomised 
rat that received no serum at all was included as a control. 
Figure 14 shows the results of one challenge experiment 
(Experiment 4 (iii) - day 15 and 40 serum recipients). Day 15 
and 40 serum recipients had a patent parasitaemia on day 1 which 
increased subsequently at the same rate as the control rat and 
reached a peak on day 3 (44-56%). All challenged serum 
recipients died on day 4 post challenge as did the control rat.
A comparison between protection in passive transfer experiments 
and the antibody titre as measured by IFAT
Passive transfer experiments showed that the levels of serum 
protection rose rapidly from day 6 to reach a peak between day 7 
and 13 and thereafter the levels declined rapidly. On the other 
hand the antibody titre as measured by IFAT (see 
experiments 4 (i) and 4 (ii)) rose from day 5 and reached a peak 
on day 1 9 at which level it remained for at least seven weeks. 
It was not possible therefore to correlate protection with 
antibody levels as measured by IFAT. Figure 15 shows a 
comparison between serum protection in passive transfer and the 
antibody titre as measured by IFAT.
102
Figure 14:
Challenging of serum recipients with 1x108 PRBC, 
4 weeks after serum administration.
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Figure 15:
A comparison of protective in passive transfer 
experim ents and the antibody titre as measured by 
IFA T.
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Discussion
In this chapter the possible participation of humoral 
factors in acquired immunity to B. divercrens was investigated in 
splenectomised rats, using passive transfer experiments. 
Antibodies to Eu_ divergens were first detected by the indirect 
fluorescence antibody test (IFAT). This test has also been used 
for the detection of antibodies to B^  divergens in rhesus monkeys 
(Garnham and Voller, 1965), cattle (Donnelly et al., 1972; 
Blewett and Adam, 1978), deer (Adam et al., 1976), gerbils 
(Liddel et al., 1982) and in rats (Phillips, 1984). The antibody 
titre as measured by this test rose rapidly after peak 
parasitaemia (day 4), and then continued to rise while 
parasitaemia fell from day 5. This rise continued until the 
parasites had disappeared from the blood, and reached a peak 
between days 19 and 22 at which level it remained for seven 
weeks.
The protection in splenectomised rats with immune serum in 
passive transfer experiments has confirmed the participation of 
humoral factors in acquired immunity. In general the protective 
activity of the serum rose from days 5-6 (at recovery) and 
reached a peak between day 7 and day 13 after which it declined 
rapidly. It can be concluded, therefore, that it is not possible 
to correlate protection with antibody levels as measured by IFAT, 
indicating that some antibodies to B^ divergens were not 
protective. Similar findings have also been reported for 
B. microti in mice (Cox and Turner, 1970a) and previously for 
some murine malaria such as vinckei and P^_ chabaudi in mice 
(Cox et al., 1969). Depending on the volume of the serum
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injected, immune serum was either responsible for the death of 
all parasites which was reflected in the lack of patent 
parasitaemia, the temporary inhibition of the parasite, or the 
death of some parasites which was reflected in an increased 
prepatent period. Another possibility is that the antiserum 
might have had a cytostatic action on the parasite so that their 
multiplication rate is reduced to a very low level that could not 
be detected in blood smears. In a preliminary experiment, a 
volume of 2 ml of immune serum was used to compare the protective 
activity of day 4, 15 and 40 sera. Day 4 serum was not 
protective. The results were expected since the IFA test using 
this serum did not show any detectable antibody titres, although 
the antibody titres as measured by IFAT cannot be correlated with 
protection as was mentioned before. All day 4 serum recipients 
had a patent parasitaemia on day 1 and a severe infection which 
ended with their death at the same time as the controls. This 
serum was also nan-protective when the volume of the serum was 
reduced as will be mentioned later in the text. On the other 
hand, day 15 and day 40 sera were strongly protective. The data 
have shown that this volume (i.e. 2 ml) was apparently 
responsible for the rapid elimination of all parasites in day 15 
and day 40 serum recipients.
Since a volume of 2 ml of serum completely protected the 
recipients, and no difference could be found between the 
protective activity of day 5 and day 40 serum, it was decided 
therefore, to reduce the volume of serum injected from 2 ml to
0.5 ml, to compare the protective activity of day 7, 10 and 22
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sera. Day 7 and day 10 sera were apparently more protective than 
day 22 serum using this volume. In one day 7 serum recipient 
and both day 10 serum recipients, no parasites were detected in 
blood smears taken for 28 days. In the second day 7 serum 
recipient, no parasites were detected in blood smears taken for 
seven days; the parasitaemia was however, patent on day 8 and the 
rat had a mild infection which lasted for seven days after which 
it recovered. It is possible that the variation in the results 
in the two day 7 serum recipients might have been due to a fault
in the injection of either the parasite or the serum in the
second day 7 recipient, so that a smaller number of the parasites 
or the serum than the original inoculum were actually injected, 
since the same serum proved to be strongly protective when a 
reduced volume of serum was injected as will be mentioned later. 
Day 22 serum was partially protective. There was a delay in the 
onset of parasitaemia for 8-9 days. Parasitaemia was patent on 
days 10-11 which was followed by a severe infection and finally
the death of all the rats in this group.
Since 0.5 ml of serum completely protected most day 7 and 
day 10 recipients, it was decided in the following two passive 
transfer tests to reduce the volume of serum injected from 0.5 ml 
to 0.4 ml. In both passive transfer tests, both the parasite and 
the serum were injected i.p. because i.v. injections were not 
possible at that time. In these two experiments there was the 
possibility that not all the parasites injected (i.e. 1 x 10^) 
had entered the blood circulation. Some may, for example, have 
entered the gut for example as a result of an i.p. injection, and 
therefore a smaller number of the parasites or volume of serum
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than the original inoculum (1 x 10^ PRBC or 0.4 ml of serum) had 
actually entered the circulation. This was reflected in the 
variation in the results between the protective activity of the 
different sera. In one of these tests, the protective activity 
of day 4, 13 and 53 sera was compared after the i.p. injection of 
both parasites and serum. Although there was some variation in 
the results, a comparison between the protective activity of 
these sera was possible. Day 4 and day 53 sera were apparently 
not protective. Most recipients in these two groups had a patent 
parasitaemia on day 1-2 and a severe infection, and they died at 
the same time as the controls. Day 13 serum was strongly 
protective. In most recipients no parasites were detected in 
blood smears taken for 28 days.
In the second passive transfer test where both the parasite 
and the serum were injected also i.p., the protective activity of 
day "7, 13, 19 and 27 serum was compared using 0.4 ml of serum. 
In this test, there was considerable variation between the 
results. It was decided, therefore, to repeat the test using the 
same sera, but this time both parasite and serum were injected
i.v. The results have shown that day 7 and day 13 sera were 
strongly protective using this volume of serum (0.4 ml). No 
parasites were detected in blood smears taken from both serum 
recipients for 28 days. Day 19 and day 27 sera were partially 
protective. In all recipients of both groups, there was a delay 
in the onset of parasitaemia for 6-7 days. Parasitaemia was 
patent on day 7-8 followed by a severe infection. All recipients 
in both groups died between days 11-13 post infection.
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Since no difference could be made between the protective 
activity of day 7 and day 13 sera when 0.4 ml of serum was 
injected into recipients, and they both appeared strongly 
protective, it was decided to reduce the volume of serum injected 
from 0.4 ml to 0.2 ml, to test which of the sera is more 
protective. In the final passive transfer test, the protective 
activity of day 7, 13, 27 and 53 was compared using 0.2 ml of 
serum. The results have indicated that day 7 serum was more 
protective than day 13 serum. There was a delay in the onset of 
parasitaemia for 11-12 days in day 7 serum recipients, and a 
delay of 7-9 days in the onset of parasitaemia in day 13 serum 
recipients. Most rats in both groups had a severe infection and 
died on day 15 (day 7 recipients) and between days 11-14 (day 13 
serum recipients). Day 27 serum appeared to be less protective 
than day 7 and 1 3 sera, and more protective than day 53 serum. 
There was a delay in the onset of parasitaemia for 2-3 days in 
day 27 serum recipients, and a severe infection followed by their 
death on days 7 and 8 post infection. The results for day 53 
serum were expected. This serum was apparently less protective 
even when a larger volume of serum was used (2 mis). All serum 
recipients in this group had a patent parasitaemia between days 1 
and 2 as did the controls, and a severe infection, resulting in 
death on day 5-6 at the same time as the controls.
It can be concluded, therefore, that maximum protective 
activity was obtained between the serum collected immediately 
after recovery (day 7), and day 13 serum, and the protective 
activity of the serum apparently wanes by day 53. In the passive 
transfer experiments, the administration of a single dose of
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immune serum after the injection of the parasite was effective 
and it either killed all the parasites or delayed their 
appearance depending on the serum and the volume used. In 
B. bo vis in cattle (Mahoney, 1967a) and B. rodhaini in rats 
(Phillips, 1969b), it was found that the daily injection of 
immune serum was more effective than the administration of a 
single large dose of serum. In the present study, the effect of 
the daily injection of immune serum was not tested. Mahoney 
(1967a) suggested that the timing of injection of serum could be 
important in conferring a high degree of protection as the 
parasites may be vulnerable to antibody attack when passing from 
one cell to the other at the multiplication phase. Passive 
transfer experiments have shown that the injection of immune 
serum reduced only the infective dose, but the subsequent 
parasitaemia increased at the same rate as the controls receiving 
normal serum. Similar findings were also observed with rat and 
mouse serum against rodhaini (Phillips, 1969b; Abdalla et al., 
1978). Previously, Roberts and Tracey Patte, 1975b, reported 
however, that parasites surviving the lethal effect of immune 
serum in B. rodhaini infected mice, were found to have a reduced 
multiplication rate.
The data have shown that the transferred serum had no 
lasting protective activity. This was apparent when the serum 
recipients were challenged with a large number of parasites four 
weeks after serum administration. Rats which showed no patent 
parasitaemia after serum administration, had a patent 
parasitaemia on day 1 when challenged, and a severe infection
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developed. It appeared that no immunity had been acquired from 
the antigenic stimulus of the primary parasitaemia and confirmed 
that all parasites were killed after serum administration. In 
addition, the transferred serum had no lasting protective 
activity. It is also possible that while the administration of 
immune serum mediated parasite destruction it might have 
inhibited the active development of the host's immune response. 
It has been shown by some workers (Uhr and Baumann, 1961; Neiders 
et al., 1962), that it is possible to depress the animal's 
humoral antibody by passively immunising it with homologous 
antisera to an antigen such as sheep red blood cells, before or 
after antigen administration. Phillips (1969b), working on 
B. rodhaini in rats, reported that the secondary parasitaemia in 
rats treated with immune serum was severe and it appeared that no 
immunity had been acquired from the antigenic stimulus of the 
primary parasitaemia. Phillips (1969b) compared this secondary 
parasitaemia with the secondary parasitaemia in young rats which 
were treated with the babesiacidal drug babesan and found that 
drug treated rats rarely suffered a secondary parasitaemia and if 
they do, it remained at a very low level, although babesan has no 
long term activity at the dose level this author used. Phillips 
(1969b) suggested that either the injection of serum after the 
injection of the parasite in passive transfer experiments might 
have inhibited protective antibody production, or that antigenic 
variation might have played a part in protection, so that a 
population of parasites can be vulnerable to the action of 
antiserum, and another population can be resistant. Antigenic 
variation in B^ rodhaini was also reported by Thoongsuwan and Cox
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(1973) and Roberts and Tracey Patte (1975a). It was also 
reported for B. bovis in cattle (Cumow, 1973a) although Mahoney 
et al.1979 reported that variation of protective antigens in cattle 
infected with bovis had little effect on the host's immune 
response. Recently, antigenic diversity was reported for 
B. divergens in rats (Phillips et al., 1987) which suggests that 
it may play a role in the host's immune response against the 
infection.
The mechanisms of action of immune serum are not known. The 
protective activity of the immune serum might have been due to 
its direct action on the parasite or the initiation of some 
responses in the host against the parasite, such as enhanced 
phagocytosis of PRBC's (i.e. opsonic antibody was involved). 
Shroeder et al. (1966) reported that the protective activity of 
immune serum in B^ rodhaini infection in rats may be due to 
autoimmune antibodies that opsonise the infected erythrocytes and 
cause their phagocytosis by macrophages. Rogers (1974) also 
correlated opsonic activity of antiserum to B. rodhaini with its 
ability to protect rats in passive transfer tests. Abdalla and 
colleagues (1978), working on the same parasite in mice (i.e. 
B. rodhaini), injected mice with parasites mixed with serum and 
found that although antibody may kill some parasites, it does not 
eliminate them. They suggested that free parasites represent 
direct targets for the protective antibodies which prevent their 
penetration into red cells and cause their phagocytosis. Mahoney 
etaj;1979reported that when cattle are passively protected with 
hyperimmune serum, free parasites as well as infected
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erythrocytes were targets for antibody attack. Bautista and 
Kreier (1 979), working on microti in hamsters in vitro also 
suggested that immune serum inhibits parasite multiplication by 
preventing the invasion of red cells by the parasite. In the 
present study, it is not known at this stage whether opsonic 
antibody has a role in protection against B^ divergens in rats. 
The possible role of opsonic antibody in protection will be 
described and discussed in chapter seven.
Complement fixing antibody may also play a role in 
protection, but this has not been investigated. Mahoney (1964), 
however, reported that the level of complement fixing antibody in 
the serum of cattle recovered from B. bovis infection fell to a 
low level within a few weeks of recovery. Similar findings have 
been reported for B. rodhaini in rats (Phillips, 1968). In a 
later work, Mahoney (1967a) found that protection was obtained 
only with serum with a low level of complement fixing antibody 
collected from cattle that have been superinfected with B. bovis. 
It was concluded therefore that complement fixing antibodies are 
unlikely to play a part in protective immunity against B. bovis 
and B. rodhaini infections (Mahoney, 1967a; Phillips, 1968; 
1969b).
Passive transfer experiments have shown that splenectomy did 
not effect the action of passively administered serum. Similar 
findings have been reported for B^ bovis in cattle (Mahoney, 
1967a) and in B^ rodhaini in mice (Abdalla et al., 1978). The 
role of the spleen, will be, however, discussed in detail later.
The protection of splenectomised rats with immune serum has 
demonstrated the importance of humoral factors in acquired
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immunity and has suggested that the mechanisms of immunity in 
B. divergens in rats is dependent at least on the presence of 
protective antibodies. They are thus in agreement with 
conclusions made on other Babesia (Mahoney, 1967a; 1968;
Phillips, 1969b; Abdalla et al., 1978). It remains now to confirm 
that antibody does play a role in protection. In the following 
chapter, immune and hyperimmune serum were fractionated, to 
demonstrate that protection was associated with serum gamma­
globulins and to determine the class or classes of antibody 
responsible for protection.
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CHAPTER FIVE
PRACTICNATICN OF DMJNE AND HYPERBMJNE SERA AND THE PROTECTIVE 
ACTIVITY OF IgG AND IgM ANTIBCDIES
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Chapter Five
Fractionation of and hyperimmune sera and the protective
activity of IgG and IgM antibodies
iNnaoDOcncN
In Chapter Four, passive transfer experiments showed that 
humoral factors play an important role in acquired immunity to 
B. divergens in splenectomised rats and indicated that antibody 
might be involved in protection. Similar findings have been 
reported for some other Babesia species (reviewed by Callow and 
Dalgliesh, 1982). Mahoney et al;1979> working on B. bovis in cattle 
reported that serum collected after 2-3 infections (hyperimmune 
serum) was strongly protective when injected into splenectomised 
infected calves, and that protection was contained in the IgG 
fraction of the serum. There are, however, no other reports 
specifically demonstrating the class or classes of 
immunoglobulins involved in protection in the different Babesia 
species. In order to confirm that antibody plays a role in 
acquired immunity to divergens in splenectomised rats, it was 
necessary, therefore, to fractionate the immune sera to 
demonstrate that protection was associated with serum gamma 
globulins and to determine the class or classes of antibodies 
responsible for protection. In this chapter, the protective 
activity of IgG and IgM fractions of hyperimmune serum and of 
day 7-8 sera (sera collected immediately after recovery), and the 
IgG fraction of day 10 sera (sera collected 3-4 days after 
recovery) was investigated.
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Experiment 5 (i)
The protective activity of hyperimmune serum (preliminary
experiment)
In this experiment, the protective activity of hyperimmune 
serum prior to fractionation was investigated. A volume of
0.35 ml of serum was tested in splenectomised infected rats as 
follows:
Four (two males and two females) five month old 
splenectomised rats were injected with 1 x 1 0 ^  PRBC i.v. The 
rats were pooled and then a group of two rats was given 0.35 ml 
of hyperimmune serum i.v. The other group received the same 
volume of normal serum i.v. Hyperimmune serum recipients had a 
patent parasitaemia on day 1 which increased subsequently at the 
same rate as the normal serum recipients and both rats in this 
group died on day 6 post infection as did the controls 
(Figure 16).
Experiment 5 (ii)
The protective activity of hyperiinnune serun using 2 ml of serun
In the above experiment it was shown that using 0.35 ml of 
hyperimmune serum was not protective. It was decided, therefore, 
to increase the volume injected from 0.35 ml to 2 ml. A volume 
of 2 ml of serum was tested in splenectomised infected rats as 
follows:
Four female 6-7 weeks old splenectomised rats were injected 
with 1 x 107 PRBC i.v. The rats were pooled and a group of two 
rats were given 2 ml of hyperimmune serum i.v. The other group
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Figure 16:
The protective activity of whole hyperimmune
serum using 0.35ml of serum.
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received the same volume of normal sera (one i.v. and the other
i.pj. Hyperimmune serum was strongly protective. No parasites 
were detected in blood smears taken from hyperimmune recipients 
during 28 days of observation (Figure 17). On the other hand, 
normal serum recipients had a patent parasitaemia on days 1-2 and 
a severe infection. Both rats in this group died on days 5-6 
post infection.
Experiments 5 (ill)
Ite protective activity of day 4, 5, 6 and 8 sera
It was shown in Chapter Four that sera collected during the 
infection (day 4-5) were not protective in passive transfer 
tests. Sera collected after recovery from the infection (day 7- 
13) were, however, strongly protective. In this experiment, it 
was decided to test again the protective activity of sera 
collected during the infection (day 4 and 5), at recovery with a 
very low parasitaemia (day 6) and 1 day after recovery (day 7 or 
8 depending on when the rats recover from the infection), prior 
to fractionation of day 7 or 8 sera and day 10 sera (3-4 days 
after recovery). It should be noted that this experiment was 
done at a time when the parasite was avirulent (or had just 
started to become virulent) and rats normally recover from the 
infection when receiving 1 x 1 0 ^  PRBC. Day 4, 5, 6 and 8 sera 
was raised in splenectomised infected rats as follows:
Eight (five males and three females), 6 1/2 month old 
splenectomised rats were infected with 1 x 10^  PRBC i.v. and the 
course of infection was followed. There was a delay in the onset 
of parasitaemia of two days in all rats. The parasitaemia was
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Figure 17:
The protective activity of whole hyperimmune
serum using 2ml of serum.
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patent on day 3 post infection which increased subsequently. The 
rats were divided into groups of two rats and a group was 
sacrificed on day 4 (parasitaemia = 17-19%), day 5 (parasitaemia 
38-39%), day 6 (at recovery) (parasitaemia 0.2-0.5%) and day 8 
(one day after recovery), and their sera collected. The 
protective activity of day 4, 5, 6 and 8 sera was tested as 
follows:
Fifteen (eight female and seven male), 4-5 week old 
splenectomised rats were injected with 1 x 10^  PRBC i.v. It was 
shown in Chapter Four when testing the protective activity of 
day 4 and day 7 sera, that 0.4 ml of serum was not protective 
with day 4 serum and was protective with day 7 serum. It was 
decided in this experiment to inject 1 ml of serum into each 
recipient. Groups of 2-3 rats were injected with 1 ml of day 4- 
5, 6 or 8 sera immediately after the injection of the parasites. 
A control group which received the same volume of normal serum 
was included. Day 4 and 5 sera were not protective (Figure 18). 
Day 4 and 5 sera recipients had a patent parasitaemia on day 1 
which increased subsequently at the same rate as the normal serum 
recipients and they died on day 5 post infection as did the 
controls. Day 6 serum was partially protective. There was a 
delay in the onset of parasitaemia for 7-8 days in day 6 serum 
recipients. The parasitaemia was patent on day 8-9 which 
increased subsequently. All rats in this group died on days 12- 
13 post infection. Day 8 serum was strongly protective. No 
parasites were detected in blood smears taken over 28 days of 
observation, thus confirming that sera collected immediately 
after recovery were strongly protective.
121
Figure 18:
The protective activity of sera collected on days 4,
5, 6 and 8 using 1ml of serum.
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Experiment 5 (iv)
Isolation of IgG from hyperimmune serum, day 7, day 10 and normal 
serun (N.S.)
The method for isolation of IgG from the different sera was 
described in the materials and methods chapter (see Chapter Two). 
Twenty ml of serum were used for each fractionation (except 
day 7 serum where 15 ml of serum were used). The Ig fraction of 
the sera was first precipitated by sodium sulphate. The 
precipitate was resuspended in 10 ml of PBS (pH 7.2) 
(Appendix A), dialysed against PBS overnight and poured into a 
column of DEAE Cellulose to isolate the Ig fraction of each 
serum. IgG was eluted by the starting buffer (i.e. phosphate 
buffer pH =7) in a single asymmetric peak (Figure 19 
fraction B). The relative concentration of IgG was estimated 
using a spectrophotometer at an absorbence of 280 nm.
Experiment 5 (v)
Agar gel electrophoresis
Rat IgG in fraction B (Figure 19) was demonstrated by agar 
gel electrophoresis as described in the materials and methods 
chapter against neat anti-rat whole serum (Sigma), sheep anti-rat 
IgGAM and L chains and rat IgG Fc. Figure 20 shows IgG 
precipitation arcs for hyperimmune serum, compared to whole 
normal serum.
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Figure 19:
Isolation of IgG from rat serum on DEAE cellulose in 
0.07M sodium phosphate pH7 following sodium 
sulphate precipitation.
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Figure 20:
Im m unoelectrophoretic  analysis  of hyperim m une  
serum IgG eluted on DEAE cellulose compared to 
whole, normal serum.
Anti rat whole serum
Experiment 5 (vi)
The protective activity of hyperimmune serum IgG compared to 
hyperinmune serum (whole) and normal serun IgG
It was shown in a previous experiment that 2 ml of 
hyperimmune serum was strongly protective (see experiment 5 
(ii)). In this experiment, the volume of hyperimmune serum 
injected was reduced from 2 ml to 1.5 ml and the protective 
activity of hyperimmune serum IgG, hyperimmune serum (whole) and 
normal serum IgG was compared as follows:
Sixteen (11 females and 5 males) five week old
(Z
splenectomised rats were injected with 1 x 1 0  i.v. The rats 
were pooled and then groups of four rats were given 1.5 ml of 
hyperimmune serum IgG, hyperimmune serum (whole) or normal serum 
IgG. A control group receiving the same volume of normal serum 
was also included. Hyperimmune serum IgG and hyperimmune serum 
(whole) were strongly protective (Figure 21). No parasites were 
detected in blood smears taken from both sera recipients during 
28 days of observation, thus confirming the protective activity 
of hyperimmune serum IgG and hyperimmune serum (whole) in a 
previous experiment (results not shown), where 2 ml of either 
serum was injected into recipients and proved to be highly 
protective. In contrast, normal serum IgG was not protective. 
All rats in this group had a patent parasitaemia on day 1 which 
increased subsequently at the same rate as the normal serum 
(whole) recipients, and died on day 5 post infection as did the 
whole normal serum recipients.
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Figure 21:
The protective ac tiv ity  of  hyperim mune serum  
compared to whole hyperimmune serum and normal 
serum IgG.
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Experiment: 5 (vi)
protective activity of day 10 IgG compared to day 10 (whole
serum)
In order to check whether IgG was responsible for protection 
in sera collected 3-4 days after recovery (day 10), the 
protective activity of day 10 IgG was investigated and compared 
with the protective activity of day 10 (whole serum). A volume 
of 1.5 ml of either day 10 IgG or day 10 (whole serum) was 
injected into splenectomised infected rats as follows:
Twelve (ten females and two males) 5-6 week old 
splenectomised rats were injected with 1 x 1 0 ®  PRBC i.v. The 
rats were pooled and then groups of 3-4 rats were injected with
1.5 ml of day 10 IgG or day 10 (whole serum) i.v. A control 
group which received the same volume of normal serum was 
included. Day 10 IgG and day 10 whole serum were strongly 
protective. No parasites were detected in blood smears taken 
during 28 days of observation (Figure 22). Normal serum 
recipients had a patent parasitaemia on day 1 which increased 
subsequently and they all died on day 5 post infection.
Experiment 5 (vii)
Challenging of serum recipients
To test whether whole hyperimmune serum, hyperimmune serum 
IgG, whole and day 10 serum and day 10 IgG had any residual 
protective activity four weeks after administration, serum or IgG 
recipients were challenged on day 28 with 1 x 10® PRBC i.v. An 
eight week old splenectomised rat that had received no serum at
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Figure 22:
The protective activity of day 10 IgG compared to
whole day 10 serum.
o
13
GC
in©
T”
o
n
O)'
o
4-
3-
2 -
c
(0
<D
2  1
Rats d
- a -  N.S
DAY 10 
-o- DAY 10 IgG
//
4 6 8
Days Post Infection
28
129
Me
an
 
Lo
g 
Pr
bc
/1
0 
Rb
c
Figure 23:
C hallenging  of hyperimmune serum IgG, whole  
hyperimmune serum, day 10 IgG and whole day 10
recipients with 1x108 PRBC 4 weeks after serum 
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all was included as a control. All challenged recipients had a 
patent parasitaemia on day 1 which increased subsequently at the 
same rate as the control rat (Figure 23). Rats in all groups 
including the control rat were treated on days 2 or 3 
(parasitaemia between 9% and 33%) post challenge with 30 mg/kg 
Diampron subcutaneously. The parasitaemia in the treated rats 
started decreasing 1-2 days after treatment, and all rats 
recovered subsequently. No parasites were detected in blood 
smears taken 3-4 days after treatment.
Experiment 5 (viii)
The protective activity of day 7 IgG compared to whole day 7 
seznm
In this experiment, the protective activity of the IgG 
fraction of day 7 serum was tested. In this test, rats were 
injected with the corrected volume of the fractionated serum to 
allow for dilution during fractionation as shown in Table 4. The 
protective activity of day 7 IgG and whole day 7 serum using 
volumes of either IgG fraction or whole serum described in 
Table 4, was compared in splenectomised infected rats as follows:
Twelve (six males and six females) 4-5 week old 
splenectomised rats were injected with 1 x 1 0 ^  PRBC i.v. The 
rats were pooled and groups of four rats were injected with
1.5 ml of day 7 whole serum or 0.65 ml of day 7 IgG. A control 
group which received 1.5 ml of normal serum was included. Day 7 
IgG was partially protective (Figure 24). There was a delay in 
the onset of parasitaemia for 4-5 days. Parasitaemia was patent 
can day 5 and day 6 which subsequently increased and all day 7 IgG
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Table 4:
Volume of day 7 serum originally 
f ra c t io n a te d 1 5 m l
Volume of day 7 IgG fraction obtained after 
concentration of pooled IgG fractions 6 . 5 ml
Volume of day 7(whole serum) injected into 
each recipient1.5 1 . 5ml
Volume of day 7 IgG injected into each 
r ec i p i ent 0 . 6 5 m l
Figure 24:
The protective activity of day 7 IgG compared  
whole day 7serum.
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recipients died on days 8-9 post infection. Day 7 (whole serum) 
was strongly protective. No parasites were detected in blood 
smears taken during 28 days of observation. Normal serum 
recipients had a patent parasitaemia on day 1 which increased 
subsequently and they all died on day 6 post infection.
Experiment 5 (ix)
Isolation of IgM from hyperimmune serum, normal serum and sera 
collected on day 7 (immediately after recovery) by gel filtration
The method for the isolation of IgM from hyperimmune serum, 
normal serum and day 7 serum by sephadex G-200 and sephacryl S- 
300 was described in the materials and methods chapter. 
Two x 20ml of pooled hyperimmune serum were used for two 
fractionations. Fourteen ml of pooled normal serum and 6 ml of 
pooled day 7 serum were used, for one fractionation each. In 
each fractionation, hyperimmune serum, normal serum and day 7 
serum were eluted from a column of sephadex G-200 with borate 
buffer (pH 8). Three main peaks were obtained (Figure 25). The 
relative concentration of fractions in each peak was estimated 
using a spectrophotometer at an absorbence of 280 nm. Rat 
immunoglobulins of pooled fractions of each peak obtained were 
identified by double diffusion. Day 7 IgM was isolated using 
sephacryl S-300. Six ml of pooled . day 7 serum were eluted 
from a column of sephacryl S-300 with borate buffer pH 8 and 3 ml 
of the same pooled serum were eluted using the same column but 
with tris Nacl (pH 8). Four main peaks were obtained from each 
fractionation (Figure 26). Rat immunoglobulins of pooled 
fractions of each peak obtained were identified by double
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Figure 25:
Elution of IgG and IgM from a column of sephadex G-200.
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Figure 26:
Elution of serum proteins from a column of 
sephacryl S-300.
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diffusion.
Experiment 5 (x) 
Ouchterlony (Double diffusion) test on IgG and IgM fractions
Rat immunoglobulins of pooled fractions of each peak 
obtained after fractionation of hyperimmune serum, day 7 serum or 
normal serum identified on sephadex G-200 or after fractionation 
of day 7 serum with sephacryl S-300 were identified by double 
diffusion test, against IgG, IgM and IgA. The fractions were 
tested either neat or diluted 1 in 10 or 1 in 100 in PBS. It was 
found that the first peak obtained in the fractionation of 
hyperimmune serum, day 7 and normal serum on sephadex G-200 was 
IgM (Fraction A), the second peak was IgG (Fraction B) and the 
third peak was albumin (Figure 26). The first and second peak 
obtained after fractionation of day 7 sera on sephacryl S-300 was 
IgM (Fractions A and B) and the third and fourth (Fractions C and 
D) was IgG (Figure 26). Some of the immunoglobulins could not be 
demonstrated when neat undiluted fractions were tested but could 
be when the fractions were diluted 1 in 10 (see Figure 27). The 
reason for this will be explained later in the discussion.
Experiment 5 (xi) 
The protective activity of hyperimmune serum IgM compared to 
hyperi mmune serum IgG and hyperimmune serum whole
The protective activity of the IgM fraction (Fraction A) and 
the IgG fraction of hyperimmune serum which was obtained in the 
same fractionation with sephadex G-200 (Fraction B) was compared 
in two experiments as follows:
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Figure 27:
Ouchterlony (double diffusion) test on day 7 IgG and 
IgM eluted from a column of sephacryl S-300 
compared to whole, normal serum.
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Experiment A
It was shown in a previous experiment that 1.5 ml of 
hyperimmune sera IgG and 1.5 ml of whole hyperimmune sera were 
protective. In this preliminary experiment, the same volume was 
used to compare the protective activity of hyperimmune sera IgM, 
hyperimmune sera IgG and whole hyperimmune sera as follows:
Twelve (nine female and three male) 4-5 week old 
splenectomised rats were injected with 1 x 1 0 ^  PRBC i.v. The 
rats were pooled and groups of three rats were injected with
1.5 ml of hyperimmune sera IgM, hyperimmune sera IgG or whole 
hyperimmune sera. A control group which received the same volume 
of normal sera was included. Hyperimmune sera IgG and whole 
hyperimmune sera were completely protective as described before. 
Hyperimmune sera IgM was partially protective. There was a delay 
in the onset of parasitaemia for 3-4 days (Figure 28A). The 
parasitaemia was patent on days 5-6 which increased subsequently. 
All hyperimmune sera IgM recipients had a severe infection and 
died on days 8-9 post infection. Normal serum recipients had a 
patent parasitaemia on day 1 and a severe infection and they all 
died on days 4-5 post infection.
Experiment B
In the above experiment, it was shown that 1.5 mis of 
hyperimmune sera IgM was partially protective. In this 
experiment hyperimmune sera IgM recipients were injected with the 
corrected volume of another batch of fractionated hyperimmune 
serum (fractionated with sephadex G-200) to allow for dilution 
during fractionation as shown in Table 5. The protective
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activity of hyperimmune sera IgM, IgG and whole hyperimmune sera 
was compared using volumes of IgG or IgM fractions of whole serum 
as mentioned in Table 5 as follows:
Eighteen (ten female and eight male) 5-6 weeks old 
splenectomised rats were injected with 1 x 1 0 ^  PRBC i.v. The 
rats were pooled, then groups of 4-5 rats were injected with 
0.9 ml of hyperimmune sera IgM, 1.4 ml of hyperimmune sera IgG or 
2 ml of whole hyperimmune sera. A control group which received 
2 ml of normal sera was included. Hyperimmune sera IgG and whole 
hyperimmune sera were strongly protective. No parasites were 
detected in blood smears taken over 28 days of observations. 
Hyperimmune sera IgM was partially protective (Figure 28B). 
There was a delay in the onset of parasitaemia for 4-6 days. The 
parasitaemia was patent between days 5-7 which increased 
subsequently and most hyperimmune sera IgM recipients died on 
days 10 and 11 respectively. Normal sera recipients had a patent 
parasitaemia on day 1 and a severe infection and they all died on 
days 5 and 6 post infection.
The protective activity of day 7 IgM compared to day 7 IgG and 
day 7 whole serum
The protective activity of the IgM fraction of day 7 serum 
was compared in three experiments as follows:
Experiment 1
In this experiment, the protective activity of the IgM 
fraction of day 7 serum and of the IgG fraction of the same serum 
which was obtained in the same fractionation with sephadex G-200
139
Figure 28A:
The protective activity of hyperimmune serum IgM
compared to hyperimmune serum IgG and whole
hyperimmune serum using 1.5ml of serum.
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Figure 28B:
The protective activity of hyperimmune serum IgM 
compared to hyperimmune serum IgG and whole 
hyperimmune serum.
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was compared. The protective activity of day 7 IgM and IgG was 
also compared with the protective activity of normal serum IgM 
which was also fractionated with sephadex G-200. The corrected 
volume of the fractionated sera was used as shown in Table 6.
The protective activity of day 7 IgM, IgG, whole serum and 
normal serum IgM was compared using the volumes of whole serum or 
IgG or IgM fractions of day 7 or normal serum mentioned in 
Table 6 as follows:
Twenty, five week old male splenectomised rats were injected 
with 1 x 10 PRBC i.v. The rats were pooled and groups of four 
rats were injected with 0.9 ml of day 7 IgM fraction, 1 ml of 
day 7 IgG fraction, 1 ml of day 7 whole serum, 0.55 ml of normal 
serum IgM fraction or 1 ml of whole normal serum. Day 7 IgM was 
strongly protective. Two of the four day 7 IgM recipients did 
not show any parasites in blood smears taken over 28 days of 
observation (Figure 29A). There was a delay in the onset of 
parasitaemia for 15 days in one day 7 IgM recipient. The 
parasitaemia was patent on day 16, subsequently increased, and 
the rat died on day 19 post infection. There was a delay in the 
onset of parasitaemia of 21 days in the other day 7 IgM 
recipient. The parasitaemia was patent on day 22 which was 
followed by a severe infection and the rat died on day 26 post 
infection. Day 7 IgG was partially protective. There was a 
delay in the onset of parasitaemia for five days (there was a 
delay in the onset of parasitaemia for four days when 0.65 ml of 
day 7 IgG was used in a previous experiment). Parasitaemia in 
all day 7 IgG recipients was patent on day 6. This subsequently 
increased and all recipients died between days 9 and 11 post
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infection. Day 7 (whole serum) was completely protective as was 
shown previously. Normal serum IgM recipients had a patent 
parasitaemia on day 1. This increased subsequently at the same 
rate as the normal serum recipients, and all rats in both groups 
died on day 4 post infection.
Experiment 2
In this experiment, the protective activity of the IgM 
fraction of day 7 sera and of the IgG fractions of the same sera 
which were obtained from the same fractionation with sephacryl S- 
300 was compared. It was shown in Chapter Three that 0.2 ml of
whole day 7 serum was partially protective (there was a delay in
the onset of parasitaemia for 11 days). In this experiment it 
was decided to use the same volume of day 7 whole serum (i.e. 
0.2 ml) and the corrected volumes of the fractions were worked 
out from this as shown in Table 7. The protective activity of 
day 7 IgM, day 7 IgG (fraction C), day 7 IgG (fraction D) and
day 7 whole serum, was compared using the volumes of IgM or IgG
fractions or whole serum recorded in Table 7 as follows:
Twenty (14 female and 6 male) 11 week old splenectomised 
rats were injected with 1x10^ PRBC i.v. The rats were pooled, 
and groups of four rats were injected with 0.35 ml of day 7 IgM 
(Fractions A & B), 0.18 ml of fraction C, 0.2 ml of fraction D or 
0.2 ml of whole day 7 serum. A control group which received 
0.2 ml of normal serum was included. Day 7 IgM was partially 
protective using this volume (0.35 ml) (Figure 29B). There was a 
delay in the onset of parasitaemia of 6-8 days (day 7 IgM was 
strongly protective when 0.9 ml were used in a previous
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experiment). Parasitaemia in all recipients was patent on 
days 7-9 and two of the day 7 IgM recipients had a severe 
infection and died on days 1 2 and 1 3 post infection. The other 
two day 7 IgM recipients had a mild infection which lasted for 
five days and they subsequently recovered. No parasites were 
detected in blood smears taken from these two recipients on 
days 13 and 14 post infection. Day 7 IgG (Fraction C and 
Fraction D) were both not protective. Recipients in both groups 
had a patent parasitaemia on day 1 which increased subsequently 
at the same rate as the normal serum recipients and rats in both 
groups died on day 5 post infection as did the normal serum 
recipients. Whole day 7 serum was strongly protective. Three of 
the four recipients did not show any parasites during 28 days of 
observation. One recipient however, had a patent parasitaemia on 
day 1 5 and a mild infection which lasted for four days, and it 
subsequently recovered. No parasites were detected in blood 
smears taken on day 18 post infection.
Experiment 3
In order to confirm that day 7 IgM was protective, the above 
experiment was repeated using a different batch of pooled whole 
day 7 serum which was also fractionated with sephacryl S-300. In 
this experiment, a group of recipients which received pooled 
fractions of day 7 (fraction A, B, C and D) was included. This 
was to test whether the pooled fractions would give the same 
protection as the IgM fraction, since it was shown in the 
previous experiment that day 7 IgG (fractions C and D) was not 
protective, and to confirm therefore that protection in the
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pooled fractions was contained in the IgM. The same volume of 
whole day 7 serum (i.e. 0.2 ml) was injected into recipients as 
above and the corrected volume of the fractions injected was 
worked out from this as shown in Table 8.
The protective activity of day 7 IgM (fraction A and B), 
day 7 IgG (fraction C and fraction D), day 7 (fractions A, B, C 
and D pooled) and day 7 whole serum was compared as follows:
Twenty two (13 female and nine male), 5-6 week old
7
splenectomised rats were injected with 1 x 10 PRBC i.v. The 
rats were pooled and groups of 2-4 rats were injected with 0.2 ml 
of day 7 IgM, 0.4 ml day 7 IgG (fraction C), 0.27 ml of day 7 IgG 
(fraction D), 0.87 ml of day 7 pooled fractions or 0.2 ml of 
day 7 whole serum. A control group which received 0.2 ml of 
normal serum was included. Day 7 IgM was partially protective 
using this volume (i.e. 0.2 ml). There was a delay in the onset 
of parasitaemia of 4-8 days although there was a delay in the 
onset of parasitaemia for four days in most recipients 
(Figure 29C). Parasitaemia was patent on day 5-9 (day 5 in most 
recipients), and subsequently increased. Most rats died on day 9 
post infection, one rat died on day 12 post infection. Day 7 
pooled fractions was also partially protective. There was a 
delay in the onset of parasitaemia for 5-7 days. Parasitaemia 
was patent on days 4-9 which subsequently increased and both rats 
in this group died on days 10 and 12 post infection. Day 7 IgG 
(fraction C and fraction D) were both not protective. Recipients 
in both groups had a patent parasitaemia on day 1 which increased 
subsequently at the same rate as the normal serum recipients and
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Table 5
Volume of H.S. orig inally fractionated 2 0 m l
Volume of H.S. IgM (frac. 1) obtained 
after concentration of pooled peak
9 m I
Volume of H.S. IgG (frac. 2) obtained 
after concentration of pooled peak
1 4 m l
Volume of H.S. (whole) injected 
into each recipient
2 m I
Volume of H.S. IgM injected 
into each recipient
0 . 9 m l
Volume of H.S. IgG (frac. 1) injected 
into each recipient.
1 . 4 m l
Table 6
Day 7 N.S.
Volume of serum fractionated 6 m I 1 4 m l
Volume of fraction obtained after 
concentration of peaks
FRA 1 
IgM
5 . 5 m l
FRA 2 
IgG
*
6 m 1
FRA 1 
IgM
1
7 . 5 m l
Volume of whole serum injected 
into each recipient
1 m I 1 m I
Volume of fraction injected  
into each recipient
IgM
0 . 9 m l
IgG 
1 m I
IgM
0 . 5 5 m l
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Table 7:
Volume of serum 
f r a c t i on a t e d 6 m 1
Volume of fraction 
obtained after 
concentration of each 
peak
Fractions obtained with 
seoha ? S-300
FRA 1 
IgM
FRA 2 
IgM
FRA 3 
IgG
FRA 4 
IgG
5 . 2 ml 5 . 2ml 5. 4ml 6 m I
Volume of fraction 
injected into each 
rec i p i ent
Pooledi
0 . 3 5 m l
i
0.1 8m I
l
0 . 2ml
Volume of whole day 7 
serum injected into 
each recipient
0 . 2ml
Table 8:
Volume of serum fractionated 3 m I
Volume of fractions obtained 
after concentration of pooled 
peaks
FRA 1&2 
IgM
3 m I
FRA 3 
IgG
6 m 1
FRA 4 
IgG
4 m 1
Volume of whole day 7 serum 
injected into each recipient
i i i 
I I I 
I 0 . 2ml  I 
I I I 
I I I
Volume of each fraction injected 
into each recipient
1
0 . 2ml
1
0 . 4ml
1
0 . 2 7m
Volume of pooled fractions 
injected into each recipient 0 . 8 7 ml
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The protective activity of day 7 IgM compared to
day 7 IgG and whole day 7 serum using different
volumes of sera.
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all rats in both groups died on day 4 post infection as did the 
controls. There was a delay in the onset of parasitaemia of ten 
days in the whole day 7 serum recipients. Parasitaemia was 
patent on day 11 and the rats suffered a severe infection. All 
rats in this group died days 14 and 15 post infection.
Protein assay
The concentration of IgG and IgM in day 7 serum was 
preliminary determined with fractions collected after 
fractionation of day 7 serum on sephacryl S-300. It was found 
that there is approximately 1.5 mg/ml of IgM in fractions A and B 
6 mg/ml of IgG in fraction C and 13 mg/ml in fraction D.
Discussion
In this chapter, the role of antibody in acquired immunity 
to divergens was investigated in splenectomised rats. The 
protective activity of IgM and IgG fractions of hyperimmune sera 
and of sera collected immediately after recovery from a primary 
infection (day 7-8), and the IgG fraction of sera collected 3-4 
days after recovery from a primary infection (day 10) was 
compared. The protective activity of the IgG and IgM fractions 
of hyperimmune sera was first investigated. The data showed that 
the protective activity of hyperimmune serum was mainly contained 
in the IgG fraction of the serum. Similar findings have been 
reported for B. bovis in cattle (Mahoney, 1967a; 1979a). Mahoney 
(1979a) reported that there is a direct relationship between the 
protective activity of the antibody and its concentration in the 
serum. Although the concentration of antibody in whole 
hyperimmune serum was not determined, it was found however that a
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volume of 0.35 ml of hyperimmune serum was not protective. A 
volume of 1.5 ml and of 1.4 ml of both hyperimmune serum and 
hyperimmune serum IgG were completely protective. No parasites 
were detected in blood smears taken from both hyperimmune serum 
and hyperimmune serum IgG recipients during 28 days of 
observation.
The protective activity of hyperimmune serum by IgG antibody 
has also been reported for some malaria infections such as 
P. falciparum and malariae in humans (Cohen et al., 1 961), 
P. knowlesi in rhesus monkeys (Cohen and Butcher, 1970) and in 
rodent malaria in P. berghei infection (Diggs and Osier, 1969; 
Phillips and Jones, 1972; Green and Kreier, 1978).
The protective activity of the IgM fraction of hyperimmune 
serum was also investigated. The results have shown that 
hyperimmune serum IgM was partially protective compared to 
hyperimmune serum IgG. The degree of protectivity of hyperimmune 
serum IgM was, however, dependent on the volume administered. For 
example, a volume of 1.5 ml delayed the onset of parasitaemia for 
4-6 days, while a volume of 0.9 ml delayed the onset of 
parasitaemia for 3-4 days. Hyperimmune serum IgM recipients, 
which received either 1.5 ml or 0.9 ml, suffered, however, a 
severe infection and they all after died 4-5 days of patency. 
The concentration of IgG or IgM in the fractions injected was 
related to their physiological concentration in the whole 
unfractionated serum.
To test whether IgG in immune sera rather than hyperimmune 
serum was also protective the protective activity of the IgG
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fractions of immune sera collected on day 7 (immediately after 
recovery) and day 10 (3-4 days after recovery) was compared. The 
results have shown that day 10 IgG was strongly protective.
In order to check whether day 1 0 IgG or hyperimmune serum 
IgG retained any protective activity in the recipients, day 10 
IgG, hyperimmune serum IgG and whole hyperimmune serum recipients 
were challenged with a large number of parasites (1 x 10^ ) 4-5 
weeks after IgG or whole serum administration. All challenged 
recipients had a patent parasitaemia on day 1 which subsequently 
increased at the same rate as the control rat that had no serum 
at all, and all rats had to be treated on day 3 post challenge 
with the drug Diampron. Two conclusions were drawn from the 
challenge experiment. Firstly, the results have indicated that 
IgG in either day 10 or hyperimmune serum had no residual 
activity four weeks after administration. Campbell et al. (1956) 
reported that the half life of passively transferred rat gamma 
globulin is short lasting (6-6.5 days). Secondly, the results 
have also shown that volumes of 1.5 and 1.4 ml of hyperimmune 
serum IgG and a volume of 1.5 ml of day 10 IgG were responsible 
for the death of all parasites and it was apparent that no 
immunity had been acquired from the antigenic stimulus of the 
primary parasitaemia, as all challenged recipients suffered as 
severe an infection as the control rat.
The IgG fraction of sera collected immediately after 
recovery (day 7) was partially or not protective depending on the 
volume injected. For example, there was a delay in the onset of 
parasitaemia of five days when 1 ml was administered and a delay 
of four days when 0.65 ml were administered. Day 7 IgG
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recipients which received either 1 ml or 0.65 ml of IgG suffered, 
however, a severe infection and they all died 4-5 days after 
patency. Volumes of 0.4 ml and 0.18 ml were not protective, all 
recipients having a patent parasitaemia on day 1 and a severe 
infection which ended fatally. Day 7 whole serum was, however, 
more protective than day 7 IgG; a volume of 1 ml serum was 
strongly protective. A volume of 0.2 ml delayed the onset of 
parasitaemia for ten days. It should be noted that factors 
including the number of parasites in the inoculum at the time of 
administration of immune serum and the concentration of antibody 
in the serum might directly relate to the protective activity of 
antibody as was reported for bovis in cattle (Mahoney, 1979a).
The above results have shown that day 7 IgG was partially 
protective compared to whole day 7 serum. It is expected that 
during fractionation of the serum some of the immunoglobulins 
might be lost and this might affect some of the results, or there 
might be other factors in the whole serum which are responsible 
for protection other than IgG. The possibility that the IgM 
fraction of day 7 might be protective was investigated. The 
results indicated that the protective activity of sera collected 
immediately after recovery (day 7) was mediated by IgM antibody. 
No reports on Babesia or malaria infections have specifically 
demonstrated the role of this class of immunoglobulins in 
protection.
The degree of protection of IgM was dependent on the volume 
injected. The concentration of day 7 IgM fraction was determined 
and was found to be 1.5 mg/ml. The concentration of IgM in day 7 
serum was not, however, compared with its concentration in normal
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serum. Strong protective activity was observed when 0.9 ml of 
day 7 IgM was injected. The IgM fraction must have been 
responsible for the death of all or most parasites. The few 
parasites that remained in the circulation were not, however, 
affected by the protective effect of IgM antibody and multiplied 
normally, and led to the death of some hosts. This would explain 
the death of two hosts in this experiment on days 19 and 26. 
This is a common feature of immune sera as explained in the 
previous chapter and was also reported for other Babesia and 
malaria infections (Callow and Dalgliesh, 1982). The protective 
activity of day 7 IgM was confirmed when pooled fractions of 
day 7 serum which included IgM and IgG immunoglobulins were 
injected into recipients. The pooled fractions gave 
approximately the same protection as the IgM fraction (there was 
a delay in the onset of parasitaemia for 5-7 days) and confirmed 
that protection was mediated by IgM since it was shown that day 7 
IgG was not protective.
Immunoelectrophoresis and double diffusion tests have 
illustrated the presence of IgG and IgM antibodies after 
fractionation of day 7 serum. In some double diffusion tests, 
the presence of IgG or IgM could not be demonstrated when neat 
IgG or IgM fraction was used. This might be due to the presence 
of the highest level of antibody which is known as a prozone. 
IgG and IgM were demonstrated in this test when the IgG and the 
IgM fractions tested were diluted 1 in 10.
Passive transfer tests with the fractionated sera has, 
therefore, confirmed the role of serum gamma globulins in 
acquired immunity to B^ divergens in splenectomised rats. The
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protective activity of sera collected immediately after recovery 
(day 7) was mediated by IgM antibodies. The protective activity 
of sera collected 3-4 days after recovery (day 10) and of 
hyperimmune serum was mediated mainly by IgG antibody. IgM 
antibody in hyperimmune serum was, however, partially protection. 
Liddel et al. (1982), working on B. divergens "J" strain in 
gerbils reported a minor role for antibody in protection. They 
measured the antibody response in infected gerbils using IFAT and 
ELISA techniques and found that gerbils which received 10^-10^ 
PRBC died before an antibody response could be mounted. Animals 
which received less than 10 PRBC suffered prolonged infections 
which resulted in either death with little or no antibody 
formation, or death with significant levels of specific antibody, 
or recovery with no circulating antibody detectable. They 
suggested that these animals were able to eliminate infected 
cells before parasites were released and suggested the role of 
cell mediated immunity in eliminating infected erythrocytes. 
They also demonstrated that antibody was protective only when 
gerbils were immunised with inert Babesia antigens which were 
provided from cryostabilates, either prior to or concurrently 
with infection with intact viable parasites. Previously other 
workers also suggested a minor role for antibody in protection to 
some Babesia infections such as B. rodhaini (Roberts, 1968; 
Mitchell et al.1978 and B. microti (Allison et al., 1978) infections 
and a role of T cells has been suggested for protective immunity 
in these infections.
It can be concluded that antibody plays an important role in
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protective immunity against B divergens in vivo. Its mode of 
action is, however, unknown. Some aspects of the mechanism of 
action of antibody will be described in Chapter Seven.
In the next Chapter, the possibility that non splenic 
sources might take over antibody production and that other parts 
of the RES would have a major role in phagocytosis in 
splenectomised rats will be investigated.
Summary 'fable of Experiments 
Title Page no.
The protective activity of hyperimmune serum using 117
0.35 ml of serum (preliminary experiment)
The protective activity of hyperimmune serum using 2 117
ml of serum
The protective activity of day 4, 5, 6 and 8 sera 119
Isolation of IgG from hyperimmune serum, day 7, 123
day 10 and normal serum
Agar gel electrophoresis 123
The protective activity of hyperimmune serum IgG 1 26
compared to hyperimmune serum (whole) and normal 
serum IgG
The protective activity of day 1 0 IgG compared to 131
day 10 (whole serum)
The protective activity of day 7 IgG compared to 1 31
whole day 7 serum
Isolation of IgM from hyperimmune serum, normal 133
serum and sera collected on day 7 by gel filtration
The protective activity of hyperimmune serum IgM 136
compared to hyperimmune serum IgG and whole 
hyperimmune serum
The protective activity of day 7 IgM compared to 139
day 7 IgG and day 7 whole serum
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CHAPTER SIX
LIVER HISTOLOGY AND PRELIMINARY INVESTIGATIQNS CN THE 
RCXJS CF THE LIVER IN REMOVING PRBC'S
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Chapter Six
Liver histology and preliminary investigations on the 
role of the liver in removing FKBC's 
IOTRCDUCnCN
It was shown in Chapter Three that the course of a 
B. divergens infection in splenectomised rats was short-lived, 
and that the animals either died from the infection or recovered 
and were immune to challenge. The acquisition of acquired 
immunity was therefore not dependent on the presence of the 
spleen. The mechanisms by which the parasites or PRBC were 
removed from the circulation of immune splenectomised rats were, 
however, not known. It was also shown in a previous chapter, 
that antibody plays an important role in protection against the 
infection in splenectomised rats. In this chapter, the 
possibility that the liver is the major site of antibody 
production and that other parts of the RES would have an 
important role in phagocytosis were investigated in 
splenectomised rats that had recovered from the infection.
Since the liver is considered to be the second most 
important organ after the spleen where PRBC might be killed 
and/or phagocytosed (Jandl et al., 1965; Weiss, 1985), the 
possible removal of B. divergens infected cells or free parasites 
by the liver was investigated. This was by histological 
examination and by following the clearance of Cr^ labelled 
B. divergens infected cells from the blood and their possible 
uptake by the liver in immune splenectomised rats.
In this chapter, the effect of injecting irradiated and non-
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irradiated parasites into immune splenectomised rats was also 
compared, in order to determine whether it is the intracellular 
parasite or the free merozoite which is cleared by the immune 
animals. It is thought that irradiation of babesia parasites 
would inhibit parasite division, and therefore reduce the number 
of merozoites leaving the erythrocytes. That is, the injection 
of irradiated parasites into immune splenectomised rats should 
provide some evidence on whether infected cells and/or merozoites 
are phagocytosed.
It was shown in a previous chapter, that recovery from 
B. divergens infection in splenectomised rats was immediately 
followed by a pronounced leukocytosis which was predominately a 
lymphocytosis. It was not known whether lymphocytosis was due to 
newly formed lymphocytes entering the blood or due to altered 
patterns of migration to the different lymphoid organs. The 
possibility that lymphocytosis was due to newly formed 
lymphocytes was not investigated, but the possibility that 
lymphocytes might be accumulating in livers of recovered immune 
splenectomised rats was investigated through histological 
studies. Some preliminary immunohistological studies were also 
carried out on the livers of recovered splenectomised rats and 
will be briefly described in this chapter.
Experiment 6 (i): 
Clearance and organ uptake of Cr~^  labelled erythrocytes:
The aim of this experiment was to determine where PRBC were 
removed in splenectomised rats which survived the primary 
parasitaemia. Infected erythrocytes were labelled with Cr^ and
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their clearance from the circulation of immune splenectomised 
rats and possible uptake by the liver and lung was investigated 
as follows:
Twenty four (12 males and 12 females) 4-5 month old 
splenectomised rats were injected with 1x10® PRBC i.v. Blood 
smears were taken daily and the parasitaemia was followed. All 
rats had a patent parasitaemia on day 4 and a mild infection 
where parasitaemia did not exceed 8-10%, after which they 
recovered between days 3-9 post infection. Two weeks after 
recovery, the rats were divided into two groups and injected 
intravenously with 5x10® Cr^ labelled PRBC, or NRBC equivalent 
to the total number of erythrocytes in the infected RBC inoculum 
(see materials and methods for labelling and handling the RBC). 
A group of 24 (12 males and 12 females) naive splenectomised rats 
were included as controls. These control rats were also divided 
into two groups and injected i.v. with 5 x 1 0 ®  labelled PRBC or 
labelled normal erythrocytes equivalent to the total number of 
erythrocytes in the infected RBC inoculum. Two rats from each 
group were sacrificed at 30 minutes, 2.5, 5, 7.5, 10 and 24 hours 
post infection, and blood, livers and lungs were collected. 
Blood smears were also taken from the rats every 15-30 minutes. 
The clearance of Cr®^  from the circulation was calculated. The 
liver and lung uptake of labelled erythrocytes was also 
calculated as described in the materials and methods chapter. 
The results showed that there was no significant difference in 
the clearance of Cr®^  labelled PRBC or NRBC from the circulation 
of both immune and non immune rats (Figure 30). The clearance of
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Figure 30:
Clearance of Cr51 labelled PRBC after i.v. injection in 
immune g & ♦ and non immune o & ♦ splenectomised rats. 
Clearance of Cr51 labelled NRBC is represented by ■ & □ 
in immune rats and by 4 & a in non immune rats.
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Cr^ was gradual in both groups of rats that received either Cr^ 
labelled PRBC or NRBC. The results shown in the figure 
indicated, however, that at 24 hours the percentage of Cr^ in 
the circulation of immune or control rats that received labelled 
PRBC was less than (11-22%) the percentage of Cr^ that remained 
in the circulation of immune or control rats that received 
labelled NRBC (31-38%). Parasitaemias, as determined from blood 
smears, rose in non immune splenectomised rats, but decreased in 
immune rats and no parasites were detected in blood smears taken 
at 24 hours (Figure 31). There was also no difference in the
F~ 1
uptake of Cr by the livers of immune and non immune rats that 
received Cr^ labelled PRBC (Figure 32). There was, however, a 
higher uptake of Cr by the livers of immune and non immune rats 
that received Cr^ labelled infected cells compared to the uptake 
of Cr^ by the livers of both immune and non immune rats that 
received Cr~^  labelled NRBC (Figure 32). No noticeable uptake of 
Cr^ was observed in the lungs of immune and non immune rats 
(Figure 33). This experiment was repeated twice and the same 
results were obtained.
Experiment 6 (i±): 
The effect of injection of irradiated parasitised red cells into 
inrame and non inmune gpigngrH-rmi <»d rats
In the previous experiment, it was shown that it was not 
possible to determine whether the infected erythrocytes were 
removed by the livers of immune rats. The aim of the following 
experiment was to examine whether it was intact PRBC or free 
merozoites which are cleared by the immune rats. Irradiated and
160
Figure 31:
P e rc e n ta g e  p a ra s ita e m ia  re s u lt in g  from the
inoculation of Cr^^ lahpiipH pppp  :. «aDeuea PRBC in immune and non
immune splenectomised rats.
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Figure 32:
Liver uptake of Cr51 labelled PRBC after i.v. injection in 
immune a & ♦ and non immune n & ♦ splenectomised
rats. Uptake of Cr511 labelled NRBC is represented by ■
& a in immune rats and by a & a in non immune rats.
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Figure 33:
Lung uptake of Cr51 labelled PRBC after i.v. injection in 
immune -0- 0- and non immune -------   splenectomised rats.
Uptake of Cr511 labelled NRBC is represented by-o— o-in 
immune rats and by «------ 0 in non immune rats.
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non-irradiated parasites were injected as follows:
1. Preparation of imnune rats
Four (three male, one female) 4 month old splenectomised 
rats were injected with 1 x 10^ PRBC i.v. Blood smears were 
taken daily and the parasitaemia was followed. All rats had a 
patent parasitaemia on day 4 and a mild infection where 
parasitaemia did not exceed 10% after which they recovered on 
days 10-11 post infection.
2. Irradiation of parasites
Infected blood was irradiated as described in the materials 
and methods chapter. Some infected blood was not irradiated and 
received the same handling as the irradiated blood before it was 
injected into the rats.
3. Injection of parasites and collection of data
The immune rats were divided into groups of two. Four (two 
male and two female) splenectomised naive rats were included as 
controls and were also divided into groups of two. One group of
Q
immune and one group of control rats were injected with 1.2 x 10 
irradiated PRBC i.v. The other group of immune and control rats 
received the same number of non irradiated PRBC i.v. A blood 
smear was taken immediately from each rat and then every 15-30 
minutes for 12 hours and at 24 hours after the start of the 
experiment. The results shown in Figure 34 indicate that immune 
rats cleared irradiated parasites more rapidly than did normal 
rats. There was no obvious difference between the clearance of 
non irradiated and irradiated parasites in immune rats. Non
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Figure: 34
The effect of injecting Co60 irradiated parasites  
into immune -q- q- and non immune splenectomised
rats. Norm ai(Non i r ra d ia te d )p a ra s i te s  are
represented by in immune rats and by*— 6-in non 
immune rats.
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irradiated parasites multiplied normally in non immune rats. 
This experiment was repeated twice and the same results were 
obtained.
Experiment 6 (iii):
Histological and histochemical studies
It has been reported that the spleen is an important organ
in the initiation of primary antibody response and it is the main
site of phagocytosis of infected and uninfected erythrocytes
(Phillips, 1 969c). It has also been reported that splenectomy
reduces the level of antibodies against various antigens present
in the blood circulation (Winebright and Fitch, 1962; De Carvalho
et al., 1967). Since the liver was reported to be the second
most important organ in the RES where PRBC sequester in rats
(Ultmann and Gordon, 1965), the possibility that the liver would
take over the function of the spleen in antibody production and
phagocytosis of infected erythrocytes and/or free parasites was
examined in splenectomised rats. It was shown previously that
recovery from the infection in splenectomised rats was followed
by lymphocytosis. The possibility that lymphocytes might be
accumulating in the liver of immune rats was also investigated.
Histological studies were carried out on livers of splenectomised
and
rats that recovered from the primary infection^on livers of 
immune reinfected rats as follows:
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Experiment 6 (ill) A:
Liver histology in immune rats
A group of 10-12 male and female 4-5 month old 
splenectomised rats were injected with 1 x 1 0 ^  PRBC i.v. The 
rats had a patent parasitaemia on day 4 and a mild infection with 
a parasitaemia not exceeding 7-9% after which they recovered on 
day 10-11. The rats were reinfected one day after recovery with 
1 x 109 PRBC i.v. Blood smears were taken from the tail vein of 
the rats at 30 minute intervals. The course of parasitaemia is 
shown in Figure 35. Two rats were sacrificed at two hour 
intervals for 12 hours and their livers collected (see 
Figure 35). Impression smears were made from the livers of 
challenged rats and the rest of the tissue was cut into small 
pieces and processed for histology as described in the materials 
and methods chapter. Parasitaemia was 3.3 - 3.5% at 30 minutes 
(see Figure 35) and then started decreasing subsequently until no 
parasites were detected in blood smears taken 10 hours post 
challenge. In the liver sections of these rats an accumulation 
of cells was observed around the central veins (Figure 36A & B). 
All sections collected between 2 and 12 hours contained these 
accumulations, but they appeared large at seven hours. No 
parasitised cells or parasites were detected in impression smears 
made from the livers at the same intervals. Livers collected 
from naive splenectomised rats did not show any accumulation of 
cells (Figure 36D).
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Figure 35:
The course of parasitaemia in splenectomised rats
challenged with 1x109 PRBC one day after recovery 
from the primary infection.
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Figure 36:
Liver histology:
Accumulation of cells in livers of rats which  
recovered from the primary infection and in immune 
rats compared to naive rats.
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Experiment 6 (iii) B:
Liver histology in primary infection
In a series of experiments, groups of 4-5 month old 
splenectomised rats were injected with 1 x 1 0 ^  PRBC (avirulent 
blood). The parasitaemia in the rats was followed in blood 
smears taken daily. The rats normally had a mild infection which 
lasted for 4-5 days after which they recovered. Groups of 2-3 
rats were sacrificed during the infection (day 3) and at 
different times after recovery from day 6 to day 368 and their 
livers collected. The livers were processed for histology as 
described in the materials and methods chapter. Some pieces of 
livers were also snap frozen in liquid nitrogen after they were 
fixed in isopentane and then stored at -70°C. The liver sections 
showed accumulations of cells around the central veins 
as those described for immune rat (Figure 36A & B). All livers 
collected between day 3 and day 330 contained these accumulation 
of cells but they appeared large and most frequent between day 10 
and day 22. By day 368, these accumulations had largely 
disappeared (Figure 36C).
Experiment 6 (iv):
Tnrnmohistologica 1 studies
Preliminary immunohistological studies were carried out on 
livers collected on day 10 and 13 after the primary infection. 
The method followed is described in chapter three. The results 
showed that in livers collected on both days (i.e. day 10 and 
day 13) the cell accumulations consisted of B and T cells 
(Figure 37A & B).
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Figure 37:
Im m u n o flu o re sc en ce  for ana lys ing  B and T 
lymphocytes in livers of immune rats.
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Discussion
It has been shown in a previous chapter that splenectomised
rats either died from the infection or recovered and were immune
to challenge and it was concluded that the development and
persistence of acquired immunity was not dependent on the
presence of the spleen. In this chapter, the possible mechanisms
by which splenectomised rats survived the primary parasitaemia
were investigated. It has been reported that the spleen and the
liver are the major site of sequestration of infected red cells
in rats (Ultmann and Gordon, 1965). The possible removal of
B. diveraens PRBC by the livers of immune splenectomised rats
was, therefore, investigated. To study this possibility, the 
51clearance of Cr labelled B. divergens infected erythrocytes was
followed in splenectomised rats. The aim of this was to test
whether Cr^ labelled PRBC are cleared from the circulation of
immune rats, through uptake and phagocytosis by the liver. Cr^
51labelled PRBC or Cr labelled NRBC were transferred to recovered
(immune) or naive (non immune) splenectomised rats. It was 
51expected that Cr labelled PRBC would be removed more rapidly 
from the circulation in immune rats than in non immune rats, and 
they would be taken up by the livers of immune rats. The results 
showed that there was no significant difference in the clearance 
of Cr~^  from the circulation of immune and non immune rats which 
received either Cr^ PRBC or NRBC, although the parasitaemia in 
immune rats decreased subsequently until no parasites were 
detected at 24 hours. In contrast parasitaemia in the non immune 
rats continued to rise. The results, however, indicated that at 
24 hours, the percentage of Cr^ in the circulation of immune or
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control rats that received labelled PRBC was less than (11-22%) 
the percentage of Cr^ that remained in the circulation of the 
immune or control rats that received labelled NRBC (31-38%).
There was also no difference in the uptake of Cr^ by the 
livers of immune and non immune rats that received Cr^ labelled 
PRBC. There was, however, a higher uptake of Cr^ by the livers 
of immune and non immune rats that received Cr^ labelled PRBC 
compared to the uptake of Cr^ by the livers of both immune and 
non immune rats that received Cr^ labelled NRBC. This would 
therefore explain why the percentage of Cr^ that remained in the 
circulation of the immune or the control rats that received Cr^ 
labelled PRBC was less than the percentage of Cr~^  that remained 
in the circulation of the immune or the control rats that
C "1
received CrJ labelled NRBC. It is known from other studies
(Ebaugh et al., 1 953) that Cr^ labels the erythocyte
haemoglobin. It is also known that the erythrocyte haemoglobin
is removed in che liver after the disintegration of the red cells
where it is excreted as one of the bile pigments in the faeces.
It is possible, therefore, that the small uptake of Cr^ observed
in the livers of immune rats that received Cr31 labelled NRBC was
51because of the rapid excretion of the released Cr after it was 
removed from the liver. On the other hand, the higher uptake of 
Cr^ in immune rats which received Cr^ labelled PRBC may have 
been either due to the removal of PRBC by the liver where they 
were phagocytosed, or that the free merozoites were destroyed by 
antibody as they emerged from the erythrocytes and the damaged 
red cells containing the chromium were removed by the liver. The
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higher uptake of CrJ‘ by the livers of immune rats which received 
labelled PRBC might have resulted from the uptake into their 
livers of ruptured erythrocytes. The released merozoites must 
have invaded unlabelled erythrocytes and this was reflected in 
the rising parasitaemia in these rats. In immune rats, it is 
possible that the process of removal of infected erythrocytes or 
free merozoites happens very quickly. This may occur in the 
peripheral blood, as it was reported for P. falciparum (Trubowitz 
and Masek, 1968) in which the ingestion of merozoites by 
polymorphonuclear leukocytes was observed in blood smears taken 
from infected patients, or, by phagocytosis of parasitised 
erythrocytes by peripheral monocytes as was reported by Vernes 
(1980) in blood smears taken from children infected with 
P. falciparum in Gabon. Alternatively the PRBC could have been 
damaged through an ADCC through monocytes. An indirect evidence 
of ADCC has been reported for P^ chabaudi in mice (McDonald and 
Phi 1 lips,1978). Blood smears taken from rats that recovered from 
a divergens infection, did not, however, show any phagocytosed 
parasites or parasitised erythrocytes and impression smears 
taken from livers of immune rats did not show any parasites or 
parasitised cells phagocytosed by macrophages.
CM
Since the CrJ experiment did not show evidence that PRBC 
were removed by phagocytosis in the liver, irradiated parasites 
were injected into immune rats in another experiment to determine 
the stage of the parasite which is cleared by the immune rats. 
It is thought that irradiation, of babesia parasites would inhibit 
parasite division and therefore reduce the number of merozoites 
leaving the erythrocytes. The results showed that immune rats
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cleared parasites slightly more rapidly than did normal rats. 
The similar rates of elimination of normal and irradiated 
parasites by immune rats might indicate that although the 
parasite is prevented from leaving the cell, it is still cleared 
from the circulation at the same rate as in the rats that were 
injected with normal non irradiated parasites. It is possible 
therefore that protective antibodies reacted with infected cells. 
The red blood cells and the parasites were then removed perhaps 
by lysis or phagocytosis and it was not necessary for the 
parasites to be extracellular to be destroyed. That is, immune 
splenectomised rats were therefore able to clear PRBC from the 
blood stream and that immunity was not specifically directed at 
merozoites. This would explain the higher uptake of Cr by the 
livers of immune rats and indicate that infected red cells might 
have been phagocytosed in their livers. Roberts and Tracey Patte 
(1 974) working on IL_ rodhaini in mice did similar work to that 
described above with irradiated parasites, and although they were 
uncertain about the method by which the parasites were killed in 
the infected mice, they speculated that parasites inside red 
cells were removed by lysis or phagocytosis.
The non specific RES system clearance has also been 
suggested in malaria, by examining the intravascular clearance of 
inert particles such as colloidal carbon, 1^  ^ 5 microagregated 
albumin, and ^^Tc sulphur colloid (Lucia and Nussenzweig, 1969; 
Sheagren et al., 1970; Kitchen and Diluzio, 1971; Loose and 
Diluzio, 1976), but, in Babesia, there are no reports of 
intravascular clearance of parasitised erythrocytes by the RES.
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Quinn and tfyler (1979) working on P. berghei in rats did similar 
work as described at the beginning of the discussion, where they 
examined the clearance of Cr^ labelled P^_ berghei infected 
erythrocytes in intact rats. They found that P. berghei infected 
erythrocytes were removed more rapidly from the circulation than 
uninfected erythrocytes. The accelerated clearance was more 
rapid in rats immune to P^_ berghei than in non immune infected 
rats. They observed that this accelerated clearance was 
dependent upon splenic uptake, but all differences in clearance 
rates were, however, abolished by splenectomy, since they found 
that the clearance rates were similar in both immune and non 
immune splenectomised rats. They also observed that the 
parasitaemia in splenectomised immune rats did not rise after 
challenge, while there was a continuous rise of parasitaemia in 
non immune splenectomised rats as was observed in the present 
study. These authors concluded that the ability of immune rats 
to resist challenge with P. berghei might depend upon mechanisms 
which are largely spleen independent. They are therefore in 
agreement with observations made in the present study, although 
no clearance of Cr*^ was observed both in rats immune to
C 1
B. divergens and in non immune rats. Cr appeared to be 
accumulating in the circulation and the reason for this is not 
known.
In the present study, the reason why there was no 
significant difference between the clearance of parasites by 
immune rats and non immune rats when irradiated parasites were 
injected into both groups of rats is not known. Studies on 
rodhaini (Phillips, 1970a;1971), B^ bovis (Mahoney et al.,
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1 973a), B^_ bigemina (Bishop and Adams, 1974), major (Purnell 
et al., 1978; 1979) and B. divergens (Lewis et al., 1979a), have 
demonstrated that when these Babesias were irradiated with a dose 
of ionising radiation sufficient to stop them reproducing, they 
still retained their capacity to induce a protective immune 
response in susceptible hosts. Wright et al. (1980) ^ working on 
B. bovis in splenectomised calves concluded that the cause of 
mild infections in these animals was due to the selection by 
irradiation of an avirulent parasite population, by killing the 
more virulent individuals. Similarly, Waki and colleagues 
(1 982), working on berghei in mice reported that a strain of 
P. berghei consisted of heterologous populations different in 
virulence and susceptibility to irradiation and concluded that 
parasites attenuated by irradiation lack a certain metabolic 
function. The same can be applied to the irradiated B^ divergens 
and it could be that B^ divergens parasites attenuated by 
irradiation differ in their metabolic activity and this perhaps 
would explain the lack of remarkable difference between the 
clearance of irradiated parasites by both immune and non immune 
rats.
It has been shown in Chapter Four that antibody plays an 
important role in protection. It is well known that the spleen 
plays an important role in antibody production and it is the 
major site of phagocytosis of infected and non infected cells as 
was reported for B^ rodhaini in rats (Phillips, 1969c). Phillips 
(1969c) suggested that in splenectomised rats, extra splenic 
sites in the rat can function in synthesis of antibabesial
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antibody. In the present study, in the absence of the spleen, 
non splenic sources must have taken over antibody production and 
other parts of the RES must have an important function in 
phagocytosis, but as was mentioned in the beginning of the 
discussion impression smears taken from livers of immune rats did 
not show any parasites or PRBC phagocytosed by macrophages. It 
was shown, however, in Chapter Three, that recovery from the 
infection was immediately followed by leukocytosis which was 
predominately a lymphocytosis. Histological studies on livers 
collected from immune rats gave evidence that lymphocytes are 
accumulating in this organ. Accumulation of cells at the central 
veins that had the appearance of "pseudofollicles" as described 
by Weiss (1985) in splenectomised gerbils infected with 
P. berghei, were observed in livers collected from immune rats, 
recovering from a primary parasitaemia and in immune challenged 
rats. In livers collected during or after recovery from the 
primary parasitaemia the accumulation of cells appeared in all 
livers collected between day 3 and day 330, but they appeared 
large between day 10 and day 22. By day 368, areas devoid of 
cells were observed but few cells could still be seen. In immune 
challenged rats, the accumulation of cells was seen in livers 
collected between two hours and twelve hours post challenge but 
they appeared large at seven hours.
Weiss (1985) reported that in immune splenectomised gerbils, 
the secondary splenic germinal centre function appeared to be 
taken over by these pseudofollicles. She reported that these 
pseudofollicles consisted of B cells, T cells and macrophages 
containing malarial pigments that were similar to pigment
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containing macrophages appearing in splenic germinal centres and 
concluded that the germinal centres and the hepatic follicles 
have a similar function i.e. secondary antibody response. In the 
present study preliminary histological studies on livers 
collected from immune rats have indicated that these 
accumulations of cells also consisted of B and T cells. The 
macrophage activity in these accumulations was not, however, 
tested. It was concluded therefore, that the leukocytes 
accumulating in this organ (i.e. the liver) might be very 
important in the development of acquired immunity to divergens 
in splenectomised rats. Similar observations have been reported 
for ?. yoelii (Playfair and DeSousa, 1982) and P. chabaudi 
infections (Kumararatne et al., 1987).
It has been reported for malaria infections that toxic 
oxygen metabolites produced by activated macrophages play an 
important role in the in vivo destruction of malaria parasites 
(Allison and Eugui, 1983; Dockrell and Playfair, 1984; Brinkman 
et al., 1 985). Brinkman et al. (1 985) reported that the 
production of these toxic oxygen metabolites by macrophages is 
enhanced by lymphokines secreted by antigen specific T 
lymphocytes (i.e. through a delayed type of hypersensitivity). 
Kumararatne et al. (1987) speculated that the accumulation of 
cells observed in mice controlling a P. chabaudi infection might 
be the major site for parasite destruction via a delayed type of 
hypersensitivity response. Similar mechanisms might therefore be 
important for the destruction of parasites in splenectomised rats 
controlling a B. divergens infection.
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CHAPTER SEVEN
THE ADAPTATION CF THE RAT ADAPTED STRAIN OF Babesia diveraens 
TO CONTINUOUS CULTURE IN RAT ERYTHROCYTES AND SOME ASPECTS CN THE 
MECHANISMS QF ACTION CF ANTIBODY in vitro
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Chapter Seven
The adaptation of the rat adapted strain of Babesia divergens 
to continuous culture in rat erythrocytes and seme aspects on the 
mechanisns of action of antibody in vitro
INTKODOCnCN
It was shown in Chapters Four and Five that immunity can be 
transferred with serum and that antibody plays an important role 
in protection in splenectomised rats. In recent years, methods 
for in vitro cultivation of malaria and Babesia have been 
developed and proved to be a laboratory tool for investigation of 
various aspects of human malaria and bovine babesiosis that were 
not possible before (Trager and Jensen, 1976; Levy and Ristic, 
1980).
In order to compare the protective activity of immune serum 
in vivo with its effect on parasite growth in vitro, a method for 
cultivation of B. divergens in rat erythrocytes was established. 
In this chapter, the adaptation of the rat adapted strain of 
B. divergens to continuous culture in rat erythrocytes is 
described. Some aspects on the mechanisms of action of antibody 
and on cellular immunity were also investigated in vitro, and the 
results will be described and compared with those reported for 
other Babesia and malaria species.
Experiment 7 (i)
Cultivation procedure
The rat adapted strain of B. divergens was obtained from a 
stabilate (WEP 37) which had been passaged several times in
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splenectomised rats before it was put into culture. The method 
for cultivation of divergens, using the Candle Jar technique 
(Trager and Jensen, 1976) was described in the materials and 
methods chapter. 3^ divergens was cultured continuously for six 
months in rat erythrocytes using this technique (Figure 38). The 
cultures were initiated with defibrinated blood from a 
splenectomised infected rat. The use of standard anticoagulants 
in blood collection, such as heparin, have not been tested, but 
it was found that cultures where blood was collected in heparin 
grew as well as those initiated with defibrinated blood 
(Phillips, personal communication). Parasitaemias exceeding 35% 
infected erythrocytes have been observed in cultures which were 
initiated with 2% infected red cells (Figure 39). At high 
parasitaemia the cultures became dark. Subcultures were made 
every 48-72 hours by diluting cultures which had reached a 10-12% 
parasitaemia, by 1 in 5 or 1 in 6 with normal rat erythrocytes. 
After eight weeks in culture (approximately 24-26 subcultures) 
the parasites still caused a severe disease in a splenectomised 
rat (Figure 40). The morphology of the parasite in Giemsa's 
stained blood smears was similar to that described in rat blood 
smears. Typically divergent forms, oval, rings and maltese cross 
forms were seen (Figure 39). At high parasitaemias, a large 
number of extracellular merozoites were noticed in blood smears 
taken from these cultures (Figure 39). These free merozoites 
were collected then frozen or used for other experiments as will 
be described later in the text.
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Figure 38:
Growth of B divergens  (rat adapted strain) in 
continuous culture. Arrows indicate subcultures 
(cultures diluted to 2%)
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Figure 39:
The morphology of B divergens in cultures with 
parasitaemia of 35%.
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Figure 40:
The effect of injecting 8 week 
cultures into a splenectomised rat.
50-
40-
30-
20 -
1 0 -
0 "
0
Rat d
T  ---------- 1   r
1 2 3
Days Post Infection
B. d i v e r g e n s
%parasitaemia
4
185
Experiment 7 (ii)
Modification of foetal calf serun (PCS)
Only two batches of FCS were tested in culture. Complete 
RPMI medium containing 20% of either FCS batch no.10F154SA for 
general use or heat inactivated FCS were tested. Both sera 
appeared to support parasite growth in culture and no difference 
in parasite growth was observed in either cultures 
(Figure 4' ). It was decided therefore to use one batch of FCS 
(10F*!54SA) for preparing complete media for feeding the cultures.
Experiment 7 (iii)
Length of storage of normal rat erythrocytes
The normal rat erythrocytes used for diluting the cultures 
were used either as fresh i.e. collected from a normal rat on the 
same day, or they were kept at 4°C for 1-3 weeks before they were 
used for diluting the cultures. Normal erythrocytes were washed 
three times in incomplete medium (Appendix B) at a speed of 300 g 
for five minutes. It was found that cultures diluted either with 
fresh rat erythrocytes or erythrocytes stored for 1-3 weeks both 
grew very well and no difference was observed in parasite growth 
in both cultures (Figure 42).
Experiment 7 (iv)
Recovery of eryupreserved cultures
The method for cryopreservation and recovery of Babesia 
cultures was described in the materials and methods chapter. 
Attempts to recover the cultures using the described method were
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Figure 41:
A comparison of the growth of B. d ivergens  in 
cultures containing FCS or heat inactivated FCS.
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Figure 42:
A comparison of the growth of of 
cultures containing fresh, normal 
or 2-3 week old rat erythrocytes.
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unsuccessful. After the addition of 0.5 mis of 4.5% saline and 
4.5 mis of 3.5% saline then centrifugation, a lot of haemolysis 
was observed. There was difficulty in resuspending the pellets 
of erythrocytes in incomplete medium since they tend to clump and 
even when they were resuspended in the medium, they all lysed 
after centrifugation (N.B.: parasites cryopreserved by this 
method were viable in vivo).
Experiment 7 (v) 
Recovery of cultures that were kept at low temperature (4^ C)
It was shown above that it was not possible to recover 
cryopreserved cultures. It was decided therefore to test the 
effect of low temperature (4°C) on the growth of cultures as 
follows:
Cultures with 15-20% infected erythrocytes were emptied into 
sterile tubes, spun at 300 g for ten minutes and the supernatant 
removed. The cultures were resuspended with fresh complete 
medium and kept at 4°C. They were then recovered after 4, 5, 8 
or 11 days. The cultures were spun and the supernatant was 
removed. A blood smear was taken from each culture where a large 
number of degenerated parasites could be seen. 50-100 ul of 
normal rat erythrocytes were added and a 10% suspension was made 
with complete medium. The cultures were placed in 35 mm petri 
dishes with 1.5 ml in each, and put in a candle jar and in a 37°C 
incubator. Blood smears were taken daily and the growth of the 
parasite was followed. The parasites started appearing on 
days 3-5 in cultures that were kept for 4-5 days at 4°C, and on 
days 6-8 in cultures which were kept for 8-11 days at 4°C
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(Figure 43). The parasite started multiplying normally and the 
cultures subsequently grew normally. A percentage of 20-25 or 
more of infected erythrocytes was eventually observed.
Experiment 7 (vi) 
Collection of free merozoites
Attempts to collect free merozoites from cultures in a OO2 
deprived atmosphere (Levy and Ristic, 1980; Winger et al., 
1987a, b) were unsuccessful. Cultures with 8-15% infected 
erythrocytes were deprived of CO2 by placing them on soda lime 
for 6-3 hours. No major decrease in the percentage of infected 
erythrocytes was observed, and few extracellular parasites were 
seen in blood smears taken from these cultures. Free merozoites 
were collected from cultures with a high percentage of infected 
erythrocytes (25-30%) without depriving them from CO2 as 
described in the materials and methods chapter. A large number 
of merozoites can be obtained in these cultures and they can be 
easily seen moving when a drop of the resuspended pellet is 
placed on a haemocytometer and a x 100 objective microscrope lens 
is used.
Experiment 7 (vii) 
Cryopreservation and recovery of free merozoites
The method for cryopreservation and recovering of free 
merozoites is as described in the materials and methods chapter. 
Some of the cryopreserved merozoites were recovered and tested in 
culture as follows:
A cryopreserved merozoite ampoule was thawed, and the
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Figure 43:
The effect of recovering cultures kept at 4°C  for 4, 
7 and 11 days.
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contents emptied into a sterile tube. This .7as spun at 1000 G 
for ten minutes, the pellet was resuspended in a small volume of 
complete medium and then added to a 10% suspension of normal rat 
eryhrocytes in complete medium. Blood smears were taken daily, 
and the medium changed daily. One or two free merozoites were 
seen in blood smears taken on day 3. On day 4, 1 -2 infected 
erythrocytes were seen. The number of infected erythrocytes 
started increasing (Figure 44), indicating that the parasite was 
multiplying and the cultures subsequently grew normally.
Experiment 7 (viii)
The effect of addition of immune or normal serum into culture
The protective activity of immune serum in vivo was compared 
with its effect on parasite growth in vitro. In this preliminary 
experiment, the effect of adding immune or normal serum into 
culture was investigated. The cultures were initiated with a 2% 
infected erythrocytes as described before, and 1.5 ml of cultures 
were dispersed in 35 mm petri dishes. 0.1 ml of either immune or 
normal rat serum were added to the cultures at 0, 24 and 48 hours 
to obtain an approximate concentration of 6-7% of immune or 
normal serum in culture. Duplicate cultures for testing the 
effect of immune or normal serum were made. Cultures which 
contained no serum were included as a control. Smears from the 
cultures were taken at 24, 48 and 72 hours and the percentage of 
infected red cells was determined. The results have shown that 
both immune and normal rat sera inhibited parasite growth 
(Figure 45). There was a slight increase in the percentage of 
infected erythrocytes at 24 hours in both immune and normal serum
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Figure 44:
The growth of B. d ivergens  free m erozoites  
recovered from liquid nitrogen in cultures
containing normal rat erythrocytes.
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Figure 45:
The effect of adding whole immune serum or normal 
serum into B. divergens culture.
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cultures. By day 3 most of the parasites in both cultures looked 
degenerated and were dying. Cultures that had no serum at all 
grew normally. This experiment was repeated and the same results 
were obtained.
Experiment 7 (ix)
1)16 effect of addition of heat inactivated immune and normal sera 
into cultures
It was shown in the above experiment that both immune and 
normal sera had an inhibitory effect on parasite growth in 
culture. The experiment was repeated, but this time immune and 
normal sera were heat inactivated at 56°C for half an hour before 
they were added to culture. This was to test whether destroying 
the complement activity in the sera has any effect on the 
inhibitory activity of normal serum in the cultures. 0.15 ml of 
either heat inactivated immune or normal sera were added into 
cultures (i.e. the concentration of serum in culture is 10%) at 
0, 24 and 48 hours, and the experiment was followed as above. 
There was an increase in the percentage of infected erythrocytes 
in cultures containing heat inactivated immune serum from 2% to 
4.8% on day 2 (Figure 46). The percentage of infected 
erythrocytes decreased, however, to 1.7% on day 3. A slight 
increase in the percentage of infected erythrocytes was noticed 
in cultures containing normal serum, but it decreased to 1.5% by 
day 3. It was concluded from the results that both heat 
inactivated immune and normal sera had an inhibitory effect on 
parasite growth in culture.
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Figure 46:
The effect of adding heat inactivated immune or 
normal serum into B. divergens cultures.
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Experiment 7 (x)
The effect of addition of the Ig fraction of immune or normal 
sera into culture
It was shown in the above experiments, that no difference 
could be detected between the cultures containing whole immune or 
normal sera or heat inactivated immune or normal sera. Both sera 
appeared to have an inhibitory effect on parasite growth, when a 
concentration of 6-7% or 10% of immune or normal serum was tested 
in culture although normal serum had no effect on parasite growth 
in vivo and was completely unprotective in splenectomised 
infected rats. In a series of experiments, the Ig fraction of 
immune and normal sera was isolated and its effect on parasite 
growth was compared in cultures. A brief explanation will be 
given on the Ig fractions isolated before describing the 
experiments. The Ig fraction of either immune or normal serum 
was obtained after sodium sulphate precipitation as was described 
in the materials and methods chapter. An 18% w/v sodium sulphate 
in sera gave a precipitate which is thought to contain most of 
the globulins. When this globulin is redissolved in PBS or 
RPMI, centrifuged and again precipitated with sodium sulphate to 
give a 14% w/v solution the precipitate formed is thought to 
contain pure immunoglobulins. After the precipitation of the 
18% and the 14% Ig's, the two supernatants left were not 
discarded but they were also tested in culture. In addition, 
whole immune and normal sera and their Ig fractions were dialysed 
against PBS to test whether the inhibitory activity in the sera 
or Ig fractions can be lost after dialysis. In a series of
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experiments, the effect of adding dialysed and non-dialysed whole 
immune and normal sera, dialysed Ig fractions of both sera (18% 
and 14%), and the supernatants obtained after each precipitation 
in cultures was compared as follows:
Experiment 1
In the following experiment, the effect of addition of 
normal serum Ig's (18% and 14%), whole normal serum dialysed 
(WSD), whole normal serum not dialysed (WSND) and the supernatant 
obtained after precipitating the 18% Ig's was tested in culture 
as follows:
Cultures were set up as described before (see 
experiment 7 (i)) with a starting parasitaemia of 2% and 0.1 ml 
(i.e. concentration of serum in culture is 6-7%) of either whole 
normal serum, the Ig fractions, or the supernatant obtained after 
precipitating the 18% Ig's were added to culture at 0, 24 and 48 
hours, and their effect on parasite growth was followed. 
Duplicates were made for each culture. The percentage of 
infected erythrocytes in cultures containing (18%) Igs increased 
slightly, but did not exceed 4% on day 3 (Figure 47A). WSD and 
WSND and the supernatant obtained after the precipitation of the 
18% Ig's were inhibitory to parasite growth. Cultures containing 
the 14% Ig's of normal serum grew normally and the rate of 
multiplication of the parasite was approximately the same as in 
the control cultures that had no serum at all.
Experiment 2
In this experiment immune serum Ig's (18%and14%), immune 
serum WSD and WSND and the supernatant obtained after the
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precipitation of the 18% Ig's were tested in culture as above. 
0.1 ml (6-7% serum in culture) of the immune serum or immune 
serum fractions were added to cultures and their effect on 
parasite growth was followed. The 18% Ig's, immune WSD and WSDN 
and the supernatant obtained after the 18% precipitation of Ig's 
were all inhibitory to parasite growth. In cultures containing 
the 14% Ig's of the serum, there was an increase in the 
percentage of infected erythrocytes which reached 10% on day 3, 
but the rate of multiplication was slower than cultures 
containing no serum at all (Figure 47B).
Experiment 3
In this experiment, the effect of addition of immune serum 
Ig's (18% or 14%) and immune WSND into cultures was compared with 
the effect of addition of normal serum Ig's (18% or 14%), and 
normal WSND. The volume of immune or normal serum Ig's (18% or 
14%) or immune or normal WSND added was, however, increased from 
0.1 ml to 0.15 mis (i.e. concentration of serum in culture 
increased from 67% to 10%). Cultures were set up as described in 
experiment 47A). Cultures containing no serum were included as a 
control. The results have shown that both immune serum and 
normal serum Ig's (18%) and immune and normal WSND were 
inhibitory to cultures (Figure 47C). In cultures containing 
immune or normal serum Ig's (14%), there was an increase in the 
percentage of infected erythrocytes which reached 12% on day 3 in 
cultures containing 14% Ig's of immune serum and 9% in cultures 
containing 14% Ig's of normal serum. Cultures containing no 
serum had a parasitaemia of 18% on day 3.
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Experiment 4
In this experiment, the effect of addition of immune serum 
(day 13) Ig’s (18% and 14%) and immune WSD or WSND into culture 
was tested as above, but the volume of the cultures was reduced 
and the volume of immune serum or fractions of immune serum was 
increased. This is to test whether a difference can be found 
between cultures containing the 14% Ig's of immune serum and the 
14% Ig's of normal serum since both immune serum Ig's and normal 
serum Ig's were found to support the growth of the parasite in 
culture (see experiments 1, 2 and 3). Cultures were set up as 
follows: 24 sterile well plates were used for preparing the
cultures instead of the 35 mm petri dishes. A total volume of 
500 ul of culture was added to each well which contained 50% 
(50 : 50 culture : serum) of whole serum or Ig fractions of 
immune serum. The effect of adding immune serum Ig's (18% or 
14%), immune WSD and WSND and the supernatants obtained from the 
first and second Ig precipitations (18% and 14%) was compared in 
culture. The results have shown that all Ig's (including 14%), 
immune WSD and WSND and the two supernatants obtained after 
precipitating the 18% and the 14% Ig's were inhibitory to 
parasite growth (Figure 47D). On day 3 a small number of 
degenerated parasites were seen in blood smears taken from all 
cultures. The control cultures that had no serum grew normally. 
A parasitaemia of 21% was obtained on day 3.
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higure 47A:
A comparison of adding 0.1ml of whole normal 
serum (WD or WND) immune serum 18% Ig's, normal 
serum 14% Ig's or normal serum (supernatant 1) to 
B. divergens cultures.
Figure 47B:
A comparison of adding 0.1ml whole immune serum 
(WN or WND) immune serum 18% Ig’s, immune serum 
14% Ig's or immune serum (supernatant 1) into B.  
divergens  cultures.
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Figure 47C:
A comparison of adding 0.15ml immune or normal 
serum (WSND), immune or normal serum 18% or 14% 
Ig’s into B. divergens cultures.
Figure 47D:
A comparison of adding 50:50 (serum to culture) 
immune serum  18% or 14% Ig ’s, immune serum 
supernatant 1 or immune serum supernatant 2. into 
B. divergens cultures.
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Experiment 7 (x)
Opsonisation test
The possible role of opsonising antibody in protection was 
investigated using hyperimmune serum and EL_ divergens infected 
cells or free parasites in the presence of peritoneal macrophages 
from normal rats. The results have shown that peritoneal 
macrophages did not phagocytose parasitised erthrocytes or free 
parasites in the presence of hyperimmune serum. No 
erythrophagocytosis of Babesia infected erythrocytes was detected 
in any of the serum dilutions used during 24 hours of 
observation. This experiment was repeated twice and the same 
results were obtained.
Experiment 7 (xi)
Merozoite neutralisation test
In the merozoite neutralisation test, the free merozoites 
were incubated with either immune or normal serum in a CO2 
incubator at 37°C for one hour before they were added into 
cultures. This is to test whether antibody in immune serum will 
neutralise the merozoites and to compare this with normal serum.
c
Following the period of incubation, 20 ul of merozoites (2 x 10° 
merozoites) in serum suspension, were added to 200 ul of cultures 
containing normal erythrocytes (the number of 
erythrocytes = 1.9 x 10®/well) using a 96 sterile well plate. 
The plate was incubated for 17 hours after which a blood smear 
was taken from each well. Blood smears were taken daily 
afterwards for 8-9 days and the medium in each well was also
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changed daily and replaced by fresh complete medium (Appendix B). 
The percentage of infected erythrocytes was compared with that of 
the control cultures containing no immune or normal serum. 
Infected erythrocytes were detected on day 3 in blood smears 
taken from cultures with immune serum. On the other hand, 
infected erythrocytes were detected on day 1 in blood smears 
taken from cultures with normal serum (Table 9). This 
experiment was repeated and the same results were obtained.
Experiment 7 (xii)
The effect of addition of immune spleen cells and peripheral 
blood mononuclear cells (PBMC)in the presence of immune serum in 
culture (The ADOC assay)
It was shown in previous experiments that no difference 
could be observed between the effect of addition of immune or 
normal serum on parasite growth in culture. With immune serum 
there was no evidence that antibody agglutinates merozoites and 
prevents their invasion in vitro. Evidence that antibody 
neutralises merozoites and prevents their invasion in vitro was 
demonstrated only by preincubating free merozoites with immune 
serum before adding them to cultures containing normal rat 
erythrocytes (see experiment 7(xi)). In the following 
experiment, the possibility that antibodies might only be 
protective in the presence of cellular elements was investigated. 
An antibody dependent cellular cytotoxicity assay (ADCC) using 
immune spleen cells or PBMC was set up in culture as follows:
Two five month old male intact (non splenectomised) rats 
were injected with 2.5 x 10^ PRBC i.v. The parasitaemia in the
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Table 9:
The Merozoite Neutralisation Test
% Parasitised erythrocytes
Culture No.^
U L N.S. Control
Days in L
c u ltu re 1 2 3 . 1 2 3 1 2 3
1 0 0 0 0.01 0.023 0.04 0.09 0.06 0.06
2 0 0 0 0.02 0.03 0.045 0.1 0.1 0.2
3 0.01 0.02 0.01 0.02 0.03 0.05 0.22 0.32 0.3
4 0.01 0.03 0.02 0.024 0.06 0.07 0.4 0.4 0.5
5 0.5 0.6 0.4 0.7 0.8 1 2.5 2 4.3
6 1.8 1.3 1.2 1.7 1.5 1.4 8.6 8 11.8
7 3.2 2.9 4.3 3 4 3 20.7 17.5 20.8
8 10 6.5 5.5 6.7 6.5 9.2 23 18.6 22
9 16.8 12 10 14.5 13.2 14.4 25 24 25
205
rats was followed in blood smears taken daily. The highest 
parasitaemia was observed on day 2 post infection (3-4%) and by 
day 3 the rats had recovered. On day 7 post infection both rats 
showed lymphocytosis. They were bled and their spleens removed 
aseptically. The spleens were considerably enlarged. Two normal 
uninfected rats were also bled and their spleens removed 
aseptically. Spleen cells and PMNC were prepared as described in 
the materials and methods chapter. The plasma of both immune ard 
normal blood was also kept after the separation of the PMNC. The 
trypan blue exclusion test has shown that 90% of either immune or 
normal spleen cells were viable. The parasites in the culture 
were adjusted to a starting parasitaemia of 1% and a 10% 
suspension was made with complete medium as described before. 
The parasite suspension was then dispensed in a 96 well sterile 
microtitre plate, and the appropriate number of spleen cells or 
PBMC (see Table 10) were added to make a total culture of 200 ul 
in each well. The plate was then incubated at 37°C in a candle 
jar. The medium was changed daily and an appropriate number of 
spleen cells or PBMC were added to each well at 24, 48 and 72 
hours. Blood smears were taken daily. A ratio of 5 : 1,2 : 1 
and 1 : 1 of immune or normal spleen cells or PMBC's to parasites 
were examined. Triplicate cultures were made for each ratio. 
The degree of the ADCC was determined by assessment of the rate 
of parasite multiplication in the presence of immune spleen cells 
or immune PMNC and serum and immune spleen cells or PBMC alone 
(i.e. cellular cytoxicity assay - CMC), compared to parasite 
growth in serum alone. It should be noted that in a previous 
experiment (results not shown), it was shown that 5% ratio of
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immune serum culture proved to be not inhibitory to parasite 
growth, and this was the concentration of immune or normal serum 
used in this experiment. The results showed that there was a 
delay in the appearance of infected erythrocytes for 5-6 days in 
cultures containing immune or normal serum and immune or normal 
spleen cells at a ratio of 5 : 1 with parasites. The percentage 
of infected erythrocytes increased subsequently every day in 
wells containing immune or normal serum and immune or normal 
spleen cells (Table 11). Infected erythrocytes were detected in 
cultures containing immune or normal serum and immune or normal 
spleen cells at a ratio of 2 : 1 and 1 : 1 with parasites on 
day 1 but the rate of multiplication in wells containing immune 
or normal serum and immune or normal serum at a ratio of 2 : 1 
with parasites was relatively slow compared to those containing 
immune or normal serum and immune or normal spleen cells at a 
ratio of 1 : 1 with parasites. Similar results were obtained in 
wells containing 5:1, 2 : 1  and 1 : 1 immune or normal spleen 
cells : parasites without the presence of immune or normal serum 
(CMC assay). No difference could therefore be found between the 
effect of addition of immune or normal spleen cells into culture. 
Parasites in wells containing immune or normal serum without 
cells and wells containing immune or normal PBMC with or without 
sera grew normally at a similar rate as the control cultures that 
contained no serum and no cells. A 26-30% infection of 
erythrocytes was obtained on days 8-9.
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The rat adapted strain of B^ _ divergens was cultured 
continuously for six months in rat erythrocytes using the candle 
jar technique (Trager and Jensen, 1976) and provided an 
opportunity to study some aspects of the parasite which were 
difficult to examine in the animal host. The candle jar 
technique has previously been used for the short term cultivation 
of microti (Bautista and Kreier, 1979; 1980), and B. bovis, 
B. bigemina and B. rodhaini (Timms, 1980). Attempts by Erp and 
colleagues (1978) to use this technique for the cultivation of 
B. bovis were, however, unsuccessful. Short term in vitro 
cultivation of B. bovis (Erp et al., 1978) was achieved in 
suspension cultures (spinner flasks). Later, continuous growth 
of B^ bovis in suspension cultures was achieved (Erp et al.,
1980) but this method was limited as the growth of the parasite 
was relatively slow and large volumes of culture medium were 
required. This problem was overcome by the development of the 
microaerophilous stationary phase (MASP) culture for the 
continuous cultivation of B. bovis (Levy and Ristic, 1980). This 
method was used for the cultivation of B^ divergens in calf 
erythrocytes (Vayrynen and Tuomi, 1982) and in bovine or gerbil 
erythrocytes (Konrad et al., 1984), major (Donnelly et al., 
1984), B. bigemina (Vega et al., 1985) and B^ odocoilei (Holman 
et al., 1988).
The cultures of B. divergens described in this chapter were 
initiated with fresh infected rat blood. A stabilate of infected 
rat blood was subpassaged into a splenectomised rat before 
introduction into culture. Attempts to recover stabilates of
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culture parasites were unsuccessful. Konrad et al. (1 984) also 
used fresh infected bovine or gerbil blood to initiate 
B. divergens cultures since they were unsuccessful in recovering 
stabilates of culture parasites. In contrast, cultures of 
bovis (Palmer et al., 1 982), B^ bigemina (Vega et al., 1 985) 
and B. odocoilei (Holman et al., 1988) have been initiated using 
cryopreserved cultures.
In the experiments described in this chapter, the use of 
standard anticoagulants such as heparin in the collection of 
blood for culture has not been tested and defibrination with 
glass beads was the only method used for blood collection. It 
was found in our laboratory, however, that cultures where blood 
was collected in heparin grow as well as those initiated with 
defibrinated blood (Phillips personal communication). Levy and 
Ristic (1980) also used blood defibrinated with glass beads for 
B. bovis cultures, since they found that collecting infected red 
blood cells into heparin inhibits parasite growth. Vega et al. 
(1985) however, used heparin for collection of blood for 
B. bigemina cultures, since they found that blood collected by 
defibrination with glass beads haemolysed rapidly and contained 
fewer infected red blood cells.
B. divergens was cultured in RPMI 1640 medium containing 20% 
FCS. The cultures were incubated at 38°C in a candle jar under 
similar conditions described for the cultivation of P. falciparum 
(Trager and Jensen, 1976) i.e. in reduced oxygen and 5% CC>2 
atmosphere. This atmosphere supported the growth of the 
parasite. Only RPMI 1640 medium was used in the cultures; other
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media were not tested. It has been reported, however, that 
medium 199 also supports the growth of divergens in calf 
erythrocytes (Vayrynen and Tuomi, 1982) and in bovine or gerbil 
erythrocytes (Konrad et al., 1984) and also for the cultures of 
B. bovis (Erp et al., 1978; 1980; Levy and Ristic, 1980) and 
B. odocoilei (Holman et al., 1988).
Both FCS and heat inactivated FCS supported good growth. 
Konrad et al. (1 984) reported that FCS does not support the 
growth of B^ divergens in bovine or gerbil erythrocytes in 
culture. The same percentage (20%) of deer serum was used for 
the cultivation of Babesia of the white tail deer (B. odocoilei) 
(Holman et al., 1988). Levy and Ristic (1980), however, reported 
that relatively high concentrations (40%) of normal bovine serum 
were required to support good growth of B. bovis in cultures and 
found that using a 20% concentration of normal bovine serum 
inhibited parasite growth. Konrad et al. (1984) also used 40% of 
bovine serum for B. divergens cultures. Vega et al. (1985) 
reported that concentrations of fresh normal bovine serum of 20 
to 50% were required to sustain growth of bigemina.
FCS was normally stored aliquoted at -20°C or kept at 4°C 
and used within a week. Trager and Jensen (1 976) reported that 
storage of freshly collected human sera for more than 2-3 weeks 
at 4°C was deleterious to P. falciparum cultures. For B. bovis a 
comparison was made between cultures containing freshly collected 
bovine serum and serum stored at 4°C for 2-3 weeks. It was 
concluded that the ability of serum to support babesial growth 
decreased with time (Levy and Ristic, 1981).
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The use of fresh normal rat cells or cells stored at 4°C for 
2-3 weeks for diluting the cultures both supported growth. 
Trager and Jensen (1 976) reported that human cells stored for a 
long period at 4°C (outdated cells) supported better growth in 
P. falciparum cultures. Levy and Ristic (1981) found, however, 
that storage of bovine blood for six days at 4°C resulted in half 
the babesial growth as compared to freshly collected red cells. 
Konrad et al. (1984) also reported that fresh bovine red cells 
were better for the growth of the divergens in culture than 
stored cells. In the present study, divergens does not appear 
to be affected by white blood cells are in culture, and their 
separation from infected blood was not carried out. Timms (1980) 
reported, however, that B^ bovis in culture was inhibited by 
white blood cells.
A 10% suspension of infected rat erythrocytes in complete 
medium supported good growth of B^ _ divergens in culture. This 
haematocrit was used for the cultivation of P. falciparum (Trager 
and Jensen, 1976) and for most Babesia species (Levy and Ristic, 
1981, Vayrynen and Tuomi, 1982; Konrad et al., 1984, Holman 
et al., 1988). Timms (1980), however, reported that a 40% 
suspension of red blood cells gave better results for B^ bovis 
cultures than a 10-12% suspension.
Parasitaemias exceeding 35% have been observed in cultures 
which were inhibited with 2% B^ divergens infected cells. The 
highest parasitaemia observed with cultures of the same parasite 
but in calf erythrocytes was 5-10% (Vayrynen and Tuomi, 1982), 
10-15% in bovine or gerbil erythrocytes (Konrad et al., 1984) and
5-14% where cultures were initiated and progressively diluted
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with gerbil erythrocytes in human or bovine erythrocytes (Pudney, 
1984). For other Babesia species, the highest parasitaemia 
observed was 38% for bovis (Levy and Ristic, 1980), 1.9% for 
B. bigemina (Vega et al., 1985) and 30% in odocoilei (Holman 
et al., 1 988).
At high parasitaemia, the cultures became dark red or black. 
The addition of fresh cells and fresh medium resulted in the 
reappearance of the bright red cells. Similar observations have 
been reported for B^ _ bovis (Levy and Ristic, 1 980) and 
B. divergens (Vayrynen and Tuomi, 1982) cultures. Levy and 
Ristic (1980) suggested that the darkening of erythrocytes in 
B. bovis cultures indicated a condition of low oxygen tension 
(deoxyhaemoglobin), and that the depletion of oxygen from the 
settled cell layer results from the parasite's metabolism since 
they noticed that cultures with less than 1 % infected red cell 
failed to darken. They suggested that the medium above the cells 
acts as a barrier to oxygen exchange and its depth is crucial to 
successful cultivation. They concluded that the culture 
conditions allowed the parasite to become established as a result 
of their metabolic activity which reduces the oxygen in the 
environment. In the present study, cultures with a low 
percentage of infected erythrocytes (1-5%) also failed to darken, 
which indicates that the conclusions suggested by Levy and Ristic 
(1980) for B. bovis cultures might also be applicable to 
B. divergens cultures in rat erythrocytes.
The morphology of Babesia in culture was identical with that 
of parasites from the host. Multiparasitisation of red blood
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cells was common and four parasites in each erythrocyte were 
occasionally seen in blood smears taken from cultures with a high 
parasitaemia. Similar observations have been reported for 
B. bovis (Erp et al., 1 980; Levy and Ristic, 1 980) and 
B. odocoilei (Holman et al., 1 988). Pudney (1 984) noted,
however, that B^  divergens cultured parasites were atypical and 
differed from those seen in the infected gerbil.
B. divergens cultured for eight weeks in rat erythrocytes 
showed no loss in infectivity and virulence when injected into a 
splenectomised rat. The rat suffered a severe infection and 
died. Similar results were obtained after eight weeks in culture 
for 3^ bovis, B. divergens and 3^ bigemina in cultures (Erp 
et al., 1 980; Vayrynen and Tuomi, 1 982; Vega et al., 1 985). In 
the present study no cultures after eight weeks (56 days) were 
specifically tested for their infectivity and virulence. 
Injection of babesia cultures into a splenectomised rat was, 
however, occasionally performed after eight weeks in culture and 
this was for clearing contaminated cultures. The contaminated 
cultures were inoculated into a splenectomised rat, the parasite 
multiplied and the contamination cleared. The parasite was then 
re-isolated in new cultures.
Babesia cultures stored in medium at 4°C for up to 11 days 
could be used to initiate new cultures. No cultures were kept at 
4°C for longer than this period. Erp et al. (1980) reported that 
B. bovis cultures can be stored at 4°C for up to 30 days. Konrad 
et al. (1985), stored cultures of erythrocytes parasitised by 
B. divergens or B^ major in medium cooled at 4°C for up to eight 
weeks. The ability to store Babesia parasites at 4°C provides a
215
convenient system and eliminates the need for continuous culture 
to maintain the parasite.
Smears taken from cultures with a high percentage of 
infected erythrocytes contained a large number of extracellular 
merozoites. Extracellular merozoites were collected from the 
cultures without depriving the cultures of CO2. Attempts to 
induce release of merozoites by depriving cultures of CC>2 were 
unsuccessful. Levy and Ristic (1980) reported that extracellular 
merozoites were rarely observed in cultures during the growth 
phase and the only way to collect free merozoites was to deprive 
them of CO2. Winger et al. (1 987a) also collected EL_ divergens 
free merozoites by depriving cultures of CO2 by the method 
described by Levy and Ristic (1980). In the present study, 
extracellular merozoites were collected from pooled cultures with 
a high percentage of infected erythrocytes by differential 
centrifugation. The final pellet contained a large number of 
merozoites. The merozoites were either used to initiate new 
cultures or were frozen in liquid nitrogen. Frozen merozoites 
remained infectious and would infect rat red blood cells in 
culture. The isolation of a large number of merozoites from 
cultures permitted the study of some aspects of the mechanisms of 
action of antibody as will be described later in the text.
Passive transfer experiments have demonstrated the 
participation of humoral factors in acquired immunity to 
B. divergens and confirmed the role of antibody in protection. 
The mechanisms by which antibody protects infected splenectomised 
rats are, however, unknown. Antibodies may inhibit the invasion
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of erythrocytes by merozoites or function as agglutinins or 
opsonins against infected erythrocytes or merozoites. Antibodies 
can also be protective in the presence of cellular elements i.e. 
through an ADCC mechanism. The possible role of opsonising 
antibody in protection against 3^ _ divergens was first 
investigated in vitro using hyperimmune serum and divergens 
PRBC or free parasites in the presence of normal peritoneal 
macrophages. No evidence was found for the role of opsonising 
antibody in protection. Opsonising antibody has been reported, 
however, to be protective in vitro in rodhaini (Rogers, 1974) 
and 3. canis (Ishimine et al., 1 979) infections, and was
speculated to be involved ijQ vivo in B^ _ bovis infections 
(Mahoney, 1979).
The development of a method for the continuous cultivation 
of divergens, has provided an opportunity to study further 
some aspects of the mechanisms of action of antibody and to 
compare its protective activity in vivo with its effect on 
parasite growth in vitro. The effect of addition of immune or 
normal serum on their Ig fractions into B. divergens cultures on 
parasite growth was studied. The Ig fractions of either immune 
or normal serum were precipitated with sodium sulphate to 1 8% 
w/v, and then further precipitated with sodium sulphate to 14% 
w/v. The 18% and the 14% Ig suspensions were not tested for the 
presence of immunoglobulins. It was expected, however, that the 
18% suspension would contain most of the Ig's and the 14% 
suspension would contain pure Ig's. Whole rat immune and normal 
serum inhibited parasite growth to the same extent as the 18% 
immunoglobulin fraction of both sera even with a concentration of
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6-7% of Ig fraction in culture. In passive transfer tests 
in vivo, protective activity was observed only in the 
unfractionated and the immunoglobulin fraction of immune serum. 
The portion of the serum that remained after the Ig fraction was 
precipitated with sodium sulphate (18% and 14%), retained 
inhibitory activity. In contrast, the 14% suspension was 
partially inhibitory to parasite growth. Cultures containing 
either 14% Ig suspension of either immune or normal serum grew 
although cultures containing 14% of immune serum did not grow at 
the same rate as the control cultures which contained no serum. 
A concentration of 50% of the 14% Ig's of both immune and normal 
serum were, however, inhibitory to cultures. The cause of the 
inhibitory effect of normal serum is not known, and even dialysed 
normal serum was toxic to the parasite indicating that the 
inhibitory activity was not lost during dialysis. Heat 
inactivating the serum did not reduce its non specific inhibitory 
effect. It was concluded, therefore, that normal serum is toxic 
to cultures. This was also observed in chabaudi cultures 
(Harvey and Phillips personal communication).
Evidence that immune serum (antibody) neutralises merozoites 
and prevents their invasion in vitro was demonstrated only by 
pre-incubating free merozoites with immune serum before adding 
them to cultures containing normal rat erythrocytes. The results 
showed that at least some of the merozoites were neutralised by 
antibody. This was evident by the fact that no infected 
erythrocytes were seen in blood smears taken from cultures for 2- 
3 days, whereas after incubation with normal serum, infected
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erythrocytes were detected after 24 hours of culture. 
Neutralisation of merozoites by antibody was also reported for 
B. bovis (Ristic and Levy, 1981) and for B. divergens (Winger 
et al., 1987a)in merozoite neutralisation assays after collection 
of cell free merozoites from 002 deprived MASP cultures.
An important antigenic determinant associated with 
protection appears to be localised on the surface coat of the 
merozoites (Miller et al., 1975; Mcntenegro-James et al., 1983). 
Miller et al. (1975) reported that merozoite agglutination in 
P. knowlesi infection was caused by the binding of surface coats 
of adjacent parasites. This coat which consisted of proteins or 
glycoproteins appeared in the plasma membrane of merozoites after 
it was exposed to culture medium both with or without serum. 
They concluded that antibodies directed against this surface coat 
are crucial for the reduced invasion of erythrocytes. Ristic and 
Levy (1981) confirmed the specificity of the merozoite 
neutralisation assay in B^_ bovis by pre-incubating immune sera 
with soluble antigens derived from B^ bovis cultures. They 
observed that there was a loss in the ability of the antibody to 
prevent in vitro infection of erythrocytes by B^ bovis 
merozoites. Montenegro-James et al. (1983), working on the same 
parasite also reported that merozoites deprived of their surface 
coat were incapable of invading erythrocytes.
The addition of immune or normal serum or the Ig fractions 
into B. divergens cultures, has indicated that it is difficult to 
correlate the protective activity of immune serum and its Ig 
fraction in vivo with its action on parasite growth in vitro. In 
some malaria and babesia infections, attempts have also been made
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to correlate functional immunity in vivo with the inhibitory 
activity of immune serum in vitro. Cohen et al. (1969), studied 
the effect of immune sera on the erythrocytic cycle of 
P. knowlesi in vitro and found that immune sera had no inhibitory 
effect of the growth of intraerythrocytic parasites but inhibited 
growth at the time of merozoite release from infected 
erythrocytes and reinfection of normal erythrocytes. Similar 
observations have been reported by Brown et al. (1970) and iMiller 
et al. (1975). In a later report, Cohen and Butcher (1970) 
reported that the in vitro inhibitory activity of immune sera in 
P. knowlesi infection was concentrated in the IgG and IgM 
fractions, and that the F(ab ) fragment of IgG was responsible 
for this inhibition and not the Fab or the Fc fragments. Butcher 
and Cohen (1 972) reported that immune serum neutralised the 
merozoites, and that this mechanism may function in vivo to 
eliminate malaria parasites. Bautista and Kreier (1979) working 
with B^_ microti in the hamster found that immune hamster serum 
alone inhibited parasite multiplications by preventing the 
invasion of red cells by the parasite in short term cultures. In 
further experiments Bautista and Kreier (1980), cultured 
B. microti over peritoneal macrophage monolayers with immune or 
normal serum. They concluded that opsonisation and phagocytosis 
is not the major cause of parasite death in the culture and 
suggested that immune macrophages produce a soluble factor which 
inhibits growth of B^_ microti in the presence of immune serum. 
Bautista and Kreier (1979; 1980) did not, however, correlate the 
inhibitory activity of immune serum with any functional immunity
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in vivo.
The importance of antimerozoite antibody in protection in 
Babesia and malaria infections was confirmed by the development 
of monoclonal antibodies against merozoites of these two 
parasites. Monoclonal antibodies were found to be protective in 
P. yoelii infection when passively transferred to appropriate 
animal hosts (Freeman et al., 1980), and were inhibitory to 
merozoite invasion in P. knowlesi (Deans et al., 1982) and 
B. divergens infections in vitro (Winger et al., 1987a or b ) .
Although a relationship between functional immunity in vivo 
and serum inhibitory activity in vitro was reported by Cohen and 
Butcher (1979) as described above, this correlation had not been 
demonstrated previously by other workers using the same parasite 
(i.e. P. knowlesi) (Miller et al., 1977; Butcher et al., 1978). 
Similarly, immune sera or purified IgG from P^ falciparum 
infected Aotus monkeys (Campell et al., 1979; Chulay et al.,
1981) and from chronically infected humans (Wilson and Phillips, 
1976; Brown et al., 1982) have been shown to inhibit parasite 
growth in culture. This inhibition was, however, always 
incomplete and obtained only with high concentrations of Ig. 
Fandeur et al. (1984) found that in Saimiri monkeys infected with 
P. falciparum, some Ig preparations showing high protective 
activity in vivo provided little or no inhibition of the parasite 
in vitro. In contrast, inhibitory activity in vitro was present 
in Ig preparations unable to be protective in vivo. Furthermore, 
they reported that protective antibodies are not active through a 
simple neutralizing mechanism, and they confirmed this when they 
found that the F(ab)^ fragments derived from protective Ig
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preparations were not protective, and they suggested the 
participation of cellular immune mechanisms for the control of 
the infection.
In the present study the lack of evidence that in vitro 
antibodies agglutinate merozoites and prevent them invading 
erythrocytes has led to the possibility that antibodies might 
only be protective in the presence of cellular elements. An ADQC 
assay using immune spleen cells or immune PMBC's in the presence 
of immune serum was set up in culture. A cell mediated 
cytotoxicity assay (CMC) (i.e. in the absence of antibody) using 
immune spleen cells or immune PMBC was also set up in culture and 
the results compared with the ADCC assay. In the ADCC assay, it 
was expected that immune spleen cells or PBMCs would damage 
target cells (i.e. infected erythrocytes or parasites) in the 
presence of immune serum. No parasites were detected in blood 
smears taken for 5-6 days in cultures containing immune serum and 
immune spleen cells and parasites at a ratio of 5 : 1. Parasites
were detected in blood smears taken on days 6-7 which multiplied
normally. This indicated that multiplication of divergens 
in vitro was reduced by the presence of specific antibody and 
immune spleen cells. These results, however, were found not to 
be specific for the immune spleen cells or immune serum, and 
similar results were obtained with the control cultures i.e. 
those containing normal serum and normal spleen cells and
parasites at a ratio of 5 : 1. The results also showed no
evidence of specific ADCC mediated by immune PBMCs. The 
parasites in these cultures multiplied normally as in the control
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cultures which contained no cells and no serum.
There was also no evidence of specific cell mediated 
cytotoxicity by immune spleen cells or immune PBMCs in the 
absence of specific antibody as similar results as those 
described above for cultures containing immune serum and immune 
spleen cells and parasites at a ratio of 5 : 1 were also obtained 
with cultures containing only immune spleen cells and parasites 
at ratio a 5 : 1. Since in the ADCC assay and the CMC assay, the 
cultures were followed for ten days, it could be expected that 
the similarity in the results obtained in the two assays might 
have resulted from the production of specific antibodies by 
plasma cells which constitute a population of spleen cells in 
cultures containing only immune spleen cells without immune 
serum.
The participation of cellular immunity associated with 
humoral factors in protective immunity has been suggested for a 
number of plasmodial species but there are no reports of the 
participation of ADCC in babesial immunity. Indirect
evidence of an increased ADCC activity in the spleen of mice 
during the second week of P. chabaudi infection has been reported 
(McDonald and Phillips, 1978), and in human peripheral blood 
mononuclear cells during P^ falciparum infection (Greenwood, 
1977). Direct evidence of ADCC by PBMCs have been reported for 
P. falciparum infection in humans (Brown and Smalley, 1980) and 
by spleen cells in P^_ berghei infection in rats (Orago and 
Solomon, 1986).
In the present study, it was observed that the spleens of 
immune rats from which spleen cells were prepared for the ADCC
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assay or the CMC assay were considerably larger than those of 
normal rats (controls). The cause of splenomegaly was not 
investigated, and although the studies in the present project 
were carried out on splenectomised rats, it is expected that in 
intact rats recovering from a B^ _ divergens infection, 
splenomegaly might have resulted from the accumulation of cells 
which would probably include lymphocytes and macrophages in the 
spleen as a result of immune response to parasite antigens. 
Splenomegaly has been reported in mice recovering from a 
B. microti infection (Allison et al., 1978). These authors 
reported that T lymphocytes were required for recovery. They 
found that splenomegaly following infection of nude mice is less 
than in intact animals and suggested that a thymus-dependent 
immune response to parasite antigens is important in 
splenomegaly. They confirmed this when they placed parasitised 
erythrocytes and immune spleen cells in diffusion chambers in the 
peritoneal cavity and found that the diffusion chambers were 
surrounded by a dense mass of cell infiltrates indicating the 
recruitment of these cells from the circulation. Previously 
Wyler and Gallen (1977) described the presence of a mononuclear 
chemotactic factor and a macrophage migration inhibition factor 
in the spleens of mice recovering from malaria infections and 
confirmed the accumulation of mononuclear phagocytes in the 
spleens of infected animals. Allison et al. (1978) suggested the 
possible formation of macrophages from precursors in the spleen, 
which is a haemopoietic organ in mice, contributes to the 
splenomegaly in parasitic infections.
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It was shown in the present study that antibody plays an 
important role in acquired immunity to divergens in vi (see 
Chapters Four and Five). It was also shown in chapter six that 
the livers of immune splenectomised rats showed the appearance of 
accumulation of cells around the central veins and preliminary 
histological studies showed that these accumulations of cells 
consisted of T and B lymphocytes. The lack of evidence that 
antibody agglutinates merozoites and prevents their invasion 
in vitro, the failure to demonstrate the role of opsonizing 
antibody and phagocytosis, CMC and ADCC by immune spleen cells or 
PBMCs suggests that recovery from B^ divergens infection in 
splenectomised rats is possibly mediated by T lymphocytes. The 
role of T lymphocytes in cell mediated immunity has been reported 
for a number of Babesia and malaria infections. T cells may act 
as helper cells in protective antibody production (Brown, 1971), 
be cytotoxic to parasites (Coleman et al., 1975) or perhaps be 
necessary for the release of non antibody factors which have an 
antiparasitic activity (Clark et al., 1976). Evidence for cell 
mediated immune mechanisms in Babesia also comes from the results 
of delayed skin tests (Banarjee et al., 1977), macrophage 
inhibition tests (Perez et al., 1977) and experiments involving 
natural killer cells (Eugui and Allison, 1980). In the present 
study, it is possible therefore that certain populations of T 
cells (T helper cells) acted as helper cells for the production 
of protective antibody, or they were responsible for the release 
of non antibody factors (lymphokines) which can activate 
macrophages. Non antibody factors released by T lymphocytes 
(lymphokines) and macrophages (cytokines) can inhibit the
225
development of parasites in the erythrocytes. Similar 
suggestions have been reported for B^_ microti in mice (Allison 
et al., 1978) and in hamsters (Bautista and Kreier, 1980). 
Allison et al. (1978) suggested that opsonisation of parasitised 
erythrocytes for phagocytosis can only be a contributory factor 
in immunity to microti in mice. They also failed to 
demonstrate lysis of parasites or infected erythrocytes by immune 
T lymphocytes or by an ADCC assay and suggested the release of 
non antibody factors by T lymphocytes which would have an 
antiparasitic activity. Bautista and Kreier (1980) suggested 
that opsonisation and phagocytosis was not the major cause of 
parasitic death in B^ microti cultures. They suggested that 
immune macrophages produce a soluble factor which inhibit growth 
of B^ microti and this is facilitated by the presence of immune 
serum.
Evidence of non antibody mediated immunity to Babesia and 
plasmodium species came from observations reported by Clark 
et aJ- (1977a; 1977b), Herod et aL (1978), Wood and Clark (1984) 
and Montenegro-James et al. (1985). These authors suggested that 
a non specific type of immunity mediated by soluble factors 
secreted by activated mononuclear phagocytes may be important in 
Babesia and human malaria. Clark et al. (1977a), proposed a 
hypothesis where they suggested that mononuclear phagocytes 
become activated by parasite derived antigens in the course of 
the infection and are stimulated to release products toxic to the 
parasite. Recently, Montenegro-James et al. (1985), using a 
microaerophilous stationary phase culture (MASP) for B^ bovis
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concluded that soluble products secreted by bovine blood 
mononuclear phagocytes activated by soluble antigens or immune 
complexes inhibit the in vitro growth of bovis, and suggested 
that a possible mechanism may involve alteration of parasite 
metabolism by the restriction of passage of nutrients into the 
host erythrocytes. These observations may therefore be 
applicable to divergens, and future investigations on the 
activity of these soluble non antibody factors will clarify their 
role in protective immunity.
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CHAPTER EIGHT
THE ADAPTATION OF TWO BOVINE ISOLATES OF B. divergens TO 
CCNTTNUCUS CULTURE IN RAT ERYTHROCYTES AND THE GROWTH OF 
B.divergens IN NON RAT ERYTHRQCXTES IN CULTURE
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Chapter Eight
The adaptation of two bovine i solates of B.divergens to 
continuous culture in rat erythrocytes and the growth of 
B.divergens in non rat erythrocytes in culture
mracDucncN
The development of a method for the long term cultivation of 
the rat adapted strain of B^ divergens in rat erythrocytes (see 
Chapter Seven) has provided an opportunity to adapt new babesia 
isolates for long term cultivation. In this chapter the 
adaptation of two bovine isolates of divergens to continuous 
culture in rat erythrocytes, and the suitability of erythrocytes 
from non rat species (gerbil and human erythrocytes) to support 
growth of Ih_ divergens in culture are described.
Experiment 8 (i)
The adaptation of bovine isolates to culture
Two isolates of B. divergens have been adapted to continuous 
culture as follows: Two bovine field isolates which had been
passaged into gerbils and then cryopreserved as stabilates 
designated as WEP 407 and WEP 417 (see Phillips et al., 1987) 
were used. On recovery from cryopreservation the isolates were 
subpassaged through two gerbils each (Figure 48), and then either 
put directly into culture with gerbil erythrocytes (after one 
more subpassage in a gerbil for each isolate) or rat 
erythrocytes, or subpassaged through a splenectomised rat for one 
day before going into culture (Figure 48 Part B) without any 
additional red cells. The cultures were prepared as described
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Figure 48:
The adaptation of two bovine isolates of B. d iv e rg e n s  
to continuous culture.
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for the rat adapted strain and triplicate cultures were made for 
each. Cultures initiated with parasites in rat erythrocytes grew 
(Figure 48 Part C) and subcultures were made from these every 48- 
72 hours by diluting them with normal rat erythrocytes 
(Figure 49). These cultures grew as well as the rat adapted 
ones, and the parasite was maintained continuously over a period 
of 75 days through 32 subcultures. The highest percentage of 
infected erythrocytes obtained was between 26-30% (Figure 50). 
After five weeks of culture, some cultures were used to infect 
spienectomised rats successfully (Figure 51), while the same 
isolates that were injected directly from gerbils to 
spienectomised rats did not grow (Figure 51) (Figure 48 Part D). 
No growth was observed in cultures initiated with parasitised 
gerbil blood in normal rat erythrocytes (Figure 52) or cultures 
initiated with parasitised gerbil erythrocytes in normal gerbil 
erythrocytes (Figure 52) (Figure 48 Part C). In blood smears 
taken from both cultures, the parasites appeared dead and 
degenerated and the cultures were discontinued from day 6.
The adaptation of the two bovine isolates to continuous 
culture was repeated and the same results were obtained.
Experiment 8 (ii)
In vitro growth of rat infected erythrocytes in human red blood 
cells
Some of the rat adapted cultures were initiated with human 
erythrocytes, and the effect of diluting infected rat erthrocytes 
with normal human erythrocytes was followed. Rat adapted 
cultures with a 10-12% infected erythrocytes were diluted 1 in 5
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Figure 49:
The growth of 2 bovine isolates of B. divergens  
(WEP 407 and 417) in continuous culture in rat 
ery th ro c y te s .
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Figure 50:
Morphology of B. divergens  in cultures of WEP 407 
and 417.
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Figure 51:
The effect of passaging WEP 417 isolate and WEP 
417 culture (5 weeks) into a spienectomised rat.
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Figure 52:
Dilution of B. divergens cultures of infected rat or 
g erb i l  e r y th r o c y te s  with  h o m o lo g o u s  or
heterologous cells.
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or 1 in 6 with normal 0 Rh+ erythrocytes to make a starting 
parasitaemia of 2%. A 10% suspension was made with complete 
medium containing 20% FCS, and triplicate cultures were prepared. 
The percentage of infected erythrocytes increased subsequently 
from 2% to 11-12% at 48 hours, and subcultures were prepared by 
diluting these cultures with normal human erythrocytes as 
described above. Duplicate cultures were prepared. The highest 
percentage of infected erythrocytes obtained was 3.7% in one 
culture (five days after subculture) and 11% in the other culture 
(seven days after subculture) (Figures 53 and 54). Subcultures 
were made from the culture with 11% infected erythrocytes. The 
highest percentage of infected erythrocytes in these subcultures 
was 6% at 48 hours after which the percentage of infected 
erythrocytes started decreasing, and the parasites looked dead 
and degenerated. The cultures were discontinued five days after 
the last subculture. The increase of the number of human 
erythrocytes in each subculture did not apparently support their 
growth. This experiment was repeated and the same results were 
obtained. The modification of the serum (i.e. the use of human 
serum instead of FCS) in the cultures was not tested.
Discussion
Two bovine field isolates of divergens which had been 
passaged into gerbils and then cryopreserved as stabilates have 
been adapted to continuous culture in rat erythrocytes. 
Stabilates that were subpassaged into gerbils and then into 
spienectomised rats before going into culture grew continuously 
as well as the rat adapted cultures for 75 days. Some of these
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Figure 53:
In vitro growth of B. divergens  (rat adapted) in 
human RBC.
SUBCULTURES (CULTURES DILUTED TO 2%)
co 2 0 "
<D
1 8 : 
16 “
u -
w 12-; 
o  1 0 "
CO .
■«—» 
>* o o
.c
S.
SUBCULTURE SUBCULTURE
CO
CO1_
CO
Q.
vO
£
CO
0)
0 1 2 3 4 5 6 7 8 9 1 0 1 1 1 2
Days In Culture
237
Figure 54:
The morphology of B. d iv e rg e n s  in cultures  
containing human erythrocytes.
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cultures were used after five weeks to infect spienectomised rats 
and parasitaemias as high as 52% were obtained. In contrast, 
parasites of the same isolates which had not been cultured but 
were injected directly from gerbils to spienectomised rats did 
not survive long. In addition, cultures that were initiated with 
parasitised gerbil erythrocytes in normal rat erythrocytes or 
cultures initiated with parasitised gerbil erythrocytes in normal 
gerbil erythrocytes did not support the growth of the parasites. 
It can be concluded therefore that the two bovine isolates that 
were cryopreserved in gerbil erythrocytes can be maintained 
continuously in culture only if subpassaged through gerbils into 
spienectomised rats and then cultured in rat erythrocytes. 
Cultures initiated with parasitised gerbil blood in rat 
erythrocytes did not, however, support the growth of the 
parasite. It appears therefore that gerbil erythrocytes are not 
suitable for maintaining the parasite in culture. These results 
are not in agreement with those reported by Konrad et al. (1984) 
and Pudney (1984) using the same parasite as the present study. 
Konrad et al. (1984) grew divergens in gerbil erythrocytes 
with bovine serum at a concentration of 40% in the medium. The 
suitability of human erythrocytes to support B. divergens growth 
in culture was also investigated. Some of the rat adapted 
cultures were initiated with human erythrocytes using RPMI 1640 
and PCS. Although the parasite was maintained for two weeks in 
culture, the cultures had to be discontinued after this period as 
the growth rate of the parasite started decreasing in each 
subculture, as the number of human erythrocytes used for diluting 
the cultures increased. It was concluded that human erythrocytes
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are unsuitable for the growth of divergens in culture using 
RPMI 1640 and FCS. Pudney (1984) reported that B. divergens can 
be cultured in human erythrocytes using medium 1 99 and bovine 
serum. In the present study, no attempts were made to test the 
growth of B. divergens in human erythrocytes using other media or 
sera. It can be concluded therefore that the growth of 
B. divergens in non rat erythrocytes (gerbil or human 
erythrocytes) depends on factors which might include the medium 
or serum used in the cultures, or it might depend on other 
unknown factors.
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CHAPTER NINE
GENERAL DISCUSSICN
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Chapter Nine 
General Discussion
Little is known about the mechanisms of immunity to 
B. divergens in its normal host, the bovine. The adaptation of 
this parasite to spienectomised rats (Phillips, 1984), has 
provided an opportunity to investigate the mechanisms of immunity 
to it in the rat model. There were two principle aims to this 
project : firstly, to investigate the mechanisms of immunity to 
the parasite in vivo, and secondly to develop a method for the 
in vitro cultivation of divergens which would subsequently be 
used for investigating immune mechanisms in vitro.
B. divergens could not be adapted to intact rats (Phillips,
1984). The course of infection in intact rats lasts only for 7-8 
hours after which the parasites disappear from the circulation 
indicating the importance of the spleen in natural resistance to 
the parasite. The spleen is a major site for phagocytosis of 
parasites and PRBC and for the initiation of the primary antibody 
response (Phillips, 1969c).
The course of infection in spienectomised rats was short 
lasting (5-6 days) and no recrudescences were observed after the 
primary patent parasitaemia. The rats either died from the 
infection which indicates that there was a total or partial 
failure in the initiation of an effective acquired immunity or 
they recovered, indicating that antibody production and/or 
phagocytosis in these animals was taken over by other parts of 
the RES. The recovered rats were immune to challenge.
B. divergens in spienectomised rats became virulent with
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increasing passages and the i.v. injection of 1.5 x 10^ PRBC 
resulted in a fatal infection, although previously the injection
O
of 1.5 x 10° PRBC of the avirulent parasites resulted in an 
infection from which most rats recovered. The inoculation of a 
decreasing number of virulent parasites resulted in an increased 
prepatent period, but the infection was fatal even when 1 x 10^  
PRBC were injected. 1 x 10^ PRBC was the lowest dose of 
parasites tested. It would be preferable, therefore, to titrate 
B. divergens in spienectomised rats further in order to examine 
whether the pathogenic effect of the disease would change.
The drug diampron was used to treat spienectomised infected 
rats after the parasite became virulent. Only a single injection 
at a dose of 30 mg/kg was enough to cure the animals. 
Challenging the treated animals with a large number of parasites
Q
(1 x 10 PRBC) i.v. one month after treatment showed that they 
were strongly immune. Babesia infections are typically of long 
duration (Carson and Phillips, 1981). It has been reported that 
sterile immunity plays an important part in the resistance of 
cattle to reinfection with B^ divergens (Joyner and Davies, 
1967), and with B. biqemina (Callow, 1967; Lohr, 1972). Sterile 
immunity has also been reported for B^ microti in mice (Cox and 
Young, 1969). Joyner and Davies (1967) reported that 
spienectomised calves were resistant to reinfection for as long 
as seven years. In the present study, the duration of immunity 
after drug treatment or in naturally recovered animals was not 
investigated. It would be worthwhile to examine the duration of 
immunity in naturally recovered and drug treated rats, in order 
to test whether sterile immunity plays a role in resistance to
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reinfection.
Immunity to Babesia is probably mediated by more than one 
mechanism (Allison and Clark, 1977). The mechanisms that 
eliminate babesia from the blood might include humoral factors 
and/or cell mediated factors. In the present study, passive 
transfer experiments with immune and hyperimmune sera have 
demonstrated the participation of humoral factors in acquired 
immunity to divergens in the rat. Passive transfer tests with 
the fractionated sera have confirmed the role of antibody in 
protection. Immediately after recovery from the primary 
infection protection was mainly mediated by IgM antibodies, and 
3-4 days after recovery it was mainly mediated by IgG antibodies. 
The protective activity of hyperimmune serum (2-3 infections) was 
mainly due to IgG. IgM antibody in hyperimmune serum was, 
however, partially protective. The concentration of IgG and IgM 
in hyperimmune and in immune sera was not determined. It is 
therefore necessary to determine the concentration of these 
immunoglobulins in immune and hyperimmune sera and to compare it 
with the concentration of immunoglobulins in normal serum in 
order to correlate between protection and the concentration of 
immunoglobulins in hyperimmune or iranune sera.
In passive transfer tests with immune sera, the level of 
serum protection reached a maximum between day 7 (immediately 
after recovery) and day 13 after which it declined rapidly and no 
protection was observed on day 53 post infection. It would be of 
interest to examine the levels of protective antibody after 
reinfection to check whether these levels change, although it is
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expected that the levels of protective antibody would be the same 
as those detected after the primary infection.
Antibodies to divergens were also detected by the IFA 
test. It was not possible to correlate protection with antibody 
levels measured by IFAT which demonstrated that part of the anti 
B divergens antibody repertoire is not protective. Development 
of a vaccine against B^_ divergens would require information on 
those particular antigens which induce the production of 
protective antibodies. Immunoprecipitation of soluble antigens 
of 3^ divergens with immune rat sera, sera with and without 
significant levels of protective antibody, followed by SDS 
electrophoresis, might indicate those antigens which specifically 
react with protective antibodies.
The monoclonal antibody technology invented by Kohler and 
Milstein (1 975) has permitted the identification of molecules 
relevant to protective immunity. Monoclonal antibodies have been 
raised against B^ bovis (Wright et al., 1 983) and B^_ divergens 
(Phillips et al., 1987; Winger et al., 1987a). Two of the 
monoclonal antibodies raised against the rat adapted strain of 
B. divergens (Phillips et al., 1987) proved to be protective in 
spienectomised rats. This might provide a means of identifying 
the protective protein or glycoprotein molecules from 
B. divergens using affinity chromatography techniques.
Spienectomised rats which recovered from a primary 
B. divergens infection were immune to challenge. The mechanisms 
by which parasites or PRBC were removed from the circulation of 
immune rats were not, however, elucidated. It has been reported 
that in the rat, the liver is the second most important organ
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after the spleen where parasites or PRBC sequester (Ultman and 
Gordon, 1965). The possible removal of PRBC by the livers of 
immune rats was investigated using Cr^ labelled PRBC. It was 
concluded from this experiment that either the parasites within 
the red cells were opsonised and then removed by the liver where 
they were phagocytosed, or the merozoites may have been destroyed 
by antibody as they emerged from the erythrocytes and the damaged 
RBC were removed by the liver. Impression smears taken from 
immune livers gave no evidence that parasites or PRBC were 
phagocytosed by macrophages in that organ. In another experiment 
irradiated parasites were injected into immune rats to determine 
whether it was intact PRBC or free merozoites that are cleared by 
the immune rats. It was concluded from this experiment that 
immune spienectomised rats were able to clear PRBC from the 
circulation and that immunity was not obviously directed to 
merozoites. The effector mechanisms which were responsible for 
the destruction or removal of PRBC are unknown. It is possible 
that effector cells can recognise PRBC in the circulation, as has 
been suggested for murine malaria (Allison and Eugui, 1983), 
through FcIgG receptors which can bind to PRBC in the absence of 
antibody, and such binding triggers C>2 production. This would in 
turn lead to the destruction of PRBC. It is also possible that 
the liver might be important for the destruction of PRBC and for 
the development of acquired immunity, since in the present study, 
histological examinations showed that leukocytes accumulate in 
this organ. These accumulated cells had the appearance of 
"pseudofollicles" as described by Weiss (1985) in spienectomised
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gerbils infected with P. berghei. Preliminary studies have shown 
that some of these cells consisted of B and T lymphocytes which 
indicate that they could be a source of antibabesial antibody. 
The presence of T lymphocytes indicate that they may act as 
helper cells in protective antibody production, be cytotoxic to 
parasites or perhaps be necessary for the release of non antibody 
factors (lymphokines) which were reported to have an 
antiparasitic activity (Clark et al., 1976). It is necessary, 
therefore, to identify the different subpopulations of cells in 
the liver which might be important for the development of 
protective immunity to divergens and to test the macrophage 
activity in this organ. The possible participation of T 
lymphocytes in protection was investigated in vitro as will be 
mentioned later in the discussion when describing B^ divergens 
cultures.
The acute parasitaemia was accompanied by severe anaemia 
evident as a drop in RBC counts. The cause of this anaemia was 
not investigated. It is expected, however, that some anaemia 
must have been caused by the vascular destruction of the RBC as 
the parasites leave the cells to invade other cells, or it might 
be due to immunological factors.
Recovery from the infection was immediately followed by a 
pronounced leukocytosis which was predominately a blood 
lymphocytosis. This could be the result of a rapid production of 
new lymphocytes or indicates that there was a redistribution of 
the lymphocyte pool as they move from the blood circulation to 
the lymphoid organs and return back to the blood stream. Similar 
blood lymphocytosis was described in spienectomised animals (Ford
247
and Smith, 1979). Histological studies gave evidence that 
leukocytes are accumulating in the livers of immune rats which 
indicate that lymphocytosis was due to altered patterns of 
migration of lymphocytes to the lymphoid organs.
The development of a method for the in vitro cultivation of 
B. divergens gave the opportunity to investigate some of the 
immune mechanisms in vitro. B. divergens was cultured 
continuously for six months in rat erythrocytes using the candle 
jar technique. Some aspects of the mechanisms of action of 
antibody were investigated in vitro. The role of opsonising 
antibody was tested using hyperimmune serum and divergens PRBC 
or free parasites in the presence of peritoneal macrophages. No 
evidence was found _in vitro for a role in protection. 
Investigations on the role of opsonising antibody can be repeated 
by altering the culture conditions i.e. using different medium 
and serum, by using other populations of macrophages such as the 
kupffer cells in the liver and by testing immune sera collected 
at different times after recovery.
The protective activity of immune serum in vivo was then 
compared with its effect on parasite growth in vitro. There was 
no evidence that antibody agglutinates merozoites and prevent 
them invading erythrocytes in vitro. Evidence that antibody 
neutralises merozoites was, however, demonstrated only by 
preincubating free merozoites with immune serum before adding 
them to cultures containing normal rat erythrocytes.
Fresh normal rat serum was toxic to the parasite in culture 
and it was difficult to differentiate between cultures containing
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immune or normal serum. Attempts to reduce the toxic effect of 
normal serum either by heat inactivation or by dialysing it 
against PBS before it was added into culture were unsuccessful.
The Ig fraction of normal and immune sera was precipitated 
with sodium sulphate. The Ig fraction was first precipitated 
with sodium sulphate to give an 18% w/v Ig's and then further 
precipitated with sodium sulphate to give a 1 4% w/v Ig's. The 
18% of both normal and immune serum were inhibitory to parasite 
growth in culture. The 14% Ig's of normal or immune serum did 
not, however, have an inhibitory effect on parasite growth in 
culture, indicating that the toxic effect of normal serum was 
lost in the 14% Ig's fraction. Investigations on the toxic 
effect of normal serum in culture are therefore necessary so that 
it would be possible to use it as a control in culture. The lack 
of evidence that antibody can opsonise parasites or PRBC and 
promote their phagocytosis by peritoneal macrophages, and the 
failure to demonstrate that antibody agglutinates merozoites and 
prevents their invasion in vitro has led to the possibility that 
antibody might only be protective in the presence of cellular 
elements. An ADCC assay using immune spleen cells or PMBC's gave 
no evidence of specific ADCC damage of parasites in vitro. A CMC 
assay in the absence of antibody also gave no evidence of 
specific killing of parasites in vitro. It is suggested 
therefore that a non specific type of immunity mediated by 
soluble factors secreted by activated macrophages might be 
important in protective immunity to Babesia in spienectomised 
rats. It has been reported for B^ bovis that soluble products 
secreted by mononuclear phagocytes, activated by soluble antigens
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or immune complexes inhibit the in vitro growth of B^_ bovis 
(Montealegre et al., 1985). The main advantage of 3. divergens 
cultures is the ability to collect a large number of free 
merozoites in the culture supernatant. This would provide an 
opportunity to collect a large quantity of soluble antigens. The 
presence of soluble factors secreted by mononuclear phagocytes 
could therefore be investigated and their effect on parasite 
growth could be subsequently tested in the presence of soluble 
parasite antigens and immune complexes. In addition, the ADCC 
assay can be repeated, by testing immune sera collected at 
different times after recovery or hyperimmune serum and by 
testing different ratios of spleen cells or PMBC's in culture.
It has been suggested that the appearance of intracellular 
damaged "crisis" parasites in humans infected with P. falciparum 
is due to crisis form factors (Jensen et al., 1982; 1983; 1984; 
Butcher et al., 1987) and tumor necrosis factor (Carlin et al., 
1 985) which are present in sera of humans immune to 
P. falciparum. These non antibody factors act as toxins leading 
to the death of parasites within host erythrocytes. It has been 
suggested that this factor may be a product of T cell activated 
macrophages (Jensen et al., 1984). It is possible therefore to 
investigate the role of these non specific factors (crisis form 
factor and tumor necrosis factor) using B. divergens cultures in 
the presence of immune serum.
It has been reported that immunogens consisting of soluble 
exoantigens collected from culture supernatants are prime 
candidates for babesiosis vaccines, because they are safe,
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effective and inexpensive (Levy and Ristic, 1 980; Montenegro- 
James et al., 1987), Vaccination with soluble babesia immunogens 
has been shown to induce solid clinical protection against 
homologous (Smith et al., 1979; 1981; Kuttler et al., 1982; 1983) 
and heterologous (Timms et al., 1983; Montenegro James et al.,
1985) parasite antigens. A similar approach could therefore be 
applied for divergens using soluble antigens collected from 
culture supernatants. The percentage of infected erythrocytes 
obtained by B. divergens cultures was relatively high (35%). 
This would provide a high concentration of antigens in the 
supernatant which could subsequently be used for immunisation 
trials in spienectomised rats similar to those described for 
B. divergens, in the mongolian gerbil Meriones unguiculatus 
(Winger et al., 1 987b). B^ divergens cultures can also be used 
to develop drug sensitivity assays similar to those developed for 
B. bovis cultures (Levy and Ristic, 1 981).
The development of a method for the long term cultivation of 
B. divergens in rat erythrocytes has provided an opportunity to 
adapt new babesia isolates for long term cultivation. Two bovine 
isolates of B. divergens were adapted for continuous cultivation 
in rat erythrocytes. These cultures grew as well as the rat 
adapted cultures. The adaptation of new isolates of B. divergens 
to continuous culture would provide a good system for 
investigation different aspects on babesiosis without the need 
for the animal host.
The suitability of erythrocytes from non rat species (gerbil 
and human erythrocytes) to support growth of divergens was 
also investigated. Cultures initiated with gerbil erythrocytes
251
did not support the growth of the parasite. Cultures initiated 
with human erythrocytes were maintained for two weeks and had to 
be discontinued after this period as the growth of the parasite 
was decreasing. It was concluded that gerbil and human 
erythrocytes are unsuitable for the growth of divergens in 
culture using RPMI and FCS. The suitability of non rat 
erythrocytes to support growth of the parasite in culture can be 
tested again using different medium and serum.
Advances in recombinant DNA technology offer another 
approach to the production of suitable vaccines. Immunity 
against the malaria parasite P*_ yoelii yoelii has been 
demonstrated using single peptides (Holder and Freeman, 1 981). 
Wright et al. (1983) speculated that the antigen they described 
for B. bovis, which is both small (44 x 10 daltons) and a single 
polypeptide chain can be ideal candidate for vaccine production 
using a recombinant DNA technology. Recombinant DNA technology 
might therefore provide an opportunity to search for a vaccine 
which will protect against the pathogenic stage of the infection.
In conclusion, antibody plays an important role in 
protection in vivo. Its mode of action is, however, unknown. 
Antibody dependent cellular mediated factors may be involved. 
Non antibody mediated factors might also play an important role 
in protective immunity to Babesia. This might be mediated 
through T cell activated macrophages which would lead to the 
death of the parasite within the erythrocyte. The liver might 
play an important role in protective immunity against
B. divergens in spienectomised rats. The adaptation of three
252
isolates of divergens for long term cultivation would 
facilitate the study of different aspects of babesiosis, as 
described in the text.
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APPENDIX A 
Phosphate buffers (PBS)
1. Giemsa's buffer
3 g Na2HP04
0.6 g KH2P04
Made up to 1 litre with distilled H20 
pH adjusted to 7.2 with 1N NaOH
2. Isotonic PBS 
Stock solution
60 g Na2HP04.12H20
13.6 g NaH2P04.2H20
8.5 g Nacl
Made up to 1 litre with distilled water 
0.9 saline 
9 g Nacl
Made up to 1 litre with distilled H20 
Buffer
40 ml stock
Jtede up to 1 litre with 0.9% saline and adjusted to pH 7.2
0.07M Phosphate buffer far isolation of IgG frcm serun 
on DEAE cellulose 
Stock solution (0.5M)
(a) 78 g NaH2P042H20 Each made up to 1 litre
(b) 71 g Na2HP04 with distilled H20
Solutions (a) and (b) mixed to obtain pH 7
140 ml of mixed stock made up to 1 litre with
distilled water to obtain 0.07M solution
254
Borate buffer pH 8
6.185 g Boric acid (BDH)
9.536 g Borax (Sodium tetraborate) Na^^Oy. 10f^O (BDH)
4.384 g Nacl (Formachem)
Made up to 1 litre with distilled ^ 0  
pH adjusted to 8 with 1N Hcl
0.1 M Tris Nacl pH 8 
12.11 g Tris (hydroxymethy 1) amino methane C^ H-| -j NO^
Made up to 1 litre with distilled ^ 0  
pH adjusted to 8 with 0.5 M Nacl (29.22 g)
Formal saline
8.5 g Nacl (Formachem)
100 ml Formalin (BDH)
900 ml Distilled ^ 0
3.5% .Saline
3.5 g Nacl (Formachem)
Made up to 100 ml in distilled ^ 0  and filter sterilised
4.5% Saline
4.5 g Nacl (Formachem)
Made up to 100 ml in distilled ^ 0  and filter sterilised
0.2% Saline (far lysing PRBC)
2 g Nacl (Formachem)
Made up to 1 litre with distilled ^ 0
Tris amnoniun chloride
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0.83 g NH4cl (BDH)
Made up to 100 ml with distilled H2O 
Tris (Boehringer Mannheim)
Made up to 100 ml 
pH adjusted to 7.6 with
1 part tris and mixed with 9 parts 0.83% NH^cl
Barbitone buffer (for inmunoelec±rqpharesis) pH 8.6
1. Tank buffer
1.38 g Biethylbarbituric acid (BDH)
8.76 g Sodium barbitone (BDH)
0.83 g Calcium lactate (BDH)
Made up to 1 litre with distilled water
2. Buffer for preparation of gel
0.55 g diethylbarbituric acid (BDH)
3.5 g sodium barbitone (BDH)
0.51 g calcium lactate (BDH)
Made up to 1 litre with distilled water
Add 10 g agarose 15 (Electron - BDH) to make a 1% (w/v) agarose 
in barbitone buffer (in a water bath 70-90°C)
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APPENDIX B 
Media
1. RPMI
Stock
10.4 g RPMI 1640 powdered medium (with L-glutamine)
(Gibco)
5.94 g N2-hydroxyethyl piperazine-N1 -2 ethane
sulphonic acid (Hepes) (Sigma)
Made up to 960 ml with distilled H20 and filter sterilised 
(Millipore filter size 0.22 Urn) and aliquoted into 100 ml 
bottles
RPMI for in vivo use
100 ml RPMI (stock)
4.2 ml 5% w/v NaHOO^ (filter sterilised)
0.25 ml gentcmicin sulphate (Sigma)
5 ml foetal calf serum (Gibco)
RPMI for culture
Incomplete RPMI
100 ml RPMI (stock)
4.2 ml 5% (w/v) NaHOO^ (filter sterilised)
0.25 ml gentomycin sulphate (Sigma)
Complete RPMI
80 ml incomplete RPMI
20 ml foetal calf serum (Gibco)
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2. Medium 199
9.6 g Medium 199 with Earle's salts and glutamine (Flow)
2 g glucose (BDH)
200.000 units benzil pencillin
100.000 units streptomycin
30 ml 6.6% (w/v) NaHCC>3 in distilled ^ 0
Made up to 1 litre with distilled ^ 0  and filter sterilised
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APPENDIX C
17.5% Sorbitol for recovering of eryopreserved PRBC
17.5 g Sorbitol (BDH)
Made up to 100 ml with distilled ^ 0  and filter sterilised 
Sorbitol glycerol for cxyopreservation of PRBC 
380 g glycerol (BDH)
29 g sorbitol (BDH)
6.3 g Nacl (Formachem)
Made up to 1 litre with distilled ^ 0  and filter sterilised 
10% DMSO in puck's saline (for cxyopreservation of merozoites)
1 g DMSO (Sigma)
0.2 g glucose (BDH)
Made up to 10 ml with puck's saline (Gibco)
APPENDIX D 
White cell diluting fluid
490 ml distilled ^ 0
10 ml glacial acetic acid (Analar - BDH)
Few drops crystal violet stain (Edward Gurr Ltd.)
APPENDIX E
Oocmasie blue stains and destains (for iranunoelectrcphoresis)
10 ml glacial acetic acid (BDH)
45 ml Methanol (BDH)
45 ml distilled water
0.5 g Coomassie blue (Sigma)
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Destain
10 ml glacial acetic acid (BDH)
45 ml methanol (BDH)
45 ml distilled water
Blue dextran 2000 
0.01 g blue dextran 2000 (Sigma)
0.5 g sucrose (BDH)
Add 10 ml distilled water
1% Bromphenol blue 
0.1 g bramophenol blue (BDH)
Made up to 10 ml with distilled water
APPENDIX F 
Fiooll hypaque (fear separation of PBMC)
34% Isopaque
20 ml Isopaque (NyCcmed UK Ltd.)
24 ml Sterile distilled water
9% Fiooll
9 g Ficoll 400 (Pharmacia)
Made up to 100 ml distilled water 
10 ml 34% isopaque are mixed with 21 ml 9% Ficoll and filter 
sterilised.
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